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Prokaryotic organisms employ various mechanisms for defending against parasitism by
viruses and other mobile genetic elements. One form of defense comprises the adaptive
immune systems derived from clustered, regularly interspaced, short palindromic
repeat (CRISPR) loci and CRISPR-associated (cas) genes. CRISPR-Cas immune systems
enable the acquisition of heritable resistance to specific mobile genetic elements on the
basis of nucleic acid sequence recognition, but do not necessarily discriminate between
target elements which are burdensome and those which are beneficial. My thesis is
concerned with the consequences of CRISPR-Cas immunity directed at a particular
breed of bacterial DNA viruses, known as temperate phages, which cause both harmful
(lytic) and benign (lysogenic) infections under different conditions.

Initial studies investigating prokaryotic CRISPR-Cas immunity seemed to indicate that
functional, DNA-targeting systems cannot stably co-exist with their target elements in
vivo. For example, in studies where immunity was directed at temperate phages, DNAtargeting CRISPR-Cas systems were found to prevent both lysogenic and lytic infections
except when targeting was altogether abrogated via mutation or inhibition of the
CRISPR-Cas system. The first part of my thesis work includes in vivo experiments which
challenged the generality of this view, with regard to the different types of DNAtargeting CRISPR-Cas systems. Namely, I demonstrated that a staphylococcal branch of
the ‘type III’ CRISPR-Cas systems is capable of tolerating lysogenic infections by
specific temperate phages which are otherwise targeted during lytic infections. I further

established that the capacity for conditional temperate phage tolerance results from a
transcription-dependent targeting modality which was not anticipated for this
particular DNA-targeting type III system. In contrast, I observed only the expected
genetic escape outcomes when temperate phages were targeted by a ‘type II’ CRISPRCas system with a transcription-independent (Cas9-based) DNA targeting modality.
These findings laid the groundwork for subsequent studies of CRISPR-Cas immunity to
phages in Staphylococcus aureus hosts, and guided my colleagues towards in vitro
characterization of the type III system’s transcription-dependent targeting mechanism.

CRISPR-Cas systems have been identified in about 50% of sequenced bacterial
genomes, and the factors which influence this distribution are still not fully understood.
My description of conditional tolerance by a staphylococcal, type III CRISPR-Cas
system illustrated that, in principle, these particular systems could stably co-exist with
their temperate phage target elements in lysogenic hosts while maintaining their ability
to protect against lytic infections. During the second part of my thesis work, I set out to
define additional phenotypic consequences for the lysogenized lineages of S. aureus
which maintain conditional tolerance, in an effort to better understand how this
phenomenon might influence the distribution and stability of type III systems among
natural isolates. Notably, I found that the maintenance of certain temperate-phagetargeting systems can incur fitness costs in lysogenic populations. I showed,
furthermore, that these costs are potentially greater if more than one temperate phage is
targeted in populations of double lysogens, but that they can be alleviated by mutations
which do not abrogate phage targeting during lytic infections. Collectively, these
findings imply that long-term maintenance of type III systems in natural populations of
lysogens might require additional evolutionary fine-tuning, particularly among lineages
which are prone to multiple infection.

This thesis is dedicated to my family and dear friends
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CHAPTER 1: INTRODUCTION

1.1

Implications of Horizontal Gene Transfer for prokaryotic evolution

The ‘vertical’ transfer of a genome from parent to progeny during reproduction can
result in the stochastic alteration of its sequence content via mutation. Mutations are a
source of genetic variation and may give rise to novel adaptive genotypes that can be
selected for during evolution. However, mutations occurring at random are more likely
to be deleterious than beneficial. According to Muller’s ratchet mechanism (Muller,
1932, 1964), genomic degeneration occurring via random mutation can drive an
organism to extinction in the absence of a recombination process to increase the chance
of reconstructing fully functional genomes (Felsenstein, 1974). This fate may be averted
through sexual recombination, as it is exhibited in extant eukaryotes (Figure 1-1A).
Moreover, sexual recombination offers an additional mechanism for generating novel
genotypes during reproduction, but it has evolved with reproductive barriers that help
to moderate the variation produced by ensuring that genetic exchanges occur between
closely related genomes (for example, within a species) (Seehausen et al., 2014). By
contrast, recombination can occur between more distantly related genomes through
horizontal gene transfer (HGT), which constitutes another key avenue for genome
diversification (Keeling and Palmer, 2008; Thomas and Nielsen, 2005).
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Figure 1-1. Genome evolution can result from vertical or horizontal transmission of
DNA.
(A) Schematic summary of genome evolution in a unicellular and haploid eukaryote
that reproduces sexually. Mutation can generate novel, mutant alleles (brown lines with
stars) within chromosomes during DNA replication, which may be either deleterious or
beneficial. Recombination between homologous chromosomes (yellow or blue) can
occur during a tetraploid zygotic stage, before any cellular division. Sexual
recombination in this manner provides opportunities for the removal of deleterious
alleles (red lines) as well as for the introduction of beneficial alleles (green lines). Both
processes occur vertically during reproduction. (B) Schematic summary of genome
evolution in a haploid and unicellular prokaryote that reproduces asexually. Mutation
may once again generate mutant alleles (shown as brown lines with stars) vertically
during reproduction of the prokaryote’s chromosome (blue); however, recombination
with exogenous sources of DNA (yellow) must occur through horizontal processes that
are not tied to reproduction.
2

Broadly speaking, HGT refers to the transmission of genetic material from one
organism to another, through processes that are not tied to reproduction. Following
physical transport into the recipient organism, genetic material may be incorporated
into the genome through recombination with the chromosome (or chromosomes) or
through autonomous replication as an episome. Evidence for HGT in eukaryotes has
accumulated over the years, but most reports involve free-living protists and fungi, or
endosymbionts inhabiting the cytosol of multicellular organisms (Dunning Hotopp,
2011; Keeling and Palmer, 2008). Meanwhile, the mammalian nuclear genome appears
to be well insulated from HGT, and this has been suggested to result from the isolation
of their germline cells in the gonads (Andersson et al., 2001). One could further
speculate that this represents an evolutionary strategy that helps to preserve genomic
fitness in mammalian lineages, as HGT can introduce deleterious mutations in addition
to those generated vertically and might be superfluous if sufficient recombination and
genetic variation is already achieved through sexual reproduction. However, for
unicellular, asexually reproducing organisms such as prokaryotes, HGT provides an
avenue for recombination that, in theory, can operate like sexual recombination in
averting Muller’s ratchet (Takeuchi et al., 2014), in addition to providing genomic
variation (Figure 1-1B). Stricter definitions of HGT, also known as lateral gene transfer
(LGT), may distinguish it from gene transfers that result in gene conversion or repair at
homologous loci (Ochman et al., 2000; Vos, 2009). In other words, HGT/LGT may be
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defined in certain contexts as only those transfers that introduce non-homologous (also
known as heterologous) sequences to a genome. When recombinations with
exogenously derived donor DNA are considered, however, both heterologous DNA
insertions and gene conversions/repair at homologous loci can result from the same
molecular processes (e.g., homologous recombination between related segments of
DNA) (Johnston et al., 2014; Vos, 2009). Therefore, the term ‘horizontal DNA transfer’
(HDT) can also be employed to describe, more precisely, the transfer of DNA from one
organism to another without distinguishing between outcomes (Croucher et al., 2016).
In practice, because relatively little is known about horizontal RNA transfer in
prokaryotes, the less stringent definition of HGT/LGT often invoked in the prokaryotic
literature (and throughout this work) is essentially synonymous with HDT. Sequencing
of diverse prokaryotic phyla and comparative genome analyses suggest the virtual
ubiquity of HGT, as well as its potential to drive rapid genome evolution through the
acquisition of novel genes en bloc (Dobrindt et al., 2004; Koonin and Wolf, 2008).
Notably, HGT appears to be a common route through which evolving pathogens
acquire particular traits, including resistance to antibiotics (Croucher et al., 2011).
Nevertheless, in the absence of reproductive barriers, the risk of introducing deleterious
information into the genome is theoretically greater with HGT than with conventional
sexual reproduction. For example, HGT can introduce mobile genetic elements (MGEs)
from unrelated organisms — such as transposons, viruses or plasmids — which can, in
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turn, parasitize the genome (Doolittle and Sapienza, 1980; Orgel and Crick, 1980). This
matter is further complicated by the fact that MGEs are themselves often vectors of
HGT in the prokaryotic domain, as I explain below.
Molecular mechanisms for prokaryotic HGT have been established using various
experimental systems, beginning with the discovery of pneumococcal capsule
acquisition (Griffith, 1928). Overall, three major categories have been studied
extensively in bacteria: conjugation, transduction and natural transformation.
Conjugation involves the direct transfer of DNA from a donor to a recipient cell during
physical contact through pili (Llosa et al., 2002) or pore-like structures (Grohmann et al.,
2003). It is typically orchestrated by conjugative plasmids or transposons that carry the
necessary genetic functions to ensure their own transfer through this process.
Transduction refers to the transfer of non-viral DNA encapsulated in viruses or viruslike particles. During lytic infections, the viruses of bacteria (known as phages) can
package parts of the lysing host genome into a few of their particles, and this DNA may
then be delivered to distant cells (Weinstock, 2002; Zinder and Lederberg, 1952).
Natural transformation involves the uptake of free DNA from the environment and
occurs after the recipient cell enters a physiological state known as ‘competence’
(Johnston et al., 2014). Although natural transformation of competent bacteria is a hostencoded process and usually results in unbiased DNA uptake, most known examples of
conjugation and transduction are tied to the activity of MGEs that need not benefit the
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host and can even be detrimental. Unlike typical genes that rely strictly on a host
genome for carriage, mobile genetic elements can propagate independently of host
replication. Therefore, their presence in genomes could reflect parasitism rather than
natural selection for their phenotypic contributions to host survival (Orgel and Crick,
1980). For example, although conjugative plasmids and transposons can carry adaptive
traits such as genes for antibiotic resistance that promote survival, horizontal
dissemination of these elements can occur even when they burden their hosts with
extraneous genetic cargoes that do not promote fitness or vertical transmission. Lytic
phages represent an extreme form of genomic parasitism in that they immediately
dispose of their host after the process of self-amplification. Hence, molecular barriers
that limit the spread of MGEs can directly contribute to prokaryotic survival (Labrie et
al., 2010; Makarova et al., 2013; Thomas and Nielsen, 2005). Some barriers, such as
abortive infection systems, offer highly selective resistance to lytic infection by certain
phages or classes of phages (Chopin et al., 2005; Depardieu et al., 2016; Labrie et al.,
2010). When considering the potential benefits of HGT, there appear to be tradeoffs
associated with generalized versus selective resistance mechanisms. For example,
although selective barriers do not necessarily offer resistance to diverse types of
elements, they are less likely to interfere with HGT outright. Among the known
prokaryotic defense mechanisms, restriction–modification (R–M) and CRISPR–Cas
(clustered, regularly interspaced short palindromic repeat–CRISPR-associated proteins)
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systems are distinct in that they can resist diverse MGEs while still offering selectivity.
Thus, both systems can safeguard against genomic parasitism without necessarily
interfering with HGT. These properties, furthermore, provide a central basis for the
comparisons to mammalian immunity discussed in this work.

1.2

Prokaryotic immune systems are optimized for selective resistance to MGEs

Across all domains of life, the fitness of an organism may be threatened by parasitic
interactions with foreign elements. Accordingly, organisms have evolved several
biological barriers that aid in the defense against parasitism. Physical barriers, such
as the cellular envelope and those at the surface of mammalian skin and mucosal
linings, repel foreign elements rather indiscriminately (McGuckin et al., 2011; Proksch et
al., 2008). Immune systems, by contrast, offer the potential to repel particular target
elements while tolerating others and can thus function as highly selective barriers.
However, the balance of selectivity must be well calibrated when relying on active
means of surveillance and resistance; a system that is too selective risks evasion by
pathogens, whereas one that is unselective risks damaging the host organism through
immunopathology. In this regard, the mammalian immune system serves as an
excellent example, with innate and adaptive activities (Medzhitov, 2007) that are
optimized to reliably combat parasitism and generally tolerate host constituents.
Prokaryotic R–M and CRISPR–Cas systems resemble the mammalian immune system in
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their ability to actively resist infectious elements with a high degree of selectivity, as
well as in their capacity for tolerance (Barrangou and Marraffini, 2014; Goren et al.,
2012; Tock and Dryden, 2005). In the following two subsections, I describe the core
mechanisms through which these systems achieve selectivity and ‘self’ tolerance via
nucleic acid surveillance within the cell. Analogy to features of mammalian immunity is
also considered in more detail.

1.2.1

Restriction-Modification systems

A minimal R–M system encodes enzymes with two activities: a restriction endonuclease
(REase), which cleaves double-stranded DNA upon recognition of specific target
sequences, and a methyltransferase (MTase), which modifies these sites through
methylation to prevent cleavage (Tock and Dryden, 2005). Depending on the type of
system, these activities may be associated with separate proteins, a complex, or a single
protein (for a comprehensive review on their nomenclature, see (Roberts et al., 2003)).
Recognition sites for an R–M system are typically palindromic sequences of 4–8 bp in
length — short enough to occur frequently in the genome of a prokaryotic organism at
random. Hence, without a nuclear envelope to insulate their genetic material from the
cytoplasm, prokaryotes use methylation to protect their chromosome and other native
DNA elements from attack by the REase. Meanwhile, the REase can provide immunity
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against invading genetic elements that have not had sufficient exposure to the MTase of
the cell, including the DNA of phages and plasmids (Arber and Linn, 1969) (Figure 1-2).

Figure 1-2. Schematic summary of antiviral defense mediated by Restriction–
Modification systems.
(A) Intracellular restriction endonuclease enzymes (REases; shown in red) cleave
injected viral DNA (black double helix) at short sequence motifs known as recognition
sites (pink boxes). Meanwhile, methyltransferase enzymes (MTases; shown in blue) can
modify DNA at the same recognition sites (appended with blue boxes) to prevent
cleavage by their cognate REase. The sequence specificity of a REase is hardwired for a
particular recognition site and thereby offers innate immunity to unmodified phages
that harbor these sites in their DNA. Whereas unmodified invading DNA is rarely
methylated fast enough to receive protection from restriction, modification is generally
effective in preventing cleavage of the host chromosome (bottom) and thus allows for a
rudimentary form of self and non-self discrimination.
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Thus, methylation provides the R–M system with an intrinsic basis for distinguishing
self from non-self, and each system is hardwired for surveillance of a particular
recognition sequence, similarly to pattern recognition by mammalian pattern
recognition receptors (Medzhitov, 2007). In these regards, R–M activities are akin to
mammalian innate immune functions and may have an analogous role in the resistance
against viruses and other MGEs (see (Vasu and Nagaraja, 2013) for a review on
additional functions that have been described for some of these systems).
R–M systems have been identified in about 75% of sequenced prokaryotes,
averaging roughly two systems per genome (Oliveira et al., 2014). As alluded above, the
relative ubiquity of their recognition sequences in DNA dictates that the selectivity of
the R–M system for foreign target elements must be primarily informed by methylation
patterns (although underrepresentation of recognition sequences can also occur (Rocha
et al., 2001)). However, this rudimentary mechanism for self and non-self discrimination
is particularly susceptible to host mimicry evasion paradigms (Damian, 1964); even
exogenous DNA may bypass restriction if it arrives pre-methylated (for example,
through modification in a neighbouring cell possessing the same MTase) (Bertani and
Weigle, 1953; Korona and Levin, 1993). In this scenario, the methylated foreign DNA is
effectively tolerated as a self-component and recognized by the host MTase during
subsequent rounds of replication. Therefore, an infectious MGE can propagate freely in
spite of REase surveillance once it manages to achieve methylation. In parallel,
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prokaryotic organisms may acquire resistance to these infectious elements through
other defense mechanisms, such as their CRISPR–Cas systems (Dupuis et al., 2013;
Hynes et al., 2014).

1.2.2

CRISPR-Cas systems

Among the two major classes of CRISPR-Cas systems, six distinct types (I-VI) and 19
subtypes (A-U) have now been defined (Makarova et al., 2015; Shmakov et al., 2017),
but they all share two key genetic components: a CRISPR locus and a set of genes that
encode Cas proteins. Cas proteins include nucleases that can degrade invading DNA or
RNA targets, and they identify their targets via base pair complementarity using small
RNA guides known as CRISPR RNAs (crRNAs) (Brouns et al., 2008; Gasiunas et al.,
2012; Jinek et al., 2012; Zhang et al., 2012). Depending on the class of CRISPR-Cas
system, crRNAs can function as guides in complex with a single effector protein or with
a multiprotein effector complex (Shmakov et al., 2017; van der Oost et al., 2014). Class I
CRISPR-Cas systems include the type I and type III systems that utilize a multiprotein
effector complex, while Class II CRISPR-Cas systems include the type II, type V, and
type VI that utilize a single protein effector. The crRNAs themselves are derived from
transcription of one or more CRISPR loci, which are structured as arrays of short
palindromic repeat sequences (~40 bp in length) that are intercalated with unique
sequences of a similar length, known as spacers (Figure 1-3). After being processed into
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Figure 1-3. Schematic summary of antiviral defense mediated by CRISPR–Cas
systems.
(A) CRISPR arrays are composed of alternating units of repeat sequences (black
squares) interrupted by unique spacer sequences (colored diamonds). Newly
encountered phage DNA sequences (boxed in red) can be incorporated as spacer DNA
within the host CRISPR array through the process of CRISPR adaptation, which
provides a genetic memory of past infection. Transcription of the CRISPR array
provides primary transcripts, known as pre-CRISPR RNAs (pre-crRNAs), which are
processed into short, mature species that each include a single spacer sequence. During
CRISPR–Cas targeting, Cas protein complexes are guided by individual mature crRNAs
to mediate the destruction of invading nucleic acids that harbor a matching target
sequence. By virtue of sequences in their flanking repeat elements, spacer DNA of the
CRISPR array is intrinsically spared from CRISPR–Cas targeting to prevent
autoimmunity (Marraffini and Sontheimer, 2010a; Shmakov et al., 2017; Wiedenheft et
al., 2012).
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minimal, mature species, each crRNA contains a single spacer sequence that specifies a
target for its Cas nuclease complex (Brouns et al., 2008; Carte et al., 2008; Charpentier et
al., 2015; Hatoum-Aslan et al., 2011). In this way, Cas nucleases can be programmed to
recognize diverse DNA or RNA targets, according to the spacer sequence of their
crRNA. Importantly, the spacer content of a CRISPR locus can be actively modified
through a process known as CRISPR adaptation (Barrangou et al., 2007) (reviewed in
(Amitai and Sorek, 2016; Jackson et al., 2017)). During this process, spacer DNA can be
acquired directly from an invading element for incorporation into the CRISPR locus
(Figure 1-3). This provides the cell with a novel target sequence for its Cas nucleases as
well as a genetic memory of the encounter to pass on to daughter cells. In this manner,
CRISPR–Cas function is particularly analogous to mammalian adaptive immunity.
However, it should be emphasized that memory acquired through CRISPR is fully
heritable, whereas newborn mammals are only thought to receive short-lived,
maternally derived passive immunity (Grindstaff et al., 2003). Furthermore, whereas the
mammalian immune system relies heavily on clonal deletion and anergy of self-reactive
cells to establish central tolerance (Kyewski and Klein, 2006), CRISPR–Cas systems do
not require such mechanisms because spacer sequence diversity is not randomly
generated but instead derived from invading genetic elements in an apparent
Lamarckian evolutionary fashion (Barrangou and Marraffini, 2014; Haerter and
Sneppen, 2012). Nevertheless, given that the spacer sequences in CRISPR loci are
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themselves perfect matches for the crRNAs they encode, additional mechanisms are
required to protect the CRISPR locus DNA from autoimmune responses (Marraffini and
Sontheimer, 2010b; Shmakov et al., 2017; Wiedenheft et al., 2012). In this sense, CRISPR
loci can be viewed as immune-privileged regions of the genome.
The majority of naturally occurring spacer sequences with known targets match
to viral elements, although matches to plasmids and other MGEs are also observed
(Brodt et al., 2011). A growing body of experimental work indicates that CRISPR–Cas
systems are indeed capable of resisting a wide range of MGEs targeted by their spacers
(Barrangou et al., 2007; Edgar and Qimron, 2010; Marraffini and Sontheimer, 2008;
Tamulaitis et al., 2014). Unlike R–M systems, which discriminate targets primarily
through methylation, CRISPR–Cas systems derive their selectivity first and foremost
from an exquisitely specific sequence recognition capability based on crRNA
complementarity. On the one hand, the spacer sequence of a typical mature crRNA is
20–40 nucleotides—presumably long enough to discriminate different target elements
on the basis of sequence alone. Accordingly, a phage- or plasmid-derived spacer
sequence is unlikely to specify targeting of the host’s own chromosome (generally not
exceeding ~5 Mbp for a prokaryotic genome (Koonin and Wolf, 2008)). On the other
hand, it has been shown that spacers engineered to specifically target the chromosome
appear to be lethally self-reactive (Bikard et al., 2014; Jiang et al., 2013a), so the
observation that self-targeting spacers rarely occur in nature might be explained by the
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immediate culling of cells that acquire such spacers — in a manner akin to clonal
deletion. Interestingly, however, experimental evidence indicates that spacer acquisition
is biased towards extra-chromosomal sequences from the outset (that is, even in the
absence of CRISPR–Cas target degradation), despite the overrepresentation of
chromosomal DNA by mass (Levy et al., 2015; Modell et al., 2017; Yosef et al., 2012).
Evidently, this bias helps to ensure that CRISPR–Cas surveillance processes display a
selective preference for foreign genetic elements, given that many types of HGT events
do not involve physical linkage of foreign DNA to the chromosome. The phenomenon
known as ‘primed’ CRISPR adaptation may also help to ensure that the adaptation
machinery is selectively directed towards foreign elements, and that robust immunity is
achieved in the face of recurring infections (Datsenko et al., 2012; Fineran et al., 2014;
Jackson et al., 2017; Musharova et al., 2017). This phenomenon is analogous to affinity
maturation and class-switching of antibodies in the mammalian immune system (Wabl
and Steinberg, 1996), in the sense that it can refine the CRISPR repertoire to ensure more
effective resistance during subsequent infections. Perhaps one distinction here,
however, is that antibody development can be driven by antigen-presenting cells
(Medzhitov, 2007) even after a particular infection is cleared, whereas primed CRISPRCas adaptation still requires re-exposure to the infectious element(s).
As discussed in section 1.1, while the uptake of DNA from exogenous sources
can introduce parasitic MGEs that compromise host fitness, it can also introduce
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beneficial genes (Croucher et al., 2016). Four of the six (I-VI) types of CRISPR-Cas
systems which have been classified to date (Makarova et al., 2015; Shmakov et al., 2017)
include systems that cleave the DNA of their target elements (Jinek et al., 2012; Samai et
al., 2015; Westra et al., 2012; Zetsche et al., 2015). It was therefore proposed that
resistance to foreign DNA elements by CRISPR-Cas systems could jeopardize the
survival of bacterial hosts which rely heavily on horizontal gene transfer (HGT)
(Marraffini and Sontheimer, 2008), and in turn promote the evolution of strains that do
not harbor CRISPR-Cas systems (Marraffini, 2013; Palmer and Gilmore, 2010). CRISPRCas systems are indeed absent from ~50% of sequenced bacterial genomes (Touchon et
al., 2016), despite evidence that they can be transferred horizontally (Chakraborty et al.,
2010; Godde and Bickerton, 2006; Horvath et al., 2009; Seed et al., 2013) and function in
heterologous hosts (Bikard et al., 2012; Brouns et al., 2008; Heler et al., 2015). Moreover,
the potential for genetic loss of CRISPR-Cas systems has been clearly demonstrated in
laboratory settings. For example, population bottlenecks imposed by antibiotics were
found to select for mutant or deleted CRISPR-Cas systems when a target element
carrying resistance to the antibiotic was introduced prior to treatment (Edgar and
Qimron, 2010; Fischer et al., 2012; Goldberg et al., 2014; Gudbergsdottir et al., 2011;
Jiang et al., 2013b). In this manner, tradeoffs associated with targeting of favorable
genetic elements could influence the distribution of CRISPR-Cas systems in wild
populations. It should be emphasized, however, that CRISPR-Cas systems were not
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found to impose a general barrier to HGT when evolutionary timescales were
considered in silico (Gophna et al., 2015)—perhaps owing to their optimizations toward
selectivity.
Fitness costs associated with the maintenance of CRISPR-Cas systems, including
those that result from ‘immunopathological’ self-targeting, have also been proposed to
influence the distribution of these systems (Goldberg and Marraffini, 2015; van Houte et
al., 2016; Vercoe et al., 2013). As mentioned above, previous studies have demonstrated
that chromosomal targeting by CRISPR-Cas systems in bacteria is severely detrimental
to growth and potentially lethal (Jiang et al., 2013b; Vercoe et al., 2013). Therefore, high
rates of CRISPR-Cas adaptation are potentially detrimental to the host, insofar as they
engender a greater risk of acquiring self-targeting spacers (Heler et al., 2017). In certain
cases, immunopathology may result from CRISPR-Cas immunity directed at temperate
phages that integrate into their host’s chromosome during lysogeny (Cady et al., 2012;
Edgar and Qimron, 2010; Goldberg et al., 2014). ‘Temperate’ phages are distinct from
strictly lytic ‘virulent’ phages in that they can establish an alternative infection state,
known as lysogeny (Lwoff, 1953), wherein the host is spared from lysis. Integrative
temperate phages, such as lambda-like (lambdoid) temperate phages, integrate into
their host’s chromosome as a so-called prophage upon establishment of a lysogenic
infection (Figure 1-4). The difference between the lambdoid temperate phage’s infection
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Figure 1-4. Summary of phage λ’s alternate infection pathways.
(A) Following injection and circularization of the λ genome (red), infection can follow
either a lysogenic or lytic pathway. During a lytic cycle, λ genomes are propagated and
packaged into phage particles, which are ultimately released via lysis of the host cell.
During a lysogenic cycle, the host is spared from lysis via repressor-mediated
immunity, and the λ genome is integrated into the bacterial chromosome (blue) as a socalled prophage. Subsequent rounds of cell division allow passive replication of the
prophage within the chromosome. During a process known as ‘prophage induction’,
phage λ can excise from a lysogen’s chromosome and re-enter the lytic cycle.
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states reflects changes in its transcriptional activity within the host, rather than
alterations of its DNA sequence (Johnson et al., 1981). Therefore, when CRISPR-Cas
immunity is directed at an integrative temperate phage, targeting of phage DNA may
occur at prophage loci in the event of lysogenization. In the next section, I briefly
summarize the transcriptional regulation that determines a lambdoid phage’s infection
state, as well as some other relevant features of lambdoid temperate phage biology.

1.3

Lambdoid temperate phages

Typically, the term ‘lambdoid’ is used to describe temperate phages of Escherichia coli
that are similar to phage λ (lambda) (Brüssow et al., 2004; Gottesman and Weisberg,
2004). The mechanisms of gene regulation (Dodd et al., 2005) and site-specific
integration (Kotewicz et al., 1977) that that are central to phage lambda’s lytic and
lysogenic life cycles have been characterized in extensive detail. However, these life
cycles are not specific to temperate phages infecting E. coli, and lambda’s mechanisms
therefore serve as more general models for understanding certain types of temperate
phages. In this work, I consider a temperate phage lambdoid if its prophage integrates
site-specifically, and if its life cycle decisions are principally determined by a cI-/cro-like
regulatory mechanism, or ‘genetic switch’, akin to that of phage lambda (Johnson et al.,
1981; Ptashne, 2011).
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Under typical laboratory conditions, the majority of lambda infections give
rise to a lytic cycle. A proportion of these infections, however, will lead to establishment
of a lysogenic cycle and prophage integration (Figure 1-4). This occurs when lambda’s
cI-encoded repressor accumulates early during infection to sufficient levels that repress
transcription of cro, a gene required for establishment of the lytic cycle (Casjens and
Hendrix, 2015). During lysogeny, cI expression remains on, and its repressive action
ensures that transcription of cro (and also as a consequence most of the phage genome)
remains off (Ptashne, 2011). In cases where cro was not sufficiently repressed, a lytic
cycle ensues. Under these conditions, the cro gene product—also a repressor—
accumulates to sufficient levels that prevent cI transcription, and thereby ensures that
expression of the other early-transcribed lytic genes can proceed. In turn, some of these
early-transcribed lytic genes include regulators that allow transcription of late genes
and subsequent completion of the lytic cycle (Casjens and Hendrix, 2015).
In order to exert their regulatory control early during infection, CI and Cro
repressors compete for binding at two regions on the lambda genome, known as
operators, which each possess three binding sites. The right operator (OR) is located
between the oppositely oriented cI and cro ORFs, and serves as the primary site of
action for determining the decision between lytic and lysogenic life cycles (Johnson et
al., 1981). Although CI and Cro can occupy each of the three OR binding sites (OR1, OR2,
and OR3), they have evolved with distinct preferences that allow differential
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accumulation at each site. Thus, CI and Cro can preferentially repress their partner’s
transcription without completely repressing their own transcription up front (Figure 15). The molecular details of transcriptional regulation by CI and Cro are discussed
elsewhere in more depth (Dodd et al., 2005).

Figure 1-5. Schematic diagram summarizing transcriptional regulation that stabilizes
phage λ’s decision between lysogenic and lytic life cycles.
(A) During infections, the cI and cro ORFs (thick purple and orange arrows,
respectively) can be transcribed from the PRM and PR promoters, respectively (grey bent
arrows). Homodimers of their gene products (CI and Cro, respectively) can bind at each
of the three operator binding sites (solid grey rectangles). Cro’s preference for OR3 and
OR2 over OR1 allows it to dominate the operator such that cI transcription is turned off
while cro’s can initially remain on; a lytic cycle ensues (right). Meanwhile, CI’s
preference for OR1 and OR2 over OR3 allows it to dominate the operator such that cro
transcription is turned off while cI’s can remain on; a lysogenic cycle ensues (left).
Features of the diagram are scaled arbitrarily.
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In temperate phages with related genomic architecture, similar operators can
be found between divergently transcribed cI- and cro-like ORFs. Later in the text, I’ll
refer to such regions more generally as early lytic control regions (ELCRs) for simplicity.
Another region, which I’ve termed the late lytic control region (LLCR), refers to a
conserved region that was identified within various temperate phages infecting gram
positive bacteria (Ferrer et al., 2011; Quiles-Puchalt et al., 2013). As its name implies,
this latter region appears to be specifically involved in regulating transcription of late
lytic genes and completion of the lytic cycle, but it is not directly controlled by the CI- or
Cro-like proteins.
Unlike toxic lytic infections, lysogenic infections do not necessarily reduce
host fitness and can even be advantageous (Brüssow et al., 2004; Dykhuizen et al., 1978;
Edlin et al., 1977). In addition, they provide immunity to lytic superinfections by the
same phage, because the CI(-like) repressors expressed from a resident prophage
during lysogeny can also suppress lytic development of an injected phage in trans
(Casjens and Hendrix, 2015). However, this is not always a stable arrangement:
functional lambdoid prophages retain the ability to re‑initiate the lytic cycle and excise
from the chromosome, both stochastically and in response to DNA damage or other
signals (Bailone et al., 1979; Johnson et al., 1981; Little and Michalowski, 2010; Schubert
et al., 2007). This process arises from derepression via autoproteolytic cleavage of the
prophage’s CI(-like) repressors, and is known as ‘prophage induction’ (Figure 1-4). CI(-
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like) repressors possess an intrinsic serine protease activity, but their autoproteolysis
only occurs efficiently in the presence of activated RecA (RecA*) co-factors (Erill et al.,
2007; Livny and Friedman, 2004; Mo et al., 2014). Host-encoded RecA becomes activated
when it associates with ssDNA, typically arising via DNA damage. Accumulation of
RecA* triggers the host’s ‘Save-Our-Ship’ (SOS) stress response, and in turn leads to
upregulation of RecA precursors (Erill et al., 2007). Once a threshold of RecA*
accumulates, prophage induction is also triggered. These processes can be stimulated
with DNA-damaging treatments such as UV light or Mitomycin C (MMC). When
lambdoid lysogens are grown in the absence of overt DNA-damaging stimuli,
‘spontaneous’ prophage induction can still occur at a moderate to low frequency
(Nanda et al., 2015). However, even spontaneous prophage induction appears to be
largely dependent on RecA*, because its frequency becomes almost undetectably low in
host backgrounds that have lost their SOS-responsiveness (Fuchs et al., 1999; Little and
Michalowski, 2010; Nanda et al., 2015).
Whereas superinfection of a lambdoid lysogen by identical or closely related
phages is prevented if the prophage utilizes the same repressor-mediated immunity
module, superinfection by divergent phages that do not share the immunity module—
known as ‘heteroimmune’ phages—can still occur. During infection by a heteroimmune
phage, a lysogenic host can become lysogenized with more than one prophage, or
‘polylysogenized’. In these cases, induction of more than one prophage can still be
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coordinated via the SOS response, but intracellular competition and/or cross-talk within
the host may result in asymmetric propagation of one prophage over another (Refardt,
2011).
Among certain bacteria with pathogenic lifestyles, such as Staphylococcus
aureus, polylysogeny is a common phenomenon (Brüssow et al., 2004). For example, one
screen of 291 S. aureus clinical isolates based on site-specific integrase typing
determined that most (87%) harbored one or more prophage, and about half (51%)
contained two or more (Goerke et al., 2009). Similar to lambda and other lambdoid
phages, the temperate phages of S. aureus have typically been identified as Siphoviridae
with genome sizes of ~39-43 kbp (Xia and Wolz, 2014). Many of S. aureus’s prophages
are predicted or confirmed to contribute to their host’s pathogenicity (Xia and Wolz,
2014). In the next section, I elaborate on some examples relevant to this work.

1.4

Examples of temperate phages that contribute to staphylococcal
pathogenicity

In cases where lysogenization is associated with a phenotype independent of repressormediated immunity, the phenomenon can be referred to as ‘lysogenic conversion’
(Bondy-Denomy and Davidson, 2014). This was first described for the ability to produce
diphtheria toxin conferred by lysogenization with certain phages (Groman, 1955).
Numerous other examples of phages (and in particular prophages) contributing to
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bacterial pathogenicity have been documented in the literature, and are reviewed
elsewhere (Brüssow et al., 2004; Canchaya et al., 2003; Casjens, 2003). Lysogenization by
integrative temperate phages results in two principle genomic alterations: disruption of
the integration site locus, and incorporation of a heterologous stretch of DNA—the
prophage. Either alteration can result in lysogenic conversion phenotypes (BondyDenomy and Davidson, 2014). These phenotypes are highly homogeneous in cases
where the temperate phage reliably integrates into a specific locus. Likewise, the
prophage itself may encode functions that reliably confer a phenotype. For example,
temperate phages can harbor seemingly extraneous segments of DNA that are not
required for their lytic or lysogenic functions, known as ‘morons’ (Brüssow et al., 2004;
Cumby et al., 2012; Juhala et al., 2000). Moron DNA may include toxin or virulence
genes, and even promoter elements that allow for their efficient expression during
lysogeny. In certain cases, processes which occur during prophage induction may also
contribute to lysogenic conversion phenotypes (Tyler et al., 2013). For example, toxin
expression can be enhanced via coordinated upregulation of phage late promoters
during the lytic cycle (Wagner et al., 2002). In addition, it has been shown that lysis can
allow for efficient release of toxins which accumulate in the periplasm of gram-negative
bacteria (Shimizu et al., 2009). In the following two subsections, I outline some phages
and phage-like elements that are proposed or confirmed to contribute to staphylococcal
pathogenicity in various ways.
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1.4.1

β-hemolysin-converting phages

Lysogenization with the β-hemolysin-converting phages of Staphylococci, also known as
Sa3int phages, is found to simultaneously disrupt the β-hemolysin (hlb) gene harboring
their integration site and also provide morons—including a cluster within the 3’ end of
their genomes (Coleman et al., 1989; van Wamel et al., 2006; Verkaik et al., 2011; Xia and
Wolz, 2014). This ‘immune evasion cluster’ (IEC) can encode for several secreted
proteins: staphylococcal enterotoxin A (SEA) (Dohlsten et al., 1993), staphylokinase
(SAK) (Jin et al., 2004), chemotaxis inhibitory protein of S. aureus (CHIPS) (de Haas et
al., 2004), and staphylococcal complement inhibitor (SCIN) (Rooijakkers et al., 2005).
Some of these ORFs were found to be upregulated at the transcriptional level in various
strains, following prophage-inducing treatments with Mitomycin C (Cao et al., 2012;
Goerke et al., 2006; Sumby and Waldor, 2003). In addition, such treatments were found
to increase the extracellular concentrations of SEA released by certain strains (Cao et al.,
2012). However, it remains to be clarified whether the process of prophage-mediated
lysis itself can contribute to the release of functional IEC proteins (or other secreted
proteins) from S. aureus lysogens. Given that canonical processing of signal peptides
requires secretion across the plasma membrane (Schneewind and Missiakas, 2012), it’s
possible that rapid cell lysis via induction could even diminish the release of functional
secreted proteins by disrupting the integrity of plasma membranes prematurely.
Whereas the ɸ13 phage of NCTC8325 appears to be fully functional (Goerke et al., 2006;
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Iandolo et al., 2002; van Wamel et al., 2006), other β-hemolysin-converting prophages
appear to be at least partially defective (Bae et al., 2006; Holt et al., 2011; Sumby and
Waldor, 2003; van Wamel et al., 2006). For instance, S. aureus Newman-derived single
lysogens harboring the ɸNM3 prophage (‘TB3’) do not produce infective particles (Bae
et al., 2006). S. aureus Newman has been studied as a model clinical isolate in numerous
works, and its pathogenicity has also been investigated in animal models (Baba et al.,
2008). In addition to its ɸNM3 prophage, Newman harbors three other prophages:
ɸNM1, ɸNM2, and ɸNM4 (Figure 1-6A). All four prophages integrate site-specifically at
distinct loci (Figure 1-6B & C). Unlike the ɸNM3 prophage, ɸNM1, ɸNM2, and ɸNM4
represent functional temperate phages that can form infective particles (Bae et al., 2006).
They are also ‘pac’ phages that utilize a headful packaging mechanism, and are
therefore capable of generalized transduction (Chen et al., 2015a; Chen and Novick,
2009; Chen et al., 2015b). When a S. aureus Newman transposon insertion screen was
used to look for virulence genes required in a nematode killing assay, one candidate
ORF was identified in ɸNM3 (separate from the IEC), and five were identified among
Newman’s three pac prophages (Bae et al., 2004). The mechanistic basis for this remains
unclear to me. No precise molecular function was ascribed to any of the candidate
ORFs; and, all three of Newman’s pac prophages were found to be dispensable for
pathogenesis in a mouse liver abscess model (Bae et al., 2006). However, various pac
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Figure 1-6. Summary of S. aureus Newman’s four prophages (ɸNM1, ɸNM2, ɸNM3,
and ɸNM4) and their integration sites within the host chromosome.
(A) Schematic summary of the predicted ORF (thick arrow) positions and orientations
in each prophage genome. ORFs are color-coded according to tentatively assigned
functions (listed at the bottom). The sea, sak, chp, and scn ORFs at the 3’ end of ɸNM3
constitute its immune evasion cluster. Other virulence determinants (red) were
identified in a transposon insertion screen for mutants defective in nematode killing,
and are numbered according to locus tags (SAV numbers) of S. aureus Mu50 prophage
homologues originally used as a reference (prior to the complete sequencing of
Newman). Dashed lines indicate that ɸNM3’s cell wall hydrolase ORF is truncated, and
that its xis ORF is missing, although these are intact within the other prophages. (B)
Summary of the prophage positions (black triangles) along S. aureus Newman’s
chromosome; the Mu50 genome was used as a reference. ‘L’ and ‘R’ denote the relative
position of attL and attR attachment arms at each prophage (and thereby denote the
relative orientation of prophage insertions at each locus). Positions of the chromosomal
origin of replication (ori) and replication termination site (ter) are also indicated, with
oppositely oriented black arrows used to denote bi-directional DNA synthesis. (C)
Schematic summary as in ‘B’, but zoomed in to show relevant genomic regions in
Newman that contain the integration sites for each of its prophages. Where a predicted
function could not be assigned, ORFs were labeled according to their SAV numbers
from the Mu50 annotation originally used as a reference. hlb, encodes β-haemolysin;
geh, encodes glycerol ester hydrolase. Figure elements were reprinted from (Bae et al.,
2006) with permission.
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phages of S. aureus— including Newman’s—have been found to mobilize S. aureus
Pathogenicity Islands (SaPIs) (Chen and Novick, 2009; Chen et al., 2015b; Dearborn and
Dokland, 2012; Penades et al., 2015). SaPIs are a natural repository for putative and
confirmed superantigen toxin genes (Penades et al., 2015; Sloane et al., 1991). Therefore,
even when pac phages do not carry genes that contribute to pathogenesis directly, they
can indirectly contribute to pathogenicity by functioning as ‘helper’ phages that spread
SaPIs.

1.4.2

SaPIs and their SaPI-mobilizing ‘helper’ phages

SaPI helper phages include many of the well-studied S. aureus phages, such as ɸ11 and
80α (Xia and Wolz, 2014). Whereas 80α is thought to represent a laboratory recombinant
(Christie et al., 2010; Lindsay et al., 1998), ɸ11 is derived from a prophage of the
NCTC8325 isolate (Iandolo et al., 2002; Novick, 1967). Similar to phage lambda, both
prophages encode cI-like repressors, and can be induced by treatment with DNAdamaging agents (Ferrer et al., 2011; Penades et al., 2015; Quiles-Puchalt et al., 2013).
The ELCR of ɸ11 was also confirmed to include binding sites for its CI-like repressor in
vitro (Ganguly et al., 2009). When a SaPI-containing strain is lysogenized with a helper
phage for its SaPI, the SaPI genome can be excised, replicated, and packaged during
prophage induction. In a sense, this phenomenon represents a SaPI-dependent
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lysogenic conversion phenotype. Below, I provide a coarse-grained summary of how
SaPIs interact with—and apparently parasitize—their helper phages.
SaPIs are small prophage-like elements (~15 kbp) found in the genomes of many
S. aureus isolates (Novick et al., 2010; Penades et al., 2015). Their mobility is regulated by
master repressor ‘Stl’ proteins (Figure 1-7), similar to how the lytic activity of lambdoid
temperate phages is regulated by CI-like repressors (Johnson et al., 1981). Unlike
phages, however, SaPIs do not encode the full complement of genes required for
infection, and therefore rely on helper phages for packaging and transmission.
Moreover, whereas the lytic cycle of many bona-fide prophages can be induced in
response to host signals alone (Little and Michalowski, 2010; Nanda et al., 2015; Refardt,
2011), induction of SaPIs requires interactions with helper-phage-encoded antirepressor
proteins (Penades et al., 2015; Tormo-Mas et al., 2010). Helper phages express SaPI
antirepressors during their lytic cycle, such that SaPI induction only occurs during
infection or prophage induction. Various SaPI antirepressor proteins have been
described, such as the Dut (dUTPase) and Sri proteins found in 80α, ɸNM1, and ɸNM2
(Dearborn and Dokland, 2012; Tormo-Mas et al., 2010). Once a SaPI is de-repressed, it
expresses proteins that allow it to excise from the chromosome, replicate, and hijack its
helper phage’s packaging machinery (Figure 1-7A). Hijacking is mediated by SaPIencoded ‘interference’ proteins (Ram et al., 2012; Ram et al., 2014) which ensure
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Figure 1-7. Summary of helper-phage-mediated SaPI mobilization and transfer.
(A) Schematic summary of SaPI mobilization in lysogens during induction of a helper
prophage. SaPI induction is normally repressed by its master repressor, ‘Stl’. Once the
lytic cycle of a cohabiting helper prophage is induced (e.g., via the host’s SOS-response
(Erill et al., 2007; Nanda et al., 2015)), phage-encoded antirepressor proteins are
expressed, and relieve repression by Stl. SaPI excision and replication ensues, while
expression of SaPI-encoded interference proteins ultimately re-directs the phage’s
packaging machinery to concatemeric SaPI genomes for encapsidation. Packaging of
phages can still occur, albeit inefficiently. In some cases, SaPI interference involves
proteins that modify phage capsids such that they are ~1/3 the size and therefore too
small to package complete phage genomes (Christie and Dokland, 2012). This too can
reduce the maximal yield of infective (phage) particles. (B) Schematic summary of SaPI
transfer via modified phage particles, which are large enough to encapsidate a typical
complete SaPI genome. Following injection, the SaPI can be site-specifically integrated
into the host chromosome via attS (SaPI) and attC (chromosomal) attachment sites,
where it is maintained by Stl-mediated repression. (C) Same as in ‘A’, except that SaPI
mobilization is licensed by an infecting helper phage; note that this may occur before
Stl-mediated repression of an injected SaPI was ever established. Figure adapted from
(Novick et al., 2010) with permission.
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preferential packaging of the SaPI in phage or modified phage particles (Christie and
Dokland, 2012) that are ultimately released upon completion of the helper phage’s lytic
cycle. These include proteins which prevent the phage’s small terminase (TerSɸ)
subunit from recognizing of its own genome during packaging, and thereby allow the
SaPI’s alternative small terminase (TerSSP) subunit to re-direct capsids to the SaPI
genome (Chen et al., 2015b; Penades et al., 2015). Upon transfer into a new host that
lacks active helper phages, SaPIs may once again be established within the chromosome
via site-specific integration and Stl-mediated repression (Figure 1-7B).
By impeding the packaging of helper phage genomes, SaPI-encoded interference
proteins can substantially reduce the helper phage’s infective burst size (Lindsay et al.,
1998). Importantly, this effect can provide the SaPI-containing host with a survival
advantage by preventing plaque formation. Functional SaPIs, therefore, offer a highly
selective form of defense against (helper) phages, but operate more like abortive
infection systems (Chopin et al., 2005; Depardieu et al., 2016; Labrie et al., 2010) than
CRISPR-Cas systems in the sense that they do not rescue the viability of infected cells.
Meanwhile, by allowing for lysis during infection or prophage induction, SaPIs permit
both the transfer of host genes via generalized transduction pathways and the efficient
transfer of their own genomes (Chen et al., 2015b). Accordingly, it was recently
proposed that this feature of SaPIs could offer a unique advantage over CRISPR-Cas
systems, and perhaps explain the relative abundance of SaPIs (and scarcity of CRISPR-
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Cas systems) in S. aureus populations which are thought to benefit heavily from
frequent horizontal gene transfer (Ram et al., 2014). This idea is compelling, but seems
to disregard the contributions of helper-phage-mediated mobilization and transfer of
SaPIs, which might be sufficient to explain their relative abundance in temperatephage-rich populations of S. aureus. Furthermore, while type III-A CRISPR-Cas systems
in S. aureus genomes display signatures of recent horizontal acquisition (Cao et al., 2016;
Golding et al., 2010; Kinnevey et al., 2013), intrinsic mobility has yet to be demonstrated
for any extant CRISPR-Cas system (Beguin et al., 2016; Krupovic et al., 2014). Hence, the
relative immobility of extant CRISPR-Cas systems could also explain their scarcity
among S. aureus genomes. A recent PCR-based screen of 636 S. aureus clinical isolates
derived from four Chinese hospitals determined that only 6 isolates contained type IIIA CRISPR-Cas systems (Cao et al., 2016). Despite this scarcity, type III-A systems are
relatively well-represented among Staphylococci compared to other CRISPR-Cas
systems, and my advisor Dr. Marraffini first noticed this while browsing the available
genomes and CRISPR database (Grissa et al., 2007a, b). In the next section, I summarize
some additional developments that led us to embark on our study of type III-A systems
in S. aureus hosts, about five and a half years ago.
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1.5

Rationale for the study of type III-A CRISPR-Cas systems in S. aureus hosts

Although the first experimental demonstration of a CRISPR-Cas system’s adaptive
immune functionality was carried out with Streptococcus thermophilus and virulent
phages, prior in silico analyses of these systems and their CRISPR spacer content
(Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005) seemed to suggest that they
would also be capable of defending against other classes of mobile genetic elements,
such as plasmids. A seminal study led by Dr. Marraffini subsequently confirmed this
prediction, in showing that a CRISPR-Cas system in Staphylococcus epidermidis RP62a
(Gill et al., 2005) can target DNA (plasmid) elements, and thereby prevent horizontal
gene transfer (Marraffini and Sontheimer, 2008). Staphylococci are thought to engage in
frequent horizontal transfer of mobile genetic elements and accessory genes (Lindsay
and Holden, 2004), and in this light the implications of Dr. Marraffini’s findings were
particularly intriguing. Apparently, by preventing horizontal gene transfer, CRISPRCas immunity could be detrimental to bacteria in certain circumstances. Negative
selection operating on CRISPR-Cas systems that target favorable elements might
therefore explain their scarcity among S. aureus genomes, and perhaps even explain
their absence from about 50% of bacterial genomes overall (Grissa et al., 2007a, b), and
Dr. Marraffini conveyed this intriguing notion to me once I’d begun work in his
laboratory. Dr. Marraffini also pointed out that spacers matching to temperate phages
could be identified among the CRISPR loci of type III-A systems in sequenced
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Staphylococci, suggesting these systems do indeed interface with temperate phages in
the wild, and presumably protect their hosts from them. For example, the second spacer
in RP62a’s type III-A system matches to the CNPH82 temperate phage of S. epidermidis
(Daniel et al., 2007). Moreover, whereas plasmid or non-phage integrative elements in S.
aureus were often found to confer antibiotic resistance, temperate phage or phage-like
elements in S. aureus were often found to confer putative or confirmed virulence traits
(Lindsay and Holden, 2006). Targeting of temperate phages by type III-A systems in S.
aureus, therefore, might be expected to present a barrier to virulence acquisition, in the
same sense that antibiotic resistance acquisition could be prevented by plasmid
targeting. Consistent with this idea, CRISPR-Cas targeting of a fully functional
temperate phage (lambda) had been tested in one study, and it was found to resist
lysogenic infections (Edgar and Qimron, 2010). In two other studies, resistance to lytic
infection by a virulent mutant of lambda (λvir) had also been shown (Brouns et al., 2008;
Sapranauskas et al., 2011). The time was ripe for testing whether CRISPR-Cas targeting
of temperate phages in S. aureus would license a similar state of genetic incompatibility.
There were practical reasons for working with type III-A systems in S. aureus as
well. In December 2011, my colleague Wenyan showed that the type III-A system from
S. epidermidis RP62a could license anti-conjugative-plasmid immunity in S. aureus hosts,
once cloned on an autonomously replicating plasmid vector. This provided a proof of
principle that targeting by a type III-A system could operate as expected in
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heterologous staphylococcal hosts, and allowed us to readily modify the system’s
CRISPR array and cas genes via standard plasmid cloning manipulations. Modification
of S. epidermidis RP62a and its derivatives, meanwhile, is less trivial, and we were
initially lacking a phage that could infect these strains. By contrast, a variety of S. aureus
phages were available to us, and Dr. Marraffini recommended that I begin work with
the three functional temperate phages of S. aureus Newman: ɸNM1, ɸNM2, and ɸNM4.
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CHAPTER 2: INVESTIGATION OF CRISPR-CAS IMMUNITY IN S. AUREUS
REVEALS AN UNEXPECTED MECHANISM FOR CONDITIONAL
TEMPERATE PHAGE TOLERANCE

When this work was begun, the type I-E CRISPR-Cas system’s potential to resist both
lytic and lysogenic infections by phage lambda or its derivatives had been
demonstrated in Escherichia coli (Brouns et al., 2008; Edgar and Qimron, 2010;
Sapranauskas et al., 2011), but little else was known about CRISPR-Cas immunity to
temperate phages in bacteria. Spacers matching to temperate phages had been
identified in various CRISPR-Cas systems, including type III-A systems of Staphylococci
(Gill et al., 2005; Golding et al., 2010). However, a phage-defense function for CRISPRCas immunity in staphylococcal hosts had yet to be demonstrated experimentally.
Enabled by my colleague Wenyan’s recent cloning of the S. epidermidis RP62a type III-A
system on a plasmid vector, I set out to characterize the genetic outcomes of temperate
phage targeting by type III-A systems in S. aureus. The plan involved reverseengineering of our type III-A system’s upstream CRISPR locus, such that it would
contain spacers matching to the functional temperate phages of S. aureus Newman
(ɸNM1, ɸNM2, and ɸNM4). The spacer in position 1 of this CRISPR locus had already
been shown to license immunity to plasmids that bore a matching nickase (nes) target
sequence, so it was conceivable that temperate-phage-matching spacers, once
engineered, would also be able to license anti-phage immunity. By working with three
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heteroimmune temperate phages, moreover, I could presumably emulate the effects of
CRISPR-Cas targeting in natural S. aureus populations, where infection by multiple
(pro)phages is not uncommon (Brüssow et al., 2004; Goerke et al., 2009). Most of the
phage- and prophage-targeting experiments described in sections 2.1, 2.2, and 2.3 were
initially carried out with the ‘TB4’ host or its derivatives (Bae et al., 2006). TB4 is a
prophage-cured derivative of S. aureus Newman that can be re-infected with ɸNM1,
ɸNM2, or ɸNM4, and thereby serves as a native host background for these phages. This
strain and its lysogenic derivatives lack endogenous CRISPR-Cas systems, but can be
readily transformed with plasmids miniprepped from S. aureus RN4220—a restrictiondeficient and prophage-cured laboratory derivative of NCTC8325 which also lacks an
endogenous CRISPR-Cas system (Nair et al., 2011). Once it was clear that RN4220 could
be used to reproduce the core findings directly, however, I focused on conducting
experiments with this more genetically tractable host. The majority of the data
presented in Chapter 2—and ultimately included for publication (Goldberg et al., 2014)
—was therefore derived from experiments with RN4220.

2.1

Initial demonstration of CRISPR-Cas immunity to phages in S. aureus

My work on this project began with the isolation of ɸNM1, ɸNM2, and ɸNM4 phage
stocks. Supernatants from overnight cultures of S. aureus Newman contain a mixture of
spontaneously induced infective particles derived predominantly from ɸNM1 and
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ɸNM2 (Bae et al., 2006). Single plaques were isolated by plating the supernatant mixture
on a sensitive soft agar lawn, and then genotyping plaques with primers specific for
each phage. This allowed for the direct identification of ɸNM1 and ɸNM2 plaques,
which were then propagated to produce high-titer lysates. Temperate phages such as
these do not produce completely clear soft agar lawns upon lysis. Rather, lawns become
‘turbid’ because a high proportion of cells are lysogenized during initial infections,
which then survive subsequent infections via prophage repressor-mediated immunity.
In turn, lysogens can be isolated by re-streaking from a region of turbid lysis. I obtained
TB4::ɸNM1 and TB4::ɸNM2 single lysogens in this manner, which were genotyped
using my original phage-specific primers. A TB4::ɸNM1+ɸNM2 double lysogen was
subsequently constructed by infecting TB4::ɸNM1 with ɸNM2, and re-streaking from a
region of turbid lysis in the same way. This double lysogen allowed me to identify
ɸNM4 plaques from S. aureus Newman supernatants, because it counter-selects against
ɸNM1 and ɸNM2 phages. Finally, a TB4::ɸNM4 single lysogen was similarly obtained
during propagation of ɸNM4 on sensitive lawns.
Shortly after I began work on the phage isolations, I started working to reengineer the CRISPR locus of Wenyan’s type III-A CRISPR-Cas plasmid, which he
called pWJ30β. In order to readily replace the native phage-targeting spacer in position
2 of this plasmid with engineered spacers targeting S. aureus Newman’s phages, I
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needed to create a new plasmid lacking all repeats and spacers downstream of its nes
spacer in position 1. This new plasmid, pGG3 (Figure 2-1), served as the parent

Figure 2-1. Plasmid-borne type III-A CRISPR-Cas systems for initial experiments in
S. aureus.
(A) Schematic representations of the pWJ30β (left) and pGG3 (right) type III-A CRISPRCas plasmids. pWJ30β harbors the wild type system from S. epidermidis RP62a,
including its conserved leader sequence (‘L’, dark grey box) immediately upstream of
the CRISPR array. To construct pGG3, the CRISPR array of pWJ30β was reduced to a
single repeat-spacer element (middle). pC194 backbones include a chloramphenicol
acetyltransferase (cat) gene conferring resistance to chloramphenicol, which is also
depicted alongside cas genes in the plasmid diagrams.

vector for my initial phage-targeting constructs. It was immediately apparent that the
pGG3 plasmid in TB4 did not prevent infection by the Newman phages. In fact, TB4
derivatives harboring pGG3 were arbitrarily used for propagation during some of my
initial lysogen isolations (once it was cloned), probably because this allowed me to
prophylactically treat the culturing media with an antibiotic (chloramphenicol).
Accordingly, the effects of phage-targeting spacers could be subsequently tested
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relative to this isogenic and phage-sensitive background. PCR-based methods using our
standard oligo sizes (~ 60 bp) allowed for one-step addition of repeat-spacer units to the
pGG3 backbone, with the phage-targeting spacer introduced at position 2 but lacking a
downstream repeat. Dr. Marraffini pointed out to me that this should not present an
issue, because single repeat-spacer units were found to be sufficient for anti-plasmid
immunity in conjugation assays (Hatoum-Aslan et al., 2011). In addition, Dr.
Marraffini’s previous work with the type III-A system had demonstrated that excessive
matching between the 5’ tag of the crRNA and the corresponding flanking sequence in
the target would prevent immunity (Marraffini and Sontheimer, 2010b), so I designed
my spacers to avoid this, as per his recommendation. Beyond this, it was not known
whether there would be additional requirements for type III targeting, such as the
PAMs which had been described for type I and type II systems (Deveau et al., 2008;
Semenova et al., 2011). It had been pointed out to me, furthermore, that previous
reports seemed to indicate CRISPR-Cas systems could provide immunity to phages and
plasmids regardless of the DNA strand or genomic context targeted (Barrangou et al.,
2007; Deveau et al., 2008; Garneau et al., 2010; Marraffini and Sontheimer, 2008). I
naïvely doubted that I would not encounter further constraints on the type III-A (DNA)
targeting mechanism, even with spacers engineered to match their targets perfectly. In
any event, I reasoned that I could satisfy my own skepticism by designing a few
different spacers; if there really were no other targeting constraints, I should be able to
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Figure 2-2. Summary of target positions and spacer design for type III CRISPR-Cas
immunity directed at ɸNM1 (or other S. aureus Newman phages) in Chapter 2.
(A) Schematic representation of the ɸNM1 genome’s rightward-oriented (golden) and
leftward-oriented (purple) ORFs, scaled in accordance with their annotated lengths
(Accession number: NC_008583.1). The target positions for various type III spacers with
crRNAs complementary to the top (‘T’) or bottom (‘B’) strand of the genome are also
indicated. Oppositely oriented bent grey arrows represent the PcI (leftward) and Pcro
(rightward) promoters found within the early lytic control region (ELCR) designated for
ɸNM1. (B) Base-pairing potential between the spacer 16B or 16T crRNAs and the DNA
of perfectly conserved target regions in ɸNM1, ɸNM2, and ɸNM4, as indicated by
vertical lines between the sequences. The 5’ crRNA tag is an 8 bp sequence derived from
the CRISPR repeat that must be sufficiently mismatched with the target’s flanking
sequence in order to license immunity. (C) Plaquing efficiency of ɸNM1 on lawns of
RN4220 harboring pGG3- or pGG3-BsaI-derived type III CRISPR-Cas plasmids with
different phage-targeting spacers. High plaquing efficiency implies that the CRISPR-Cas
plasmid did not provide immunity to infection; the functionality of these plasmid
backbones was verified in at least one independent CRISPR-Cas targeting assay prior to
publication (Goldberg et al., 2014), such as the pG0400 conjugation assay (Figure 2.3).
Dotted line represents the limit of detection under these assay conditions. Error bars,
mean ± s.d. (n = 3, technical replicates).
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provide CRISPR-Cas immunity with virtually any spacer matching to a phage’s
genome. Moreover, in perhaps equally naïve fashion, I attempted to increase my odds
of encountering such constraints by initially designing spacers that match to all three
phages (ɸNM1, ɸNM2, and ɸNM4). Besides these considerations, the first spacer I
successfully cloned, 16B, was arbitrarily designed with a sense sequence matching to
one of the rightward-oriented ORFs (gp16 in ɸNM1, numbered ‘866’ in Figure 1-6)
reported to encode a conserved nematode virulence determinant (Bae et al., 2006; Bae et
al., 2004). When considering the rightward-oriented ORFs in these phages (e.g., those
encoding various lytic genes), sense spacers produce crRNAs with complementarity to
the ‘bottom’ strand, hence the ‘B’ (Figures 2-2A & 2-2B). The 16B spacer did not
detectably reduce plaque formation by any of these phages. Representative data from
experiments with ɸNM1 are shown in Figure 2-2C. I next designed three additional
spacers (2B, 19B, and 56B) targeting different regions of the phage genomes, even
though we expected that DNA targeting by CRISPR-Cas systems would provide antiphage immunity regardless of the target’s genomic context. For consistency, sense
spacers were again designed to target the bottom strand of conserved sequences.
However, I made a point to include a spacer targeting a gene in the lysogeny region,
because I surmised that targeting of this region would be more likely to have distinct
functional consequences. This was made possible by the well-conserved, rightwardoriented excisionase ORF (gp2) present in the lysogeny region of each phage. Although
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the 19B and 56B spacers matching to lytic regions did not reduce plaque formation, the
2B spacer did. Again, representative data from experiments with RN4220 and ɸNM1 are
shown in Figure 2-2C. Meanwhile, all three of these strains exhibited anti-plasmid
immunity when I tested them as conjugative plasmid recipients in control assays
(Figure 2-3), owing to the nes spacer retained at position 1 of their CRISPR. The
conjugation efficiencies I observed are comparable to published values reported by our
lab for pG0400 and pG0mut (Hatoum-Aslan et al., 2013; Jiang et al., 2013b; Marraffini
and Sontheimer, 2008): efficiency is only reduced for the pG0400 plasmid with a wild
type target for the nes spacer. The rare pG0400 transconjugants I observed were
presumed to represent CRISPR-inactive genetic escapers, since, at this time, my
colleagues Wenyan and Inbal were well under way with their characterization of
similar transconjugants in S. epidermidis RP62a, which they found to be genetic escapers
in all cases (Jiang et al., 2013b). Evidently, however, we still didn’t fully understand the
requirements for phage targeting by type III-A systems in plaque assays, because 3 of
my first 4 spacers failed to license anti-phage immunity by otherwise functional
CRISPR-Cas systems. Given that these particular phage-targeting spacers were all
engineered, it initially seemed plausible to me that the non-functional spacers could be
lacking in target recognition capacity, or were poorly expressed in our host background.
I hadn’t, for example, considered their predicted RNA-DNA hybridization potential
when designing them, or assessed crRNA abundance. Moreover, a requirement for
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Figure 2-3. Integrity of pGG3 backbones can be functionality validated using
conjugation assays.
(A) Schematic diagram depicting the conjugative transfer of pG0(400 or mut) plasmids
conferring mupirocin resistance from S. aureus RN4220 donors to TB4 recipients
containing pGG3 or pGG3-derived CRISPR-Cas plasmids with the native nes-targeting
spacer in position 1. The solid white rectangle on pG0 signifies the presence of a perfect
or partially matching target for the nes spacer in pGG3. The wild type (pG0400) and
mutated (pG0mut) target site sequences are shown on the right, with red lettering used
for mutated bases. (B) Conjugation assays for validating the functionality of CRISPRCas plasmids conferring resistance to chloramphenicol. In this example dataset,
recipients harbor type III CRISPR-Cas plasmids with one of the four indicated phagetargeting spacers, or the pGG3 parent vector (C). After filter mating with either pG0400
or pG0mut donors, recipient and transconjugant concentrations (CFU / ml) were
quantified as described in the methods. Dotted line represents the limit of detection
under these assay conditions. Conjugation efficiencies denote the ratio of
transconjugants to recipients measured in each experiment.
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previously unidentified target flanking motifs, such as PAMs, had still not been
rigorously ruled out. In any case, it was easy for me to suspend judgment on this matter
rather than attempting to pursue these ideas directly, since there were other
experiments to be done. For example, Dr. Marraffini had pointed out that the rare
plaques which arise on immune lawns with the 2B spacer are probably caused by
escaper mutant phages (Barrangou et al., 2007; Deveau et al., 2008; Semenova et al.,
2011), and he recommended that I isolate some of these phages to determine whether
they had target site mutations. He also recommended that I begin by picking some big
and some small plaques. Presumably, this could increase our odds of sampling different
phages (i.e., with different plaque size phenotypes). These endeavors ultimately proved
fruitful, as I explain below.

2.2

Initial characterization of phages and lysogenic hosts that escape type III-A
CRISPR-Cas immunity via genetic means

Plaques picked from CRISPR-immune lawns can be re-plated on the same lawns to
ensure additional counter-selection against residual wild type phage particles. In this
manner, I initially isolated six ɸNM1 mutants, two ɸNM2 mutants, and six ɸNM4
mutants. My colleague Wenyan had used the Greek letter, β, to distinguish his pWJ30β
plasmid from its pWJ30 predecessor, so I initially adopted a similar practice when
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Figure 2-4. Preliminary genotyping of spacer 2B escaper phages (γ-series).
(A) Schematic diagram depicting a relevant genomic region of ɸNM1, scaled according
to its reference annotation (Accession number: NC_008583.1). The integrase and
excisionase (xis) ORFs correspond to gp1 and gp2, respectively. Grey rectangle denotes
the position of the xis target sequence. Dashed line denotes the location of target region
PCRs initially attempted with primers oGG25 and oGG26. (B) Same as in ‘A’, except the
schematic depicts a relevant genomic region of ɸNM2, scaled according to the ɸNM2
(NC_028913.1) reference annotation. (C) Same as in ‘A’, except the schematic depicts a
relevant genomic region of ɸNM4, scaled according to the ɸNM4 (NC_028864.1)
reference annotation.

naming my phage mutants. For example, the spacer 2B escapers were the first phages
which I provided with a ‘γ’ designation, in order to help distinguish them from wild
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type. To genotype these ‘γ-series’ mutants, I initially attempted to PCR-amplify small
regions which include the conserved xis target for spacer 2B (Figure 2-4). After repeated
attempts at this PCR, I was only successful at reproducibly amplifying from one of my
ɸNM1 mutants, ɸNM1γ6, but Sanger sequencing confirmed that its amplicon lacked
mutations (data not shown). Incidentally, this was the only one of my γ-series mutants
which exhibited a small plaque phenotype when plating on spacer 2B lawns (Figure 25A). Importantly, this reduction in plaque size was not observed when control lawns
were infected with ɸNM1γ6 (Figure 2-5B); and, a ‘clear-plaque’ phenotype was readily
apparent on these lawns (Figure 2-5C). This indicated that, although its plaque size

Figure 2-5. ɸNM1γ6 plaque phenotypes.
(A-B) Plaque formation by a ɸNM1γ6 lysate spotted on lawns of TB4 harboring the
spacer 2B CRISPR-Cas system (A) or the pGG3 parent vector (B). Pictures are
representative of at least two experiments performed under the same assay conditions.
(C) Comparison of ɸNM1 (turbid) and ɸNM1γ6 (clear) phenotypes by spotting of high
phage titers on a sensitive lawn. Picture is representative of at least four technical
replicates.

phenotype was CRISPR-dependent, the ɸNM1γ6 phage did have heritable alterations—
elsewhere—that could produce a clear-plaque phenotype even in the absence of
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CRISPR-Cas targeting. In contrast, all of my other γ-series mutants escaped targeting
with apparently wild type plaque sizes, regardless of whether they also exhibited clearplaque phenotypes. I began to surmise that the small-plaque phenotype of ɸNM1γ6
could reflect incomplete escape of the 2B spacer, or partial targeting, enabled by the
presence of its intact target sequence. The complete escape observed with the other
mutants for whom an intact target sequence could not be amplified, meanwhile, might
be explained by deletions at the target region which included one or more annealing
site for my PCR primers. Consistent with this notion, I was generally able to PCRamplify wild type amplicons when I used my original ɸNM1-, ɸNM2-, or ɸNM4specific primer sets that did not encompass the target region.
At this stage, the source of the ɸNM1γ6 phenotypes was still quite puzzling.
Regarding clear-plaque phenotypes, Dr. Bikard explained to me that this can arise if the
phage is incapable of establishing lysogeny. Indeed, the few surviving colonies I was
able to isolate after clearance of lawns with high titers of pure ɸNM1γ6 were never
found to be lysogenized. These survivors were presumed to have acquired CRISPRindependent resistance mutations, since no expansion of CRISPR arrays was observed
even when the infected lawn harbored a type III-A CRISPR-Cas plasmid (data not
shown). Growth phenotypes were also observed in some cases while re-streaking these
survivors in the absence of phage, which would not be expected for CRISPR-adapted or
lysogenized lineages.
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In a separate experiment, I characterized a few clones that survived infection by
one of my other clear mutants, ɸNM4γ4. In this case, the infected lawn also harbored
the spacer 2B CRISPR-Cas plasmid, which is fully escaped by the ɸNM4γ4 mutant.
Although I was again unsuccessful at isolating type III-A CRISPR-adapted clones here,
two of my isolates had apparently become lysogenized (Figure 2-6A), as determined by
PCR-amplification with my original ɸNM4-specific primer set. One of these lysogenic
survivors, ɸNM4γ4-S1, appeared to have an altered CRISPR region in its spacer 2B
plasmid, given that I could not amplify its CRISPR array with my standard primers.
The other survivor, ɸNM4γ4-S2, still had an intact CRISPR array amplicon. In both
cases, the xis target region could be amplified, but the ɸNM4γ4-S2 isolate gave a
shortened product (Figure 2-6A). Sanger sequencing revealed an 81 bp deletion,
confined within the ORF, which included 23/35 base pairs of the original target
sequence (Figures 2-6B & C). Aside from allowing CRISPR-escape, this deletion did not
appear to produce a phenotype, since I could isolate plaques from lysogen
supernatants, and use them to re-lysogenize TB4. Evidently, this mutant was distinct
from ɸNM4γ4. Soon afterwards, I realized that the ‘ɸNM4γ4’ stock used for infection in
this particular experiment had not been purified to homogeneity, because I was able to
amplify faint, wild type products from the xis target region (indicative of
contaminating, parental ɸNM4 phages). Therefore, these lysogenic survivors were
probably derived from residual wild type phages in the lysate which ultimately
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Figure 2-6. Characterization of two ɸNM4-derived lysogens that genetically escaped
prophage targeting by spacer 2B.
(A) PCR amplification from two clones that survived ɸNM4γ4 infection on TB4 lawns
with the spacer 2B CRISPR-Cas plasmid (‘S1’ and ‘S2’). After re-streaking, a single
colony lysate from each isolate was used to template three different PCRs using primers
for the xis target region (middle), primers for amplifying the CRISPR array (right), or
primers for amplifying from ɸNM4 phages at a separate locus (left). Note the shorter
size of the xis amplicon derived from the S2 isolate, and the lack of CRISPR array
amplification from the S1 isolate. Control amplification (C) from the CRISPR array of
the pGG3 parent vector lacking spacer 2B is shown in lane 10. Size markers of 3 kbp and
0.5 kbp in lane 1 are indicated. Additional replicates were not performed on the original
isolates. Lanes 2, 3, 6 and 7 were used for other experiments. (B) Sequence of the xis
target region in ɸNM4 and ɸNM4γ4-S2. Red highlighting denotes sequences from the
xis ORF; target sequences matching the 2B spacer are boxed in grey. Note that while
only 12 bp of the original target sequence remain in ɸNM4γ4-S2, the deletion
regenerated a ‘T’ immediately downstream (dotted yellow box). (C) Schematic diagram
as in Figure 2-4C, with the position of the ɸNM4γ4-S2 deletion indicated (Δ81 bp). PCR
amplification with the oGG25/oGG26 primer set (dashed line) produces a shortened
product size of 364 bp.
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protected their hosts from superinfection by ɸNM4γ4 mutants. Indeed, none of my
clear mutants were capable of superinfecting their respective lysogens, even when high
titers were spotted on lysogen lawns around the time of initial isolation (data not
shown). Notwithstanding, this result seemed to provide at least one example of how a
type III-A CRISPR-Cas system could select for temperate phage mutants that
completely evade immunity—even during lysogeny—via target sequence deletions.
This mutational, or genetic form of CRISPR-escape seemed to mirror what my
colleagues had found in conjugation experiments (and also what had been reported
previously on temperate phage targeting in E. coli (Edgar and Qimron, 2010)), where
functional CRISPR-Cas systems do not co-exist with their DNA target elements.
Consistent results were obtained in transformation assay pilot experiments where I
electroporated the spacer 2B CRISPR-Cas plasmid into S. aureus Newman (which
harbors 3 prophage targets). Although S. aureus Newman was comparably transformed
with pGG3 and spacer 16B CRISPR-Cas plasmids (data not shown), only a single
transformant was isolated from the two experiments where I attempted to introduce the
spacer 2B plasmid. This transformant maintained an intact CRISPR array, but was
presumed to have lost its CRISPR-Cas targeting functionality by other means (e.g., via
mutation of one or more cas gene), in part because I was able to amplify from all four of
its prophages using PCR. Accordingly, I saved the strain but proceeded with other
experiments described below, under the assumption that this putative escaper would
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Figure 2-7. Spacers matching to conserved sequences in ɸNM1, ɸNM2, and ɸNM4
can license type III-A CRISPR-Cas immunity to all three phages.
(A) Schematic representations of the ɸNM1, ɸNM2, and ɸNM4 genomes; ORF (thick
arrow) lengths were scaled according to their respective NCBI annotations
(NC_008583.1, NC_028913.1, and NC_028864.1). Colored ORFs contain a conserved or
partially conserved target for spacer 2B (red), spacer 32T (blue), or spacer 61T-1 (green).
(B) Schematic summary of the CRISPR arrays in CRISPR-Cas plasmids used for initial
phage-targeting experiments in TB4 hosts. The 2B, 32T, and 61T-1 spacers are colormatched to their target ORFs shown in panel ‘A’. CRISPR-Cas plasmids with a phagetargeting spacer in position 2 were derived from pGG3 as described in the methods. The
spacer 32T∆nes CRISPR-Cas plasmid is a derivative of the spacer 32T CRISPR-Cas
plasmid, and was isolated by miniprepping from a pG0400 transconjugant that escaped
mupirocin counter-selection via loss of the nes spacer in position 1. (C) Quantification of
plaque-forming potential (PFU / ml) measured for lysates of ɸNM1, ɸNM2, or ɸNM4
plated on soft agar lawns of S. aureus TB4 harboring one of the five CRISPR-Cas
plasmids summarized in ‘B’. Lawns with the pGG3 parent vector plasmid lack phagetargeting spacers and thus serve as a sensitive control in this assay. Data represents
single biological replicates; for each phage, the same lysate was used for plating on the
five lawns. Dotted line represents the limit of detection under these assay conditions.
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not offer particularly novel insights (about six months later, I confirmed that the strain
had indeed lost CRISPR-Cas targeting functionality in a pG0400 conjugation assay; data
not shown).
Meanwhile, additional phage escaper data corroborating these preliminary
results was promptly procured, once I’d found two additional spacers, 32T and 61T-1,
which reduced plaque formation by the three Newman phages (Figure 2-7). The first
was the 32T spacer, which was originally identified as a naturally occurring spacer in
the type III-A CRISPR-Cas locus of S. argenteus MSHR1132 (Holt et al., 2011). Dr.
Marraffini, and also my colleague Wenyan, brought this spacer to my attention when
they found that it partially matches to the Newman phages I was working with. Partial
complementarity between this spacer’s crRNA and the Newman phage target regions is
illustrated in Figure 2-8. In parallel, I constructed two variants (32T*A and 32T*B) which
perfectly matched their targets in ɸNM1/ɸNM2 and ɸNM4, respectively, because it was
unclear at the time whether the naturally occurring mismatches would abrogate
immunity. Ultimately, all three spacers were found to provide immunity. Having been
generally advised on the pitfalls of studying engineered systems, however, I
endeavored to work with the unmodified 32T spacer whenever possible. Using this
spacer, I isolated three ɸNM2 and three ɸNM4 escaper plaques, which I designated as
‘α-series’ mutants to distinguish them from escapers of spacer 2B. Unlike the 2B spacer,
which targets the bottom strand of Newman phage genomes, spacer 32T targets their
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Figure 2-8. Partial complementarity between the spacer 32T crRNA and its DNA
target regions in ɸNM1/ɸNM2 or ɸNM4.
(A) Vertical lines denote base-pairing potential between sequences of the 32T crRNA
and the DNA of conserved ɸNM1/ɸNM2 target regions; G:U base-pairing potential was
not considered. The 5’ crRNA tag is an 8 bp sequence derived from the CRISPR repeat
that must be sufficiently mismatched with the target’s flanking sequence in order to
license immunity. (B) Same as in ‘A’, but with base-pairing potential to DNA of the
ɸNM4 target region depicted instead.

‘top’ strands, hence the ‘T’. Having now found, somewhat fortuitously, that I could
obtain immunity with spacers targeting either strand, I designed four additional spacers
(61B-1, 61B-2, 61T-1, and 61-T2) matching a separate region of the genome, this time
with deliberate targeting of both strands. I was initially unsuccessful at cloning the 61T2 spacer. However, among the other three spacers which I promptly cloned, the 61T-1
spacer was the only spacer which provided immunity. Using this 61T-1 spacer, I again
isolated some escaper plaques, and designated them as ‘τ-series’ mutants. Two ɸNM1
mutants, and one ɸNM2 mutant, were isolated. None of these α- or τ-series escapers
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were found to produce wild type PCR amplicons at their target regions, and in some
cases I was able to map deletions which included all or part of their target sequences.
Aside from their CRISPR-escape phenotypes, however, they were generally
indistinguishable from wild type. One exception was the ɸNM2τ1 phage, which
exhibited a small plaque phenotype (Figure 2-9A). Unlike the ɸNM1γ6 phenotype,
however, the ɸNM2τ1 plaque phenotype was observed even on control lawns (Figure
2-9B), and was therefore deemed to be CRISPR-independent and not studied further.

Figure 2-9. CRISPR-independent, small-plaque phenotype of ɸNM2τ1.
(A-B) Plaque formation by a ɸNM2τ1 lysate spotted on lawns of TB4 harboring the
spacer 61T-1 CRISPR-Cas system (A) or the pGG3 parent vector (B). Pictures are
representative of at least two experiments performed under similar assay conditions.

Given that this phage had escaped CRISPR-Cas targeting of the parental tail fiber gene,
I presumed its plaque phenotype to reflect impaired phage particle functionality (such
as a defect in adsorption) resulting from a deletion in that target region. Taken together,
these putative and confirmed deletion escapers stood in stark contrast to the ɸNM1γ6
escaper, which did not possess target site mutations and appeared to only partially
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evade targeting by spacer 2B. I initially considered the possibility that ɸNM1γ6 had in
some way acquired a general CRISPR-escape phenotype, but this was promptly ruled
out by plating on lawns harboring the spacer 32T CRISPR-Cas plasmid. Representative
results from experiments with RN4220 are depicted in Figure 2-10A, and demonstrate
that ɸNM1γ6’s plaquing efficiency was reduced appreciably by the 32T spacer, but not
the 2B spacer. Somehow, the heritable changes in ɸNM1γ6 that allowed for partial
escape were still ostensibly specific to targeting by spacer 2B. Unfortunately, I could not
also investigate the ɸNM1γ6 CRISPR-escape phenotype in the context of a lysogenic
infection (i.e., chromosomal targeting by spacer 2B), because it apparently didn’t form
lysogens. It was now clear to both me and Dr. Marraffini that full genomic sequencing
of this phage would likely provide additional insight into its phenotypes (which were
not lost upon passaging in the absence of CRISPR, as one might expect for an epigenetic
form of escape (Bertani and Weigle, 1953; Korona and Levin, 1993)). We had also
discussed plans to produce a more thorough characterization of my various escaper
mutations, which in many cases still hadn’t been mapped by PCR, so I was already
considering the prospect of sequencing entire phage genomes. Meanwhile, Dr. Bikard
was isolating phages in separate experiments, and plans were conceived to pool our
phages together in a multiplexed, next-generation sequencing run at the Rockefeller
University Genomics Core. Both phenotypes of ɸNM1γ6 would ultimately be
explained, but it was some time before this sequencing was completed. In the interim, I
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Figure 2-10. ɸNM1γ6 can escape type III targeting of the bottom strand to the left of
the ELCR, owing to a SNP that reduces leftward transcription from its PcI promoter.
(A) Plaquing efficiency of ɸNM1γ6 on lawns of RN4220 harboring pGG3- or pGG3BsaI-derived type III CRISPR-Cas plasmids with different phage-targeting spacers.
Dotted line represents the limit of detection under these assay conditions. Error bars,
mean ± s.d. (n = 3, technical replicates). (B) Consensus sequences of the leftwardoriented PcI promoter within the ELCR of ɸNM1 and ɸNM1γ6. The SNP found in
ɸNM1γ6’s –10 element is shown in clay-red lettering. A putative transcription start site
(+1) is indicated by the bent grey arrow for ɸNM1. (C) Schematic diagram depicting a
relevant genomic region of ɸNM1γ6 that includes the ORF2 (xis) and ORF4 (cI-like
repressor) target regions, as well as the ELCR. Open black rectangles denote the
approximate positions of spacer 2B/2T and 4B/4T target sequences. The location of the
SNP in PcI is marked by a clay-red vertical line. Rightward-oriented bent grey arrow
represents the intact Pcro promoter. (D) Comparison of phage transcription profiles from
cells infected with ɸNM1 (grey lines) or ɸNM1γ6 (clay-red lines), 15 min post-infection.
Phage-derived transcripts are plotted in reads per million total-mapped reads (RPM)
relative to their position on the genome (only the first 5 kbp are shown). To improve
readability, curves were smoothened by plotting average reads per million values over
a 500 bp sliding-window. Arrows up top indicate the direction of transcription plotted
in each graph; the vertical dotted line marks the position of the ELCR.
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was conducting experiments with lysogens and the spacer 32T CRISPR-Cas plasmid,
which also proved fruitful.

2.3

Initial evidence for co-existence between functional type III CRISPR-Cas
systems and their DNA target elements in S. aureus lysogens

As explained in section 2.2, my analysis of two lysogenic clones which survived the
infection by ɸNM4(γ4) in a spacer 2B lawn seemed to suggest that type III-A CRISPRCas targeting could select for genetic escape outcomes in the event of lysogenization by
a lambdoid, chromosomally integrated prophage (Figure 2-6). In order to demonstrate
this more clearly without the need for co-infecting ɸNM4 wild type and ɸNM4γ4
mutant phages, Dr. Marraffini recommended that I take advantage of the lysogenic
conversion phenotype associated with ɸNM4 integration to screen for lysogenized
clones, by plating cells on egg yolk-supplemented agar after a brief infection. Upon sitespecific integration into TB4’s glycerol ester hydrolase (geh) locus, the ɸNM4 prophage
disrupts expression of this secreted lipase, and thereby reduces the visible breakdown
of lipids caused by colonies formed on egg yolk agar plates (Bae et al., 2006). The
unmodified, 32T spacer was initially tested in this ‘egg-yolk screen’. Approximately
1000 colonies were plated, and two were found to be geh- (that is, displaying reduced
lipid clearance on the egg yolk agar). A representative image of the two lysogenic
isolates plated on egg yolk agar is presented in Figure 2-11A alongside lysogenic and
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Figure 2-11. Characterization of ɸNM4 lysogens isolated from the egg yolk screen
with spacer 32T or 61T-1 CRISPR-Cas plasmids.
(A) Visualization of TB4-derived strains grown on egg yolk-supplemented agar.
Integration of ɸNM4 within the host’s geh locus results in strongly reduced breakdown
of lipids in the media, enabling a screen for ɸNM4 lysogenization. Right-most lanes
display two lipase-negative isolates (‘L1’ or ‘L2’) from the spacer 32T lysogenization
screen; left-most lanes display lipase-negative and lipase-positive control strains,
respectively (according to the labeling above). Picture is representative of at least five
technical replicates for each strain. (B) ɸNM2-sensitivity assay for the strains shown in
‘A’ (arranged in the same order from left to right). Single colonies were streaked
through the ɸNM2-seeded region from top to bottom. The ɸNM4 lysogen harboring
pGG3 and the non-lysogen harboring spacer 32T streaked in the two left-most lanes
serve as sensitive and insensitive controls, respectively. Picture is representative of
three technical replicates for each strain. (C) ɸNM2 plaquing efficiency on soft agar
lawns of the strains analyzed in ‘A’ and ‘B’, calculated by comparison with plaquing on
non-lysogenic lawns of TB4 harboring the pGG3 plasmid. (D) PCR amplification from a
lipase-negative isolate (‘L3’) of the spacer 61T-1 lysogenization screen, or from control
templates that produce wild type amplicon sizes (C). A colony lysate from the L3 isolate
was used to template three different PCRs using primers for the spacer 61T-1 target
region (right), primers for amplifying the CRISPR array (left), or primers for amplifying
from Newman phages at a separate, xis, locus (left). Size markers of 3 kbp and 0.5 kbp
in lane 1 are indicated. Additional replicates were not performed. Lanes 4, 5, 6, 7, 10, 11,
12, and 13 were used for other experiments. (E) ɸNM1 sensitivity assay for the 61T-1(L3)
egg yolk isolate characterized in ‘D’. The ɸNM4 lysogen harboring pGG3 in the leftmost lane serves as a sensitive control. Single colonies were streaked through the
ɸNM1-seeded region from top to bottom. Additional replicates were not performed.
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non-lysogenic controls displaying geh- and geh+ phenotypes, respectively. After
determining by PCR and Sanger sequencing that both isolates maintained intact
CRISPR arrays, I proceeded with more functional testing. Firstly, I confirmed that each
of the isolates maintained (CRISPR-dependent) immunity to ɸNM1 in plaque assays
(data not shown). In other words, these isolates hadn’t genetically inactivated their
spacer 32T CRISPR-Cas systems. I next investigated whether the resident prophage was
still wild type, by collecting supernatants with spontaneously induced PFU and replating them on both spacer 32T lawns and control lawns. Although some plaquing was
observed on control lawns, none was observed on spacer 32T lawns (data not shown).
This indicated that the phages derived from each lysogen were indeed still wild type, or
at least the majority of them were. While examining these isolates again prior to
publication (Goldberg et al., 2014), I confirmed that both are also resistant to ɸNM2
infection (as expected for strains with an intact spacer 32T CRISPR-Cas system).
Representative experiments with ɸNM2 are depicted in Figures 2-11B & C. Shortly after
the original egg yolk screen with spacer 32T, I repeated the screen under similar
conditions using the 61T-1 or 2B spacers. Although no colonies were identified in the
spacer 2B screen, in the 61T-1 screen, one geh- colony was again identified among the
~1000 colonies plated. I determined by PCR that this isolate had wild type amplicon
sizes at both its CRISPR array and prophage target region, and subsequently confirmed
its resistance to ɸNM1 by the streak-test method (Figures 2-11D & E). I also analyzed
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the spontaneously induced PFU derived from this isolate, and found that while some
plaques were formed on control lawns, none were formed on 61T-1 lawns (data not
shown). Again, this finding seemed to suggest that its resident prophage was wild type.
The results of these egg yolk screens seemed to indicate that, at least with certain
spacers, functional CRISPR-Cas systems could co-exist with non-mutant prophage
targets within lysogenic isolates. I noticed, however, that the number of spontaneously
induced PFU derived from these isolates appeared to be reduced relative to that of wild
type ɸNM4 lysogens. In my mind, this phenotype was reminiscent of the ɸNM1γ6
escape phenotype: co-existence between a functional CRISPR-Cas system and intact
target sequence occurred at least transiently, but not without evidence of a partial
interaction (presumably targeting). Corroborating the lysogeny results, I found
transformation of TB4::ɸNM4 single lysogens with spacer 32T CRISPR-Cas plasmids to
be moderately efficient. In one experiment, four transformants were confirmed by PCR
to have both their CRISPR array and target region amplicons intact (Figure 2-12A).
However, seemingly conflicting results were again obtained via electroporation of
spacer 2B CRISPR-Cas plasmids, this time into TB4::ɸNM1 single lysogens instead of
Newman. Of the nine transformants that were found in one experiment, 8/9 had lost
their CRISPR-Cas targeting functionality, as assessed by sensitivity to ɸNM4 infection
in the streak-test assay (Figure 2-12B). The remaining ɸNM4-resistant transformant was
noted to have lost its ɸNM1 prophage, although it’s unclear from my notes how this
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Figure 2-12. Transformation of single lysogens with type III CRISPR-Cas plasmids.
(A) PCR amplification from four randomly selected transformants isolated via an
electroporation of TB4::ɸNM4 lysogens with the spacer 32T CRISPR-Cas plasmid. After
re-streaking, a single colony lysate from each transformant was used to template two
different PCRs using primers for the 32T target region (left) or primers for amplifying
the CRISPR array (right). Size markers of 3 kbp and 0.5 kbp in lanes 1 and 10 are
indicated. Additional replicates were not performed on these isolates. (B) ɸNM4sensitivity assay for the nine transformants isolated via an electroporation of
TB4::ɸNM1 lysogens with the spacer 2B CRISPR-Cas plasmid. After re-streaking, single
colonies were streaked through the ɸNM4-seeded region from top to bottom. A
TB4::ɸNM1 lysogen harboring pGG3 and a TB4 non-lysogen harboring spacer 2B were
streaked in the two left-most lanes as sensitive (-C) and insensitive (+C) controls,
respectively. Additional replicates were not performed on these isolates. (C)
Transformation of RN4220::ɸNM1 lysogens with different CRISPR-Cas plasmids as
indicated. The pGG3 plasmid was transformed as a control (C). Transformation
efficiencies were calculated as the number of CFU per nanogram of miniprepped DNA
used for electroporation. Error bars, mean ± s.d. (n = 3, technical replicates).
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was assessed at the time. Plausibly, the strain was found to be sensitive to one of my
ɸNM1-derived spacer 2B escapers, such as ɸNM1γ1 or ɸNM1γ6, or that the ɸNM1
prophage simply could not be detected by colony PCR. Representative transformation
efficiency data, later collected with RN4220::ɸNM1 lysogens, are shown in Figure 212C.
At this point, I was piecing together a model that could account for the various
results. On the one hand, immunity to lytic infection was licensed by spacers targeting
either strand of the phage genomes (2B, or 32T and 61T-1). On the other hand, the 2B
spacer exhibited a distinct phenotype from the 32T and 61T-1 spacers in the context of
lysogeny (Figures 2-6 & 2-12). Meanwhile, most of the sense-oriented spacers that had
been tested so far (16B, 19B, 56B, 61B-1 and 61B-2) all failed to license immunity. The 2B
spacer is distinct from other bottom-strand-targeting spacers in that its target is located
within a cluster of leftward-oriented ORFs to the left of the ELCR (Figure 2-2). At least in
part, ORF orientations are predicted to reflect differences in the directionality of
transcription throughout phage genomes. Based on these predictions, I reasoned that a
directional transcription requirement for type III-A targeting could explain functional
consequences associated with the orientation of spacers relative to their target region(s).
In other words, if type III-A immunity required that targets are transcribed in the
antisense orientation relative to a spacer’s crRNA, this could explain why the 2B, 32T,
and 61T-1 spacers were all functional, while the others were not. An apparent
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inconsistency here was that the wild type nes spacer is sense-oriented relative to its
target ORF, but was shown to license pG0400 targeting in conjugation assays
(Marraffini and Sontheimer, 2008). However, my colleague Wenyan had also found that
an antisense-oriented spacer complementary to the opposite strand of this target
sequence (but arbitrarily also shifted 2 bp upstream; ‘nes3’) could provide immunity to
pG0400 (personal communication). Therefore, the results would still be explained if this
nes target region is bi-directionally transcribed, such that the sense-oriented wild type
spacer would in fact be complementary to a non-template strand when considering
transcription from downstream. Given that the downstream ORF was oriented in the
opposite direction, this seemed plausible. Also note that my model assumed the
directional transcription requirement to be a pre-requisite for DNA targeting, which,
would not necessarily distinguish between whether the sequence was coding or noncoding, and instead distinguish directionality on the basis of whether the strand was
templating or non-templating for an RNA polymerase. Thus, the rightward-oriented
reading frame of xis would not necessarily impact targeting by 2B. Moreover, evidence
was mounting that type III systems could directly cleave complementary RNAs (Hale et
al., 2012; Hale et al., 2009; Zhang et al., 2012), and this did not go unnoticed by our lab.
RNA transcripts, naturally, are produced from transcribed DNA, and the strand
polarity of a given transcript is derived from the directionality in which it is transcribed.
I reasoned, therefore, that it would not be entirely unprecedented if our type III-A
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system could also in some way respond to the polarity of transcriptional events
(possibly, but not necessarily, via the RNA transcripts—even if this were to ultimately
result in DNA targeting). Importantly, a directional transcription requirement for type
III-A targeting could account for the various results I was observing with lysogens.
During lysogenic infections, lambdoid prophages repress transcription of most lytic
genes, but can sustain transcription of one or more genes required for maintenance of
lysogeny (Casjens and Hendrix, 2015; Ptashne, 2011). Targets of the 32T and 61T-1
spacers lie within lytic regions of the Newman phage genomes and were presumably
repressed during lysogeny, whereas the spacer 2B target lies within a small intervening
region of the lysogeny genes downstream of the cI-like repressor, just before int.
Conceivably, the 2B target could be transcribed in lysogens by read-through from an
upstream promoter, such as the leftward PcI promoter found in the ELCR (Figures 2-2).
In other words, chromosomal targeting would occur in lysogens where a target in the
proper orientation falls within an actively transcribed region, but not necessarily where
a repressed lytic gene is targeted. Although sustained integrase expression is not
required for lysogenic maintenance in phage λ (Casjens and Hendrix, 2015), there are
noticeable differences in the genomic organization of λ and the Newman phages, so it
was reasonable to suspect that their transcriptional patterns would also differ. For
example, in lambda, the xis ORF is oriented in the same direction as int, but they’re
oppositely oriented in the Newman phages. Furthermore, the possibility that targeting
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was licensed by even low levels of transcriptional read-through in this region could not
be excluded (i.e., regardless of whether the transcription was functionally relevant to int
expression), and would perhaps explain why lytic infection was blocked by the 2B
spacer despite the position of its target between lysogeny genes. Finally, I reasoned that
the ɸNM1γ6 CRISPR-escape and clear-plaque phenotypes might also be explained if its
mutation(s) disrupts leftward transcription of the lysogeny genes: weakened leftward
transcription could both reduce the chance of DNA targeting by the spacer 2B CRISPRCas system during lytic infections, and also prevent the establishment of lysogeny.
A number of these points were still hypothetical of course, so I conceived some
plans to test the model further. In particular, I wanted to confirm the directional
transcription requirement using an inducible promoter system (ideally carried on a
plasmid, for ease of manipulation) where I could insert a target sequence in both
orientations relative to the promoter, and then assay for targeting upon induction.
When I shared these ideas with Wenyan, he excitedly agreed that, if confirmed, the
directional transcription requirement would nicely explain the phage results, and
perhaps other findings as well. For example, in some of his early experiments where he
designed a few chromosome-targeting spacers for the type III-A system in S. epidermidis,
only the antisense-oriented spacers seemed to offer strong targeting. Furthermore,
when we looked into some of the naturally occurring, temperate-phage-targeting
spacers that had been sequenced, all of them (including the 32T spacer) appeared to be

74

antisense-oriented relative to their target ORFs. At the time, however, no one in the lab
had been working with tightly regulated inducible systems (which I assumed might be
valuable in this case), so we consulted Dr. Marraffini to discuss the logistics. When I
proposed the idea, he suggested that I use one of the pCL55-derived integrative vectors
we had received from Angelika Gründling, which were already designed for inducible
expression. These were the IPTG- and (Anhydro)tetracycline-inducible vectors referred
to as pCL55-iSpac and pCL55-iTET, respectively. The pCL55-iTET plasmid, I now
presume, refers to the pitet plasmid published previously (Grundling and Schneewind,
2007). My CRISPR-Cas plasmids contained the same chloramphenicol resistance
marker, so Dr. Marraffini pointed out that I would simply need to replace the resistance
marker on one of these pCL55-based vectors. Moreover, because these vectors allow
plasmid manipulations to be carried out in E. coli, cloning with them was expected to be
straightforward (and indeed, at least for the pCL55-iTET vector, generally was).
Ultimately, although chromosomal targeting of these integrative vectors imposed
certain experimental limitations, it provided the answers we were looking for, and
nicely emulated the prophage-targeting scenario encountered during lysogeny.
Both the design and results of these inducible targeting experiments, along with
additional evidence which confirmed the directional transcription requirement for type
III targeting, are described in the following section (2.4). Before these experiments were
completed, however, the data from our phage sequencing was received and proved to
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be highly encouraging. I owe a great many thanks to Dr. Bikard for procuring free
software to analyze this data in a timely fashion (including SAMtools (Li et al., 2009)
and IGV (Robinson et al., 2011), and later also ABySS (Simpson et al., 2009) for de novo
assembly). Quite excitingly, ɸNM1γ6 turned out to harbor a SNP at a crucial position of
the -10 element in a leftward promoter immediately upstream of its cI-like repressor
gene (Figure 2-10B). Although this SNP was located ~1700 bp away from the target
sequence (Figure 2-10C), presumably, it would reduce leftward transcription and allow
escape from spacer 2B (as well as reducing the phage’s ability to lysogenize). The
remaining CRISPR-escape mutants that hadn’t been mapped by PCR were confirmed to
harbor target site deletions. Preliminary analyses for 14 deletion mutants (Figure 2-13A)
were presented along with the results of Figure 2-7 at the Bacteria, Archaea, & Phages
Meeting in Cold Spring Harbor (August 2012). Among these was the ɸNM4γ4 clear
mutant that was ultimately adopted by my colleagues for type II adaptation
experiments (Heler et al., 2015; McGinn and Marraffini, 2016; Modell et al., 2017), and
which infects RN4220 somewhat more robustly than my ɸNM1γ6 clear mutant. In
addition to its 2784 bp deletion in the lysogeny cluster, ɸNM4γ4 harbored a stretch of
sequences (~3101 bp) in its late structural/lytic gene cluster that mapped more closely to
other phages, such as bacteriophage ROSA (Accession: AY954961.1), than to ɸNM4 or
any of the Newman phages. Presumably owing to the potential for recombination
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Figure 2-13. Summary of γ-series, α-series, and τ-series phage mutants that escaped
type III CRISPR-Cas targeting via target site deletions.
(A) Schematic diagrams depicting a relevant genomic region of ɸNM1 and ɸNM4
phages that includes the spacer 2B (xis) target region. (B) Same as in ‘A’, except for the
spacer 32T target region escaped by three ɸNM2 and four ɸNM4 phages. The ɸNM4ω8
phage was originally isolated from a lysogen that escaped pG0400 conjugation,
following ɸNM4 infection of TB4 cultures harboring the spacer 32T CRISPR-Cas
plasmid. Sequencing revealed a 656 bp target site deletion that was also found in two
ɸNM4 α-series escapers. (C) Same as in ‘A’, except for two ɸNM1 and one ɸNM2
escaper of the 61T-1 spacer. In each case, deleted sequences are delimited by vertical
lines, and their sizes are denoted on the far right (Δ). ORFs were labeled according to
their predicted gene products (where applicable), and target ORFs were color-coded as
in Figure 2-7. Open black rectangles denote location of the 35- or 36-bp target sequence.
In some cases, incomplete deletion of the target sequence was sufficient for evasion of
the CRISPR-Cas system.
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during co-infection, phage ‘mosaicism’ appears to be a common phenomenon (Brüssow
et al., 2004; Martinsohn et al., 2008), and was assumed to explain the finding. Although
we do not work with phage ROSA, it is not inconceivable that a contaminating phage
from our lab environment, related to ROSA, could have produced this recombination
event. However, if such a recombination did occur in our lab, it likely happened prior to
the initial CRISPR selection step(s), because my other ɸNM4-derived escaper phages
also harbored the same recombinant sequence at this region. Verifying the ɸNM4
prophage sequence at this region in our Newman isolate, or in our original ɸNM4
single lysogen isolate, might help to tease out this point. The ɸNM1γ1 mutant,
meanwhile, was found to harbor a 396 bp deletion which included the integrase start
codon but did not disrupt the cI-like repressor ORF upstream. This offered an
explanation for why I was never able to isolate stable lysogens of ɸNM1γ1, despite its
turbid plaques (data not shown). In other words, ablation of its integrase function
appears to have resulted in an ‘abortive lysogeny’ phenotype (Gottesman and
Weisberg, 2004). Regarding the escapers of spacer 32T, three out of my four ɸNM4
mutants harbored the same 656 bp deletion at the target region, whereas my three
ɸNM2 mutants harbored three different deletions. The 656 bp deletions appear to have
utilized 12 bp direct repeat microhomologies that flank the 32T target in ɸNM4. The
downstream repeat is absent from ɸNM1 and ɸNM2, which may explain why the 656
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bp deletion was not observed in ɸNM2 mutants, and perhaps also why the frequency of
escape was found to be much higher for ɸNM4 than for ɸNM1 or ɸNM2 (Figure 2-7C).
On top of the phage sequencing results, I was further encouraged by a result that
I obtained at this time using the pG0 conjugation assay, which seemed to support the
notion of a directional transcription requirement for type III targeting in general.
Previously, I had cloned a spacer called nes-γ(B) which was intended to target pG0mut
on the same strand as the wild type nes spacer, but ~1000 bp upstream of the engineered
SNPs (Figure 2-14A). However, this sense-oriented spacer never provided immunity.
Once I began noticing the strand requirement pattern in my plaque assays, I finished
cloning the inverted, antisense-oriented equivalent of this spacer (nes-γT) and found
that it indeed prevented conjugation by pG0mut (Figure 2-14B). I interpreted this to
mean that inverse-oriented transcription from the downstream ORF might not read all
the way through to the nes-γB target. In hindsight, this result should be interpreted with
additional caution, because the two-spacer CRISPR arrays I was using still contain the
wild type nes spacer in position 1 (see Figure 2-7B for an example). Therefore, the wild
type nes spacer might license some effect on pG0mut at the mismatched target site
downstream, even though it does not reduce conjugation efficiency in the presence of
these mismatches. For example, type III-A systems were eventually found to cleave
complementary target RNAs
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Figure 2-14. Apparent directional transcription requirement for type III targeting of
pG0mut at a nickase sequence upstream of its mutations.
(A) Schematic diagram depicting a relevant genomic region of the pG0mut plasmid,
including its nickase target gene and oppositely oriented downstream gene encoding an
LtrC-like protein, scaled according to their ORF annotations in pGO1 (Accession
number: NC_012547.1). The location of the pG0mut SNPs at the target of the native type
III-A nes spacer in CRISPR position 1 are marked with a solid red rectangle. Along with
the native nes spacer target, the nes-γB (sense) and nes-γT (antisense) targets ~1000 bp
upstream are also indicated. (B) Conjugation assays performed with pG0mut as in
Figure 2-3. In this dataset (single experiments), recipients harbor type III CRISPR-Cas
plasmids with the nes-γB or nes-γT spacers in position 2, or the pGG3 parent vector
harboring only the nes spacer in position 1 (C). Conjugation efficiencies denote the ratio
of transconjugants to recipients measured in each experiment.
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(Samai et al., 2015; Staals et al., 2014; Tamulaitis et al., 2014), and this even occurs in the
presence of partial mismatching (Staals et al., 2014; Tamulaitis et al., 2014). Thus, the
wild type nes spacer might potentially license cleavage of antisense transcripts
originating from downstream. However, it’s unclear whether this effect could result in
sufficiently diminished transcriptional read-through to the nes-γB spacer’s target, or
whether some other less-expected effect(s) might arise from the mismatching.

2.4

Demonstration of a directional transcription requirement for in vivo targeting
by a type III CRISPR-Cas system

Prior to working with the pCL55-iTET vector, I had attempted to amplify from the
pCL55-iSpac vector in unrelated PCR experiments, but was unsuccessful. This time, I
set out with parallel efforts to replace the antibiotic resistance marker on both of these
integrative vectors. Although I was again unsuccessful at amplifying from the pCL55iSpac vector, I managed to replace the pCL55-iTET’s chloramphenicol resistance marker
with a kanamycin resistance marker to create pKL55-iTET. Using this vector, I designed
my first chromosomal targeting system around the 16B/16T spacer pair (Figures 2-2 and
2-15A), since it was the first pair of phage-targeting spacers I had designed to be the
exact inverse of each other. The 61B-1/61T-1 and 61B-2/61T-2 pairs, for example, were
still slightly off-set from one another (Table 2-1). Therefore, I could readily design
targets for the 16B/16T spacers that were the exact inverse of one another, and insert
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them downstream of the inducible promoter. In previously published work,
chromosomal targeting by CRISPR-Cas systems was shown to be toxic, and perhaps
even lethal (Edgar and Qimron, 2010). Generally, transformation experiments in the lab
thus far had yielded similar outcomes (including Wenyan and Dr. Bikard’s initial

Figure 2-15. Transformation of strains containing first-generation integrative target
vectors with type III CRISPR-Cas plasmids harboring spacer 16T or 16B.
(A) Schematics summarizing the orientation of spacer 16T or 16B crRNAs (orange and
blue arrows) relative to a forward (left) or reversed (right) target sequence downstream
of the Pxyl/tet promoter in first-generation integrative vectors. Leftward-oriented arrows
(depicted above) represent crRNAs with complementarity to the non-template strand
relative to rightward Pxyl/tet transcription; rightward-oriented arrows (depicted below)
represent crRNAs with complementarity to the template strand. (B) Transformation of
RN4220-derived strains with spacer 16T or 16B CRISPR-Cas plasmids in the presence of
ATc. Electrocompetent cells possessed either the ‘Targetless’ parent vector insertion, the
forward ‘Target’ vector insertion, or the ‘Reverse’ target vector insertion, and were
transformed using the same miniprep for either CRISPR-Cas plasmid cloned in RN4220.
A constant volume of each miniprep was electroporated across experiments, and the
concentration of transformants (CFU / ml) recovered after electroporation was
quantified by selective plating. Error bars, mean ± s.d. (n = 2, technical replicates).
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genome editing experiments (Jiang et al., 2013a) with type II systems in Streptococcus
pneumoniae, unpublished at the time). It was therefore intuited that a growth and/or
transformation efficiency reduction in the presence of ATc could likewise be used as a
readout for CRISPR-Cas targeting of my inducible vectors in the chromosome.
Although this targeting setup provided a preliminary proof-of-principle that type III-A
spacers could be either targeting or non-targeting depending on their orientation
relative to a nearby promoter (Figure 2-15B), this particular system was not inducible
(i.e., when targeting occurred, it occurred even in the absence of the ATc inducer for at
least one of the two spacer-target orientations). In order to more definitively
demonstrate a transcriptional requirement for type III-A targeting, I endeavored to
reproduce these results with a more tightly-regulated inducible promoter system.
Ideally, my spacers and targets might co-exist in the absence of the transcriptional
inducer, as they could in lysogens. The Pxyl/tet promoter architecture employed in pCL55iTET is also found in pKOR (Bae and Schneewind, 2006), and was originally designed as
an engineered promoter system for Bacilli (Geissendorfer and Hillen, 1990). By default,
this Pxyl/tet promoter in pWH353 had a single tetO operator and was known to be
relatively leaky, but various modifications—including addition of a second tetO
operator downstream—have been shown to reduce its leakiness (Geissendorfer and
Hillen, 1990; Helle et al., 2011). The modified promoter system I ultimately selected was
based on the pRAB12 architecture described previously (Helle et al., 2011), because it

84

was shown to promote virtually undetectable expression levels in the absence of
inducers, while still offering moderate expression levels in their presence. Its overall
regulatory architecture is similar, with divergently transcribed PtetR- and Pxyl/tet-based
promoters, but it includes various modifications which I introduced into pKL55-iTET in

Figure 2-16. Modification of pKL55-iTET to create pKL55-iTET-RC12 secondgeneration target insertion vectors.
(A) Scaled representations of the ATc-inducible promoter region found within pCL55iTET-derived vectors between the tetR start codon (left) and the multiple cloning site
beginning with AvrII (right). The pKL55-iTET first-generation architecture is
schematized at the top. Three-step modification produced the pKL55-iTET-RC12
second-generation architecture (bottom) based off pRAB12 (Helle et al., 2011). The
additional 17 bp in pKL55-iTET-RC12 creates a new TetR binding site (‘tetO3’)
downstream of Pxyl/tet*. Meanwhile, the TetR binding site that overlaps the PtetR promoter
(‘tetO1’) is disrupted at the modified promoter, PtetR*. Bent arrows denote the
approximate positions of transcriptional start sites for each promoter; dashed bent
arrows signify that their promoter ’s consensus is predicted to drive weaker constitutive
transcription relative to its first- or second-generation counterpart.
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three steps (Figure 2-16). Firstly, I introduced the two pRMC2 (Corrigan and Foster,
2009) SNPs which are thought to strengthen tetR expression by improving its
promoter’s –10 consensus, and perhaps also disrupting the consensus of its overlapping
tetO operator (Stary et al., 2010). In turn, stronger expression of the tetR repressor gene
is thought to reduce leakiness from Pxyl/tet-based promoters. In the next step, I weakened
the Pxyl/tet promoter by introducing a SNP into its –10 consensus. Finally, I introduced a
second tetO operator downstream to strengthen the potential for repression. The
resulting pKL55-iTET-RC12 vector with sequences matching to pRAB12 (Helle et al.,
2011) was used in downstream manipulations.
In parallel efforts, I continued to clone spacers that would corroborate the strandbiased pattern of type III phage targeting. These included the 4B, 4T, 32B, 43B, and 43T
spacers (Figure 2-2). The 4B/4T spacers matched to ɸNM1’s cI-like repressor gene, while
the 43B/43T spacers matched to its “head protein” gene (Table 2-1). By designing these
additional ɸNM1-targeting spacers, I was able to further characterize the ɸNM1γ6
escape phenotype. For example, the 4B spacer was escaped by ɸNM1γ6, while the 4T,
16T, 43T and 61T-1 spacers were not (Figure 2-10A). Assuming a directional (i.e., nontemplate strand) transcription requirement for type III-A targeting, this was consistent
with a reduction in leftward transcription across the spacer 2B and 4B targets that is
predicted to result from the upstream promoter SNP (Figure 2-10C). In addition, the
spacer 4B CRISPR-Cas plasmid—which provides immunity to wild type ɸNM1 in
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plaque assays (Figure 2-2C)—was found to reduce lysogen transformation efficiency to
a similar degree as the spacer 2B plasmid (Figure 2-12C). In this case, the reduced
transformation efficiency observed solely with these 2B and 4B spacers would be
explained if their targets are the only among those that I tested which are actively
transcribed in the proper orientation within lysogens. Meanwhile, the other spacers
target ɸNM1 within lytic regions, or within the same lysogeny region but on the
template strand of transcripts arising from the leftward promoter upstream of its cI-like
repressor. The original 2T spacer (2Told) was also cloned at this time, but provided
virtually no targeting in my plaque and transformation assays. It was later realized that
the exact inverse of the 2B spacer (found in this original 2Told construct) contained
excessive 5’ handle complementarity which probably prevented type III targeting. This
spacer was therefore re-cloned with a 2 nucleotide shift (Table 2-1) that produced the
expected targeting behavior in efficiency of plaquing (Figure 2-2C) and transformation
efficiency assays (Figure 2-12). However, transformants harboring this adjusted 2T
CRISPR-Cas system generally exhibited a small-colony phenotype. Given what I had
observed with my leaky first-generation chromosomal target vectors, where small
colonies were observed in one of the orientations even in the absence of ATc, but not at
all in the other (data not shown), it seemed plausible that this could reflect low levels of
chromosomal targeting. It also seemed plausible that this could result, specifically, from
low levels of rightward transcription across the xis ORF in lysogens. At this point, we
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were still basing our interpretation of these results on various transcriptome predictions,
largely inferred from the directionality of predicted ORFs within the ɸNM1 annotation.
It was clear that actual transcriptome data from ɸNM1-infected cells could serve to
validate these interpretations, so I discussed plans with Dr. Marraffini to obtain this
using ‘stranded’ RNA-seq. Wenyan was also planning an RNA-seq experiment to study
plasmid targeting at the time, so we ended up pooling a few samples together in what
was assumed to be a mere pilot run. Ultimately, the stranded transcriptome analysis for
one of the samples in this run—a logarithmically growing RN4220::ɸNM1 single
lysogen—was used for publication (Goldberg et al., 2014). It confirmed, among other
things, that there is indeed a slightly higher peak of rightward transcription across the
spacer 2B/2T target region, relative to other target regions (Figure 2-17). Another
sample from this run with ɸNM1-infected non-lysogens harvested 15 minutes postinfection also looked promising, and so I made plans to repeat this with four time
points in succession, and also include two equivalent early time points with ɸNM1γ6.
In additional parallel efforts, I was cloning a type II CRISPR-Cas plasmid for
targeting of ɸNM1 that I figured would be useful as a control for CRISPR-Cas targeting
of lytic regions in S. aureus lysogens. In other words, I wanted to show that a
presumably transcription-independent CRISPR-Cas system would prevent lysogeny in
this host background even if type III systems targeting the same lytic region(s) did not.
The first type II spacer I designed (16B-tII) overlapped the 16B/16T target region, and
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was intended to be able to target my ‘first-generation’ chromosomal target insertions in
either orientation, regardless of the ATc inducer’s presence or absence. My colleague
Wenyan had already cloned the entire S. pyogenes SF370 type II-A CRISPR-Cas system
on pWJ40, so I made plans to modify its CRISPR array, similar to as I had done for

Figure 2-17. ɸNM1 prophage transcription profiles from a logarithmically growing
lysogen.
(A) Rightward and leftward expression values are plotted as golden and purple lines,
respectively, in reads per million (RPM). The position of relevant spacer targets are
indicated with vertical solid lines. The dotted line with divergent arrowheads marks the
position of the early lytic control region (ELCR) with divergently oriented PcI and Pcro
promoters. To improve readability, curves were smoothened by plotting average reads
per million values over a 500 bp sliding-window. Noticeable leftward expression
originates from the ELCR and a few upstream regions that presumably encode functions
involved in lysogenic maintenance and/or prophage morons (Brüssow et al., 2004;
Cumby et al., 2012). Rightward transcription was weaker than leftward transcription as
expected, but not absent, and includes a peak that overlaps the xis ORF targeted by the
2B/2T spacers.
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pWJ30β. The first step involved reducing the CRISPR array of pWJ40 to a single repeat,
creating pGG32. Type II systems were not known to function without a downstream
repeat flanking their spacer(s) of interest, so I would have to construct the 16B-tII
CRISPR-Cas plasmid in two steps using my blunt ligation method, without drastically
increasing my primer lengths. The first step would add the spacer, and the second
would add the downstream repeat. By the time this construct was cloned, I had already
elected to use a different target region in my ‘second-generation’ chromosomal
targeting vectors (explained below). Fortunately, Dr. Bikard was cloning his first type II
parent vectors with a single placeholder spacer containing two oppositely oriented BsaI
restriction sites. These allow for 1-step replacement of the placeholder spacer with
annealed oligo pairs containing a (spacer) sequence of interest. My subsequent cloning
of type II CRISPR-Cas plasmids utilized this method, along with Dr. Bikard’s parent
vectors. Therefore, although the pGG33 construct with spacer 16B-tII was capable of
targeting ɸNM1, it was never included in my published work. However, along with the
ɸNM4γ4 clear mutant (lytic) phage I had isolated, the pGG32 (single repeat) precursor
ultimately proved useful for my colleague, Robert Heler, in some of his type II
adaptation experiments (Heler et al., 2015). Meanwhile, after learning of the BsaI
cloning method, I adopted it to construct subsequent type III CRISPR-Cas plasmids as
well. This was initially accomplished with a new type III parent vector called pGG3BsaI, which I created by introducing the same placeholder spacer from Dr. Bikard’s
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vectors at position two of the CRISPR array (just as I had previously introduced my
phage-targeting spacers into pGG3).
When designing my second-generation chromosomal targeting system, I elected

Figure 2-18. Transformation of strains containing second-generation integrative
target vectors with type III CRISPR-Cas plasmids harboring spacer 43T or 43B.
(A) Schematics summarizing the orientation of spacer 43T or 43B crRNAs (orange and
blue arrows) relative to a forward (left) or reversed (right) target sequence downstream
of the Pxyl/tet* promoter in second-generation integrative vectors. Leftward-oriented
arrows (depicted above) represent crRNAs with complementarity to the non-template
strand relative to rightward Pxyl/tet* transcription; rightward-oriented arrows (depicted
below) represent crRNAs with complementarity to the template strand. (B)
Transformation of RN4220-derived strains with spacer 43T or 43B CRISPR-Cas
plasmids in the presence or absence of ATc. Electrocompetent cells possessed either the
forward ‘Target’ or ‘Reverse’ target vector insertions, and were transformed using the
same miniprep for either CRISPR-Cas plasmid cloned in RN4220. Transformation
efficiencies were calculated as the number of transformants per ng of miniprepped
DNA used for electroporation (CFU / ng). Error bars, mean ± s.d. (n = 3, technical
replicates).
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to use the 43B/43T spacer pair (Figure 2-18A). This was done in part because, as Dr.
Marraffini pointed out to me, it would be easier to explain that we’d taken a phage lytic
gene target if its gene product was known to be a head protein, as opposed to a
‘hypothetical’ protein. Furthermore, shortly after I designed my first type III spacer
(16B), which was 34 bp in length, I realized that the majority of sequenced spacers our
lab had identified in staphylococcal type III-A systems were actually either 35 or 36 bp,
and began designing my spacers as such. Among these were the 43B and 43T spacers,
which each had 36 bp. Therefore, I figured it would also be appropriate to utilize
spacers exhibiting a more representative length, such as these. This time, the system
was ATc-inducible; virtually no targeting was apparent in the absence of ATc for either
orientation (Figure 2-18B).
After hearing of these results, Dr. Bikard voiced some concern that addition of
the ATc inducer might be simply unmasking a strand discrepancy that arises during
DNA replication (e.g., leading vs. lagging strand discrepancies), since it was always the
same DNA strand being targeted in my constructs relative to the chromosome’s origin
of replication. I was not particularly concerned in this instance, because we had already
observed type III targeting on both strands in multiple contexts. For one, my advisor
originally found this while transforming with pC194-based plasmids in which he’d
inserted the S. epidermidis RP62a nes spacer’s target region in both orientations
(Marraffini and Sontheimer, 2008). Wenyan had essentially also shown this in pG0400
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conjugation assays, when comparing the wild type nes spacer to his inverted (and 2 bpshifted) nes3 spacer as described above. Now, I was finding this as well in plaque assays
with ɸNM1, using my 4B/4T spacer pair (Figure 2-2C). The Deng et. al. report (Deng et
al., 2013) on PAM-independent targeting by a type III-B system in S. islandicus REY15A
was also encouraging in this regard, and it was released online shortly after I obtained
preliminary replicates with my second-generation chromosomal targeting vectors.
Using plasmid-targeting transformation assays, this study essentially confirmed what I
had found with my first-generation chromosomal targeting vectors: type III targeting
was only licensed by crRNAs with complementarity to the non-template strand of a
target sequence relative to a nearby promoter. This work also found that you could
complement the non-targeting, template-strand-complementary scenario by
introducing an oppositely oriented promoter downstream of the target, to ensure that
the spacer’s crRNAs would once again bear complementarity to a non-template strand
(in this case relative to the secondary promoter). Therefore, they too had demonstrated
targeting on both strands of a DNA element. Presumably, these results would not have
been observed if there was a strict replicative requirement for targeting of one particular
strand but not the other. Based on these data, however, I could not exclude the
possibility that a replicative strand discrepancy might be sufficient to license targeting
on one strand in certain contexts, even if type III targeting were otherwise transcriptiondependent. To rule out such possibilities, I inverted the attP region (including putative
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cis elements adjacent to the core motif (Lee and Buranen, 1989)) on my pKL55-iTETRC12-derived vectors such that they would integrate in the opposite orientation relative
to their host’s chromosome. Using PCR, I confirmed that my inversions were successful;
the vector-external primers must be swapped in order to amplify across an attL or attR
junction with the same vector-internal primer adjacent to attP (Figure 2-19). Essentially
the same results were observed in transformation assays when I tested these inverted

Figure 2-19. Schematic diagram summarizing site-specific integration by pKL55iTET-RC12-derived vectors and their inverted attP variants.
(A) As described for the original pCL55 vectors (Lee et al., 1991), site-specific
integration of pKL55-iTET-RC12-derived vectors utilizes an attB attachment site in the
S. aureus RN4220 chromosomal geh locus, along with an attP motif (derived from
bacteriophage L54a) present on the plasmids. Primers ‘1’ (oGG50) and ‘3’ (oGG96) can
amplify across the attL junction that results from recombination with the unmodified
attP, while primers ‘2’ (oGG51) and 3 only amplify across the attR junction that results
from integration of a vector with an inverted attP motif. Features of the diagram are
scaled arbitrarily.
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Figure 2-20. Testing of second-generation inducible targeting vectors integrated in
the inverse orientation relative to the chromosomal origin of replication.
(A) Schematics summarizing the orientation of spacer 43T or 43B crRNAs (orange and
blue arrows) relative to a forward (left) or reversed (right) target sequence downstream
of the Pxyl/tet* promoter in second-generation, inverted-attP integrative vectors.
Leftward-oriented arrows (depicted above) represent crRNAs with complementarity to
the template strand relative to leftward Pxyl/tet* transcription; rightward-oriented arrows
(depicted below) represent crRNAs with complementarity to the non-template strand.
(B) Transformation of RN4220-derived strains with spacer 43T or 43B CRISPR-Cas
plasmids in the presence or absence of ATc. Electrocompetent cells possessed either the
‘Inv-attP-Targetless’ vector insertion, the forward ‘Inv-attP-Target’ vector insertion, or
the ‘Inv-attP-Reverse’ target vector insertion, and were transformed using the same
miniprep for either CRISPR-Cas plasmid cloned in RN4220. Transformation efficiencies
were calculated as the number of transformants per ng of miniprepped DNA used for
electroporation (CFU / ng). Error bars, mean ± s.d. (n = 3, technical replicates). (C) Highresolution growth curves of Inv-attP strains harboring the spacer 43T CRISPR-Cas
plasmid. Each of the indicated strains was grown in the presence (solid lines) or absence
(dashed lines) of ATc addition at the indicated time point (black arrow), and were
originally isolated as CRISPR-Cas plasmid transformants plated in the absence of ATc.
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attP variants with both forward and ‘reverse’ target insertions (Figure 2-20A), along
with my inverted variant of the ‘targetless’ RC12 parent vector as a control (Figure 220B). The result was reassuring. At least in this region of the chromosome,
unidirectional transcription appears to be sufficient to drive strand discrepancies
associated with type III-A targeting. I also tested these vectors with the spacer 43T
CRISPR-Cas plasmid in high-resolution growth curves (Figure 2-20C), and found that
severe growth reductions were only observed upon addition of ATc with the forward
target insertion (where spacer 43T’s crRNAs are complementary to the target’s nontemplate strand). Note that transformation efficiency data collected with the parental
orientation was arbitrarily presented as ‘Inv-attP’ in the publication’s extended data
section (Goldberg et al., 2014), because I had not collected high-resolution growth
curves with the parental orientation, and we wanted to introduce transformation and
growth curve data together in a primary figure. It was decided that showing data from
two different sets of strains side by side could be potentially awkward or confusing, so
the main figure data utilized the inverted attP constructs for which I’d collected both
types of data, but it was simply presented as the default orientation rather than InvattP. Note, also, that some growth reduction is apparent upon addition of ATc at this
concentration (0.5 μg/ml), even for the targetless control strain (Figure 2-20C). This
concentration was arbitrarily adopted from a modified pKOR (Bae and Schneewind,
2006) protocol circulating in the lab, which uses the Pxyl/tet promoter for antisense secY
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transcription. In different assays more recently, I’ve worked with lower ATc
concentrations of 0.250 μg/ml and 0.125 μg/ml. Some general growth reduction is still
observable at 0.250 μg/ml, although not at 0.125 μg/ml. This is consistent with the
findings of a previous study on Pxyl/tet-based promoters in S. aureus, which reported that
growth is not noticeably affected at ATc concentrations of 0.128 μg/ml, although strong
induction could still be achieved here (Corrigan and Foster, 2009). Another study
reported working with concentrations up to ~0.185 μg/ml (Helle et al., 2011).
Concentrations in the range of 0.125-0.185 μg/ml are therefore probably ideal for the
purpose of optimally inducing Pxyl/tet-based promoters in S. aureus with minimal toxicity.
At this point, I had lingering concerns of my own, regarding the absence of a
repeat downstream from my phage-targeting spacers. Perhaps this CRISPR architecture
was producing unforeseen effects in phage assays—or worse, allowing for the
conditional tolerance phenomenon altogether! I first became suspicious when I noticed
that the pGG3 plasmid has a phenotype in the conjugation assay relative to either
pWJ30β or my phage-targeting derivatives, which, unlike pGG3, all have a repeat
downstream of the nes spacer. Although pGG3 comparably reduces conjugation
efficiency when colonies are scored by eye, it allows for something which I could only
describe as ‘pin-point puncta’ to form atop the background of counter-selected (‘dead’)
cells. I was never able to re-isolate pin-point puncta from these background spots by restreaking; and, upon prolonged incubation, they never outgrew the background (and in
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fact seemed to become part of the local lawn). In hindsight, the nature of these puncta
might have been partially clarified with the use of a basic light microscope! In any case,
before confirming that the downstream repeat was sufficient for alleviation of the pinpoint puncta phenotype, I had decided to clone a repeat downstream of the 32T*B
spacer in my pGG14 plasmid (to produce the pGG22 plasmid). Testing of this 32T*B(-R)
(pGG22) plasmid had initially allayed my concerns because the addition of the repeat
did not produce a noticeable phenotype in ɸNM4 plaque assays (data not shown).
However, I subsequently confirmed that the addition of a repeat downstream of the nes
spacer in pGG3 (creating pGG25) was sufficient to eliminate the pin-point puncta
phenotype. This confirmed that, at least in certain contexts, the absence of a
downstream-flanking repeat could produce a phenotype. Hence, there was still cause
for concern that the absence of a repeat downstream from my phage-targeting spacers
could affect my results in other assays. For example, perhaps the ‘tolerance’ of
chromosomal targets I was finding in various assays could be an unnatural by-product
of this. Note that these CRISPR array architectures are not found in natural
staphylococcal type III-A systems. I therefore compared transformation with the spacer
32T*B and 32T*B(-R) CRISPR-Cas plasmids in lysogen transformation assays. Each
plasmid produced similar numbers of TB4::ɸNM4 lysogen transformants, and also
similar numbers of RN4220::ɸNM1 lysogen transformants (data not shown). This,
finally, allayed my concern that the absence of a downstream repeat was not required
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for tolerance in S. aureus per se. My colleague Wenyan would later encounter more
striking phenotypes in some of his other assays if the targeting spacer lacked a
downstream repeat, suggestive of partial loss-of-function (personal communication).
Regarding the mechanism(s) of transcription-dependent targeting I was
observing in my in vivo experiments, some additional concerns were raised by Dr.
Bikard and other members of the lab at this time. Although direct evidence for target
DNA cleavage by type III systems had yet to be obtained by any groups, cleavage of
RNA targets had been demonstrated (Hale et al., 2012; Hale et al., 2009; Zhang et al.,
2012). On the one hand, regarding the possibility that our S. epidermidis RP62a system
could also cleave (specific) target RNAs, I was fairly confident this would be insufficient
to explain the in vivo results we’d observed thus far. For example, in the original work
by Dr. Marraffini, knockdown of RNA at the nickase-derived target loci in pG0400 and
pC194-based plasmids would not be expected to impair plasmid stability (Marraffini
and Sontheimer, 2008). Likewise, knockdown of leftward lysogenic transcripts by the 2B
or 4B spacers would not be expected to impair lytic infection by ɸNM1, and yet they
licensed immunity in plaque assays (Figure 2-2C). I had now shown that transcriptiondependent targeting of engineered chromosomal insertions is also toxic, even though
these entire insertions are non-essential for host growth (Figures 2-15, 2-18, & 2-20). On
the other hand, some compelling hypotheses had meanwhile been raised about the role
of the Csm6 and Csx1 proteins found in various type III systems, including the Csm6 of
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our RP62a system. Based on homology to RNase domains found in previously
predicted or confirmed toxin-antitoxin systems, the HEPN RNase domains found in
Csm6/Csx1 proteins were proposed to offer a similar (potentially toxic) function
(Anantharaman et al., 2013; Makarova et al., 2012). For example, toxin activities can be
leveraged by abortive infection systems to prevent the spread of phages, by
altruistically killing infected cells before their progeny phage are released (Labrie et al.,
2010). Therefore, we could not formally exclude the possibility that the type III-A
targeting phenomena observed in the lab thus far had resulted from one or more toxins
being activated by the presence of (transcribed) target DNA. Further adding to the
complexity of the matter, Dr. Hatoum-Aslan (with help from Inbal Maniv and Dr.
Samai) was finding that csm6 is required for immunity to pG0400 in conjugation assays
with the wild type nes target, although it does not stably associate with the complex.
These findings (Hatoum-Aslan et al., 2014; Hatoum-Aslan et al., 2013), still unpublished
at the time, could alternatively be explained if Csm6 were contributing to plasmid
(DNA) targeting in some way. Although Csm6 itself had not been shown or predicted
to harbor DNase domains (to my knowledge), it was not inconceivable that it could be
recruited by the type III complex to enable or augment DNA cleavage in a manner
analogous to recruitment of Cas3 nucleases by type I systems (Westra et al., 2012). In an
effort to address these concerns, I constructed a Δcsm6 knockout variant of my spacer
43T CRISPR-Cas plasmid for testing in transformation assays with my second-
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generation inducible target vectors. Presumably, if transformation efficiency were still
reduced in a transcription-dependent manner with this plasmid, I could rule out the
possibility that Csm6/HEPN-mediated cellular suicide is strictly required for our in vivo
targeting phenomena, and provide evidence in support of a model where the type III-A
targeting complex is sufficient for DNA targeting (at least in certain contexts). Wenyan
was just beginning his study on Csm6 around this time, and kindly pointed me to Dr.
Marraffini’s primers for deleting csm6 from type III-A plasmids, such as pWJ30β and its
derivatives. I tested the spacer 43T(Δcsm6) CRISPR-Cas plasmid with forward and
reverse target insertions in both orientations relative to the chromosomal origin of
replication, and found the same trends I’d observed with the wild type plasmid in
transformation assays (Figure 2-21B). Inducible chromosomal targeting was also
monitored in high-resolution growth curves with the ‘Inv-attP-Target’ strains, and
again the toxicity licensed by the 43T(Δcsm6) plasmid was found to be comparable to
that of wild type (Figure 2-21C). The recovery observed after ~6-8 hours with both wild
type and Δcsm6 targeting plasmids was assumed at the time to result from escape
mutants in the population. It’s also possible that the effects of ATc were simply wearing
off around this time; other members of the lab have anecdotally reported that resupplementation is required to maintain active concentrations of ATc in liquid cultures.
In hindsight, plating after different durations of ATc treatments to measure viable CFUs
might have helped to determine whether type III-A chromosomal targeting is lethal in
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Figure 2-21. Inducible chromosomal targeting using a Δcsm6 variant of the spacer 43T
CRISPR-Cas plasmid.
(A) Schematics summarizing the orientation of spacer 43T crRNAs (blue arrows)
relative to forward or reversed target sequences downstream of the Pxyl/tet* promoter in
second-generation unmodified-attP (left two schematics) and inverted-attP (right two
schematics) integrative vectors. Leftward-oriented arrows (depicted above) represent
crRNAs with complementarity to the template strand relative to leftward Pxyl/tet*
transcription; rightward-oriented arrows (depicted below) represent crRNAs with
complementarity to the non-template strand. (B) Transformation of RN4220-derived
strains with the spacer 43T(Δcsm6) CRISPR-Cas plasmid in the presence or absence of
ATc. Electrocompetent cells possessed either the ‘Targetless’ vector insertion, the
forward ‘Target’ vector insertion, the ‘Reverse’ target vector insertion, the ‘Inv-attPTarget’ vector insertion, or the ‘Inv-attP-Reverse’ target vector insertion, and were
transformed using a single miniprep of the CRISPR-Cas plasmid cloned in RN4220.
Transformation efficiencies were calculated as the number of transformants per ng of
miniprepped DNA used for electroporation (CFU / ng). Dashed line represents the limit
of detection under these assay conditions. Additional replicates were not performed.
(C) High-resolution growth curves of ‘Inv-attP-Target’ strains harboring either the
pGG3, spacer 43T, or spacer 43T(Δcsm6) CRISPR-Cas plasmid as indicated. Each of the
indicated strains was grown in the presence (solid lines) or absence (dashed lines) of
ATc addition at the indicated time point (black arrow), and were originally isolated as
CRISPR-Cas plasmid transformants plated in the absence of ATc. Growth curves
represent data from single biological replicates; additional replicates were not
performed.
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this assay. Nevertheless, these preliminary results did well to satisfy my curiosity, as
well as the lab’s. A small plaque phenotype was also noted while testing this
43T(Δcsm6) plasmid with ɸNM1, indicative of strongly impaired immunity. Ultimately,
Wenyan would go on to show that Csm6 (and its HEPN domain’s RNase activity in
particular) is required for robust immunity in this context because this particular target
region is transcribed late during the ɸNM1 lytic cycle (Jiang et al., 2016).
All of these findings were exciting and encouraging to me, but their general
novelty was now somewhat compromised by a publication showing evidence in
support of a transcription-dependent DNA targeting mechanism for an archaeal type III
system (Deng et al., 2013). Accordingly, I made an effort to shift our study’s focus onto
the more novel findings concerning temperate phages: namely, that transcriptiondependent immunity to lytic infection provides a mechanism for averting chromosomal
targeting during lysogeny. The strategy was to distinguish type II systems and other
transcription-independent CRISPR-Cas systems from type III systems, in that the
former would provide indiscriminate immunity both to lytic and lysogenic infections
by temperate phages, while the latter would provide immunity only under certain
conditions (which were generally only met during lytic infections). Hence, I initially
took to distinguishing the type III targeting mechanism in terms of its capacity for
‘conditional targeting’ of temperate phages. It was later pointed out to me by Dr.
Marraffini that the non-targeting scenario we observe during lysogeny—when spacers
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match to lytic genes—could be considered a form of ‘tolerance’. Focusing on the type
III-A system’s capacity for tolerance, in turn, allowed us to expand on the analogy
between CRISPR-Cas systems and mammalian immune systems (Goldberg and
Marraffini, 2015). I elaborate on this point in Chapter 4. However, considering that the
type III system maintains its capacity for targeting during lytic infections, and that
tolerance of prophages is not absolute (e.g., during prophage induction), we ultimately
decided that the phenomenon could best be summarized as ‘conditional tolerance’.
Experiments described in the next section helped us to convey this point more clearly in
the publication (Goldberg et al., 2014).

2.5

Transcription-dependent targeting by a type III-A CRISPR-Cas system allows
conditional tolerance of temperate phages

In stark contrast to what was reported for E. coli with a type I CRISPR-Cas system
targeting temperate phage λ (Edgar and Qimron, 2010), I was finding that S. aureus
strains with various type III-A CRISPR-Cas plasmids could tolerate lysogenic infections
by the same Newman temperate phages which are resisted during lytic infections.
Moreover, this conditional tolerance phenomenon was found to be contingent upon
immunity directed at lytic cycle genomic regions which are sufficiently repressed
during lysogeny (Figures 2-11, 2-12, & 2-17). However, my core findings thus far had
been gleaned from results with lysogenic transformants and egg yolk screen isolates. In
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order to corroborate these findings, and also demonstrate more quantitatively that
tolerance allows lysogeny to be established efficiently during infection, I adopted a
lysogenization efficiency assay akin to what had been tested with the type I system
(Edgar and Qimron, 2010). For sensitive hosts, lysogenization frequency can be
calculated by using survival as a direct readout for lysogenization. For CRISPR-resistant
hosts, the number of cells which survive infection is not necessarily correlated with
lysogenization frequency, because CRISPR immunity can allow cells to survive
infection even in cases where that infection was not lysogenic. To overcome this, the
type I study utilized a recombinant λ phage carrying a tellurite resistance marker that is
expressed from the prophage in lysogens. Thus, by virtue of the tellurite-resistanceconverting prophages they’ve acquired, lysogenized CFU can be quantified after brief
infections (Edgar and Qimron, 2010). Accordingly, I endeavored to engineer a similar
recombinant of ɸNM1. Unsure of where to insert a resistance marker, however, I asked
Dr. John Chen of the Novick laboratory via e-mail. His reply was prompt and
informative. He explained, among other things, that marker insertions tend to be
functional on either side of the phage attachment site, and that erythromycin resistance
would be preferable to kanamycin resistance for S. aureus. While it was too late for my
pKL55-iTET vectors conferring kanamycin resistance, I heeded his advice regarding
erythromycin resistance going forward. I designed a pKOR-based allelic exchange
plasmid (Bae and Schneewind, 2006) for inserting an erythromycin resistance marker,
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Figure 2-22. Conditional tolerance in RN4220 hosts infected with ɸNM1-ErmR.
(A) Schematic diagram depicting a relevant genomic region of ɸNM1-ErmR that
includes the ermC insertion (blue thick arrow) immediately downstream of int. ORFs
were scaled by length in accordance with the ɸNM1 (NC_008583.1) or pE194
(NC_005908.1) annotations. Grey bent arrows signify the presence of divergently
oriented promoters in the ELCR of ɸNM1. (B) Plaquing efficiency of ɸNM1 and ɸNM1ErmR on lawns of RN4220 harboring the 32T or 32T* CRISPR-Cas plasmids, or the pGG3
control plasmid (C). Error bars, mean ± s.d. (n = 3, technical replicates). (C)
Lysogenization of RN4220 derivatives harboring CRISPR-Cas plasmids with the
indicated targeting spacers, or the pGG3 control plasmid (C), quantified as the
concentration (CFU / ml) of chloramphenicol- and erythromycin-resistant colonies
obtained upon plating after brief infection with ɸNM1-ErmR. Prior to infection, cultures
were plated in the presence of chloramphenicol alone to estimate the concentration
(CFU / ml) of total recipients harboring CRISPR-Cas plasmids. Error bars, mean ± s.d. (n
= 3, biological replicates). (D) ɸNM2-sensitivity assay for eight (1-8) randomly-selected
clones isolated from ɸNM1-ErmR lysogenization experiments with the spacer 32T
CRISPR-Cas plasmid. A ɸNM1-ErmR lysogen harboring the pGG3 plasmid was used as
the sensitive control (C). After re-streak isolation, single colonies were streaked through
the ɸNM2-seeded region from top to bottom. (E) PCR amplification of the CRISPR array
(upper panel) and spacer 32T target region (lower panel) from the isolates tested in ‘D’.
Size markers of 1 kb and 0.5 kb are indicated. All eight target region PCR products were
sequenced by Sanger and no mutations were found (data not shown). (F) ɸNM2
plaquing efficiency on soft agar lawns of an additional six randomly selected clones (9–
14) isolated from ɸNM1-ErmR lysogenization experiments with the spacer 32T CRISPRCas plasmid. The ɸNM1-ErmR lysogen harboring the pGG3 control plasmid was also
tested (–C/L), and plaquing efficiency with the non-lysogenic indicator strain harboring
pGG3 is shown for comparison (–C). Error bars, mean ± s.d. (n = 3, technical replicates).
(G) Plaque-forming potential of filtered overnight culture supernatants from a ɸNM1ErmR-lysogenic isolate harboring the spacer 32T CRISPR-Cas plasmid. PFU
concentrations (PFU / ml) were measured by plating on soft agar lawns of RN4220
harboring either the pGG3 control (C) or spacer 32T CRISPR plasmid. Dashed line
represents the limit of detection under these assay conditions. Error bars, mean ± s.d. (n
= 3, biological replicates). Pictures in ‘D’ and ‘E’ were derived from single experiments.
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ermC, immediately downstream of ɸNM1’s integrase (Figure 2-22A). Recombination
with the prophage allowed me to isolate a modified single lysogen, which in turn
produced erythromycin-resistance-converting phage particles via spontaneous
induction. Using this ɸNM1-ErmR phage, which seemed to behave no differently than
ɸNM1 in plaque assays (Figure 2-22B), I confirmed that various type III-A CRISPR-Cas
plasmids do not reduce lysogenization efficiency in RN4220 (Figure 2-22C). These
included some of the same ‘conditionally tolerant’ plasmids that could efficiently
transform pre-established RN4220::ɸNM1 lysogens (Figure 2-12C). In addition, I
corroborated my results from the egg yolk screens by characterizing some ErmR isolates
harboring the conditionally tolerant spacer 32T CRISPR-Cas plasmid (Figures 2-22D, 222E, & 2-22F). For one of these isolates, I confirmed that the spontaneously induced
PFU recovered from supernatants of overnight cultures were not spacer 32T escaper
mutants (Figure 2-22G). Note that the number of PFUs derived from conditionally
tolerant lysogens was again found to be reduced relative to that of non-targeting control
lysogens. In turn, this was corroborated with wild type ɸNM1 by comparing the
number of spontaneously induced PFUs derived from three lysogenic transformation
isolates harboring either the spacer 32T, spacer 43T, or pGG3 (non-targeting) CRISPRCas plasmids (Figure 2-23A). In order to visualize the effect of CRISPR-Cas targeting on
prophage induction in conditionally tolerant lysogens, I monitored some of my strains
in high-resolution growth curves following treatment with the DNA-damaging agent,
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Mitomycin C (MMC). MMC treatments are known to be SOS-inducing for various
bacteria, including S. aureus (Anderson et al., 2006). SOS-induction, in turn, can trigger

Figure 2-23. Conditionally tolerant type III-A CRISPR-Cas systems limit prophage
induction in lysogenic hosts.
(A) Plaque-forming potential of filtered overnight culture supernatants from
RN4220::ɸNM1 lysogens transformed with either the pGG3 (C), 32T, or 43T CRISPRCas plasmids. PFU concentrations (PFU / ml) were measured by plating on soft agar
lawns of RN4220 non-lysogens harboring the pGG3 control plasmid. Dotted line
represents the limit of detection under these assay conditions. Error bars, mean ± s.d. (n
= 3, biological replicates). (B) Growth of ɸNM1-ErmR lysogens harboring the pGG3 (red)
or spacer 43T (blue) CRISPR-Cas plasmids as indicated, monitored at high-resolution in
the presence (solid lines) or absence (dashed lines) of Mitomycin C added at the
indicated time point (black arrow). An RN4220 non-lysogen harboring the 43T CRISPRCas plasmid control plasmid was also tested (green).

prophage induction by stimulating autocatalytic cleavage of lambdoid prophage CI-like
repressors (Erill et al., 2007; Livny and Friedman, 2004). Whereas lysogenic cultures
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with the non-targeting pGG3 plasmid lysed after MMC treatment, the conditionally
tolerant lysogens with spacer 43T did not (Figure 2-23B). Whether or not this
discrepancy reflects differences in viability was never rigorously determined, but my
preliminary experiments with short (~45 min) MMC treatments of RN4220 and its
derivatives in HIB media seemed to suggest that viability was diminished to a similar
degree for both non-targeting and conditionally tolerant lysogens, even when using a
subinhibitory concentration (0.5 μg/ml) of MMC such as this (Goerke et al., 2006).
Therefore, while the conditionally tolerant lysogens were found to reach the same
attenuance (D600 nm) readings as the non-lysogens harboring spacer 43T, this does not
necessarily imply that they would display equivalent viabilities upon plating, because
inviable cells that do not lyse may still contribute to attenuance measurements.
Conditionally tolerant plasmids aside, the spacer 2B type III CRISPR-Cas plasmid was
found to be ‘intolerant’ of lysogenization, in that it reduced the number of ErmR CFUs
that result from infection (Figure 2-22C). Additional characterizations of the rare
lysogenized and transformed clones isolated from spacer 2B experiments were
presented to a skeptical reviewer during the first revision (Goldberg et al., 2014), and in
all cases the isolates were shown to represent genetic escapers that had either
inactivated their CRISPR-Cas system or lost their xis target region amplicon (data not
shown).
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Soon after, I demonstrated that (transcription-independent) targeting by type II
CRISPR-Cas plasmids can likewise reduce lysogenization efficiency—in addition to
preventing lytic infection by both ɸNM1 and ɸNM1γ6 (Figures 2-24A & B). Note that
lytic infection by ɸNM1γ6 was prevented even when its bottom strand was targeted in
a lysogeny gene (using spacer 4B-tII), presumably because type II targeting is largely
indifferent to the reduced transcription in this region. Note also that the observed
lysogenization efficiency was considerably higher for one of my type II CRISPR-Cas
plasmids (harboring spacer 43B-tII), so I characterized a few ErmR isolates derived from
those infections to confirm that they were in fact genetic escapers (Figure 2-24). A
definitive explanation for the discrepancy between my two type II spacers in the
lysogenization assay is still lacking, but some ideas were offered in response to a
reviewer’s comments during the review process (although they were not explicitly
discussed within the publication). Firstly, the discrepancy might result in part from
differences in the frequency of target site mutation. Two escapers of the 43B-tII spacer
were found to harbor identical large deletions within the prophage lytic region. These
deletions (Figure 2-24H) appear to have utilized a 14 bp direct-repeat microhomology,
suggesting that target site recombinogenicity is a contributing factor (e.g., via ‘hotspots’). Meanwhile, the location of the 4B-tII target within the cI-like repressor gene that
is required for lysogenization, along with the proximity of this target to the ermC
insertion, should reduce the likelihood of detecting mutations in this region when we
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Figure 2-24. Transcription-independent targeting by a type II CRISPR-Cas system in
S. aureus precludes detectable tolerance of DNA target elements.
(A) Plaquing efficiency of ɸNM1 and ɸNM1γ6 on lawns of RN4220 harboring the
indicated type II CRISPR-Cas plasmids. The pDB184 parent vector was used as the nontargeting control. Error bars, mean ± s.d. (n = 3, technical replicates). (B) Lysogenization
of RN4220 derivatives harboring the type II CRISPR-Cas plasmids tested in ‘A’,
quantified as the concentration (CFU / ml) of chloramphenicol- and erythromycinresistant colonies obtained upon plating after brief infection with ɸNM1-ErmR. Prior to
infection, cultures were plated in the presence of chloramphenicol alone to estimate the
concentration (CFU / ml) of total recipients harboring CRISPR-Cas plasmids. Error bars,
mean ± s.d. (n = 3, biological replicates). (C) ɸNM2-sensitivity assay for seven (1-7)
randomly-selected clones isolated from ɸNM1-ErmR lysogenization experiments with
the spacer 43B-tII CRISPR-Cas plasmid. For comparison, a resistant non-lysogen
harboring the spacer 43B-tII plasmid and a sensitive lysogen harboring the pDB184
plasmid were included as controls (+C and –C, respectively). After re-streak isolation,
single colonies were streaked through the ɸNM2-seeded region from top to bottom. (D)
ɸNM2 plaquing efficiency on soft agar lawns of an additional six randomly selected
clones (8–13) isolated from ɸNM1-ErmR lysogenization experiments with the spacer
43B-tII CRISPR-Cas plasmid, measured alongside a ɸNM1-ErmR lysogen harboring the
pDB184 plasmid (–C/L). For comparison, plaquing efficiency of ɸNM2 on the nonlysogenic indicator strain harboring pDB184 or the spacer 43B-tII targeting plasmid is
also shown (–C and +C, respectively). (E) Agarose gel electrophoresis of plasmid DNA
purified from isolates 8–13 from panel ‘D’, and the parental strain harboring the spacer
43B-tII CRISPR-Cas plasmid (C). The symbols + or – indicate the presence or absence of
treatment with the BamHI restriction enzyme, which produces two bands for the wildtype spacer 43B-tII plasmid: 5367 bp and 3972 bp. Size markers correspond to 10 kb, 3
kb and 0.5 kb bands of the 1 kb DNA ladder from NEB. (F) Colony PCR spanning the
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type II CRISPR array for isolates 8–13. Spacer 43B-tII plasmid DNA was used as a
template for the control (C). Size markers of 3 kb and 0.5 kb are indicated. (G) Colony
PCR spanning the target region for isolates 8–13 and a ɸNM1-ErmR lysogen
harboring the pDB184 control plasmid (C). Isolates 10 and 11 harbor
identical deletions within the prophage that remove the target region (see
below). Size markers of 3 kb and 0.5 kb are indicated. The presence of attL and
attR prophage integration arms was also verified independently for each isolate
using PCR (data not shown). (H) Location of the 16,985 bp deletion identified
within the prophage of isolates 10 and 11 (shaded grey box). The location and
orientation of the ermC insertion cassette is also shown (thick blue arrow). Deletion was
mapped by primer walking. An ~9.1 kb product spanning the deletion was ultimately
amplified using primers oGG6 and oGG241, and the deletion junction was sequenced
by Sanger using oGG245. A perfect 14 bp direct repeat microhomology flanks the
deletion. (I) Plaque forming potential of overnight culture supernatants from isolates 8,
10 and 11. Supernatants were also plated with spacer 43B-tII targeting lawns, yielding
no detectable PFUs. No PFUs were detected from the supernatants of isolates 10 and 11
whatsoever, presumably resulting from their deletion of genes essential for prophage
induction, including the ORF 43 head protein. Dotted line represents the limit of
detection for this assay. Error bars, mean ± s.d. (n = 3, biological replicates). (J)
Transformation of RN4220-derived strains with spacer 43B-tII or pDB184 CRISPR-Cas
plasmids in the presence or absence of ATc. Electrocompetent cells possessed either the
‘Inv-attP-Targetless’ vector insertion, the forward ‘Inv-attP-Target’ vector insertion, or
the ‘Inv-attP-Reverse’ target vector insertion, and were transformed using the same
miniprep for either CRISPR-Cas plasmid cloned in RN4220. Transformation efficiencies
were calculated as the number of transformants per ng of miniprepped DNA used for
electroporation (CFU / ng). Error bars, mean ± s.d. (n = 3, technical replicates). Pictures
in ‘C’, ‘E’, ‘F’, and ‘G’ are derived from single experiments.
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select for ErmR CFU. In other words, the 4B-tII spacer might be more difficult to escape
because it targets lysogenization functions that are required for integration of the ermC
cassette associated with prophages. Furthermore, it has been shown that point
mutations in the target which abrogate Cas9-mediated target cleavage do not
necessarily abrogate Cas9-mediated binding altogether, and might therefore still allow
repression via the dCas9-like mechanism (Bikard et al., 2013). In this scenario,
knockdown of the cI-like repressor gene should also be selected against. However, these
factors may be insufficient to explain the discrepancy, given that the dominant form of
escape I observed with the 43B-tII spacer was due to CRISPR-Cas plasmid inactivation.
On this note, it’s possible that the 43B-tII spacer promoted higher frequencies of
plasmid rearrangement in the overnight cultures used for lysogenization, either due to
the spacer sequence’s recombinogenicity itself, or due to stress associated with offtarget effects. In support of this latter idea, partial matching to the RN4220 chromosome
appears to be greater for the 43B-tII spacer than for the 4B-tII spacer. To determine this,
I took advantage of a script that Dr. Bikard had designed to look for partial matching
adjacent to ‘NGG’ PAMs. When the parameters called for a minimum of 8 consecutive
bp matched at the seed sequence adjacent to the PAM, no partial matches were found
for the 4B-tII spacer, while eight were found for the 43B-tII spacer. Among these 43B-tII
partial matches was a 15 bp match to an ORF encoding a putative pyrimidine
nucleoside phosphorylase. In turn, partial matching might allow for occasional cleavage
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of the chromosome, or dCas9-like repression of target gene(s) that are potentially
essential for normal growth. The 43B-tII CRISPR-Cas plasmid was also used in
transformation assays to target my second-generation chromosomal insertion vectors
harboring the inverted attP motif. As expected, the 43B-tII transformation efficiency was
reduced for both forward and reverse targets, regardless of the presence or absence of
ATc (Figure 2-24J).
Around this time, I also obtained the results from my second RNA-seq
experiment. Dr. Bikard, again demonstrating his resourcefulness, provided me with a
script for normalizing and plotting the reads. The results corroborated my previous
results 15 minutes post-infection with ɸNM1, and expanded it to include additional
time points. Perhaps as expected, strong rightward transcription of the early lytic genes
immediately to the right of the ELCR was observed even at the early time points,
whereas late genes further downstream were not strongly transcribed until later time
points (Figure 2-25). Only moderate leftward transcription was observed to the left of
the ELCR, but it remained essentially constant across time points. A moderate peak of
rightward transcription across the xis ORF to the left of the ELCR was also discernible,
and thereby confirmed our prediction that this region is bi-directionally transcribed
during lytic infections. In a separate endpoint RT-PCR experiment (Figure 2-26), my
results tested positive for bi-directional transcription across the target region of Dr.
Marraffini’s original pC194-derived target plasmids harboring nes target insertions in

118

Figure 2-25. Visualization of ɸNM1 transcription profiles at various time points after
infection (MOI 20).
(A) RNA was harvested 6 minutes post-infection of a logarithmically growing culture of
RN4220 cells harboring the non-targeting pGG3 plasmid. Rightward and leftward
expression values are plotted as golden and purple lines, respectively, in reads per
million (RPM). The position of relevant spacer targets are indicated with vertical solid
lines. The dotted line with divergent arrowheads marks the position of the early lytic
control region (ELCR) with divergently oriented PcI and Pcro promoters. To improve
readability, curves were smoothened by plotting average reads per million values over
a 500 bp sliding-window. (B) Same as in ‘A’, except RNA was harvested 15 minutes
post-infection. (C) Same as in ‘A’, except RNA was harvested 30 minutes post-infection.
To the left of the ELCR, rightward expression is comparable to leftward expression by 30
minutes post-infection, consistent with the strand-independent targeting observed for
this region. (D) Same as in ‘A’, except RNA was harvested 45 minutes post-infection.
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either orientation (Marraffini and Sontheimer, 2008), which may also explain why he
observed targeting in both cases. Importantly, my RNA-seq experiment indicated that

Figure 2-26. Detection of transcription across target insertions for the pNes(wt-d) and
pNes(wt-i) plasmids.
(A) Reverse transcription was performed in both directions with DNase-treated total
RNA from RN4220 cells harboring the indicated plasmids, using either forward or
reverse primers for cDNA synthesis in two separate reactions for each target plasmid
(Marraffini and Sontheimer, 2008). PCR was performed on cDNA products, or plasmid
DNA templates for control (C) lanes. The symbols + or – indicate the presence or
absence of reverse transcriptase enzyme in the reverse transcription reaction mixture
used to template the PCR. Size markers of 500 bp and 100 bp are indicated. Picture is
derived from a single experiment; reaction components were not tested in additional
technical replicates.

leftward transcription from the ELCR was reduced for the ɸNM1γ6 mutant relative to
ɸNM1 at equivalent time points, while rightward transcription of ɸNM1γ6 was
essentially unchanged (Figures 2-10D & 2-27). In particular, when I calculated the fold
change for the sum of leftward expression values across the region bounded by the start
of the phage genome and the ELCR, as well as for the sum of leftward expression values
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Figure 2-27. Visualization of ɸNM1γ6 transcription profiles at two time points postinfection (MOI 20).
(A) RNA was harvested 6 minutes post-infection of a logarithmically growing culture of
RN4220 cells harboring the non-targeting pGG3 plasmid. Rightward and leftward
expression values are plotted as golden and purple lines, respectively, in reads per
million (RPM). The position of relevant spacer targets are indicated with vertical solid
lines. The dotted line with divergent arrowheads marks the position of the early lytic
control region (ELCR) with divergently oriented PcI and Pcro promoters. To improve
readability, curves were smoothened by plotting average reads per million values over
a 500 bp sliding-window. (B) Same as in ‘A’, except RNA was harvested 15 minutes
post-infection.

122

across the entire phage genome, I found approximately 32-fold and 4-fold reductions,
respectively, for ɸNM1γ6 at the 15 minute time point (suggesting a net 8-fold reduction
in leftward expression across this region).
During the initial review process, some concern was raised by an anonymous
reviewer regarding our evidence for in vivo DNA targeting. Our efficiency of plaquing
and chromosomal targeting results were difficult to explain without invoking a DNA
targeting argument, but the evidence was still arguably indirect. Similar to Dr. Bikard’s
initial concerns regarding Csm6, the reviewer seemed to be concerned that a toxic
activity associated with targeting—perhaps of RNA alone—could explain our results.
Toxicity associated with specific targeting of RNA by the complex in vivo still seemed
highly unlikely. However, the reviewer may have been privy to knowledge about
Csm6, or at least the hypotheses surrounding its non-specific, toxin-like RNase function
(Anantharaman et al., 2013; Makarova et al., 2012). Given the mounting evidence in our
lab that csm6 was not strictly required for targeting in these assays, we were not
particularly concerned (but to be fair, no mention of Csm6 or its mutagenesis was
included in the manuscript). Nevertheless, we provided some experiments that helped
to address the reviewer’s concern. In particular, I provided high-resolution growth
curves of strains harboring different CRISPR-Cas plasmids, following infection with
ɸNM1 at MOI ~10 or MOI ~100. Growth was largely unperturbed at MOI ~10 for all the
spacers tested, relative to uninfected cultures (Figure 2-28A). This suggested that cells
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were not strictly arresting upon infection (i.e., that the immunity observed in plaque
assays was not due to an abortive-infection-like mechanism), because presumably all or
most of the cells are injected at MOI ~10. In other words, infected cells appeared to be
clearing the phage, or at least surviving infection. At higher MOIs (~100), growth was
more noticeably perturbed (Figure 2-28B). This was assumed to reflect the CRISPR-Cas

Figure 2-28. Infection with ɸNM1 in liquid culture.
(A) Growth of RN4220 hosts harboring various CRISPR-Cas plasmids (as indicated)
was monitored at high-resolution following infection with ɸNM1 (MOI ~10) at time
zero (solid lines). Growth of the uninfected RN4220/pGG3 host is also shown for
comparison (dashed clay-red lines). (B) Same as in ‘A’, except cultures were infected
with ɸNM1 at MOI ~100.

system being overwhelmed with an unnaturally high amount of phage. Furthermore,
spacers targeting late-transcribed genes seemed to perform even more poorly. This
could conceivably still be explained in terms of a transcription-dependent DNA
targeting model, if these discrepancies were assumed to result from differences in the
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onset of DNA targeting. In other words, delays in DNA targeting for late-transcribed
targets might simply give the phage a head start, and generally overwhelm the CRISPRCas system more readily. Wenyan and Dr. Samai (with help from others in the lab)
would later go on to show that the robustness of type III-A immunity at normal MOIs (<
~10) is also due in part to the contributions of its Csm3 and Csm6 RNase activities (Jiang
et al., 2016; Samai et al., 2015). However, prior to establishing a function for Csm6 in
phage defense, Wenyan had also been working to engineer an inducible system for
targeting (and perhaps curing) of plasmids with the nes protospacer, such as pG0400.
His initial attempts utilized Lac-inducible promoters for expression of the type III-A
system, either in its entirety or in parts. Despite these efforts, the systems were
generally still leaky, and targeting would occur in the absence of induction.
Furthermore, curing of pG0400 could not be achieved using wild type CRISPR-Cas
systems. Once I had demonstrated that the modified ATc-inducible promoter
architecture based off pRAB12 (Figure 2-16) allowed sufficient tightness to prevent
severe chromosomal targeting by our constitutively-expressed type III-A systems
(Figures 2-18 & 2-20), and thereby allowed for conditional targeting of DNA elements
by such CRISPR-Cas systems, it became clear that this type of setup might offer a
solution in plasmid-targeting assays. Wenyan’s new approach was therefore to use this
modified ATc-inducible architecture and clone the nes protospacer downstream
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Figure 2-29. Inducible curing of a target plasmid.
(A) Schematic representation of the plasmid components used in this plasmid-curing
experiment. The pGG3 CRISPR-Cas plasmid harbors a single spacer (‘1’) matching to
the nes target sequence inserted downstream of the Pxyl/tet*-inducible promoter in
pWJ153. The size of each plasmid is indicated below in kilobase pairs (kbp). Also
depicted on pWJ153 is the ermC cassette conferring resistance to erythromycin, as well
as the tetR gene encoding the inducible promoter’s repressor. (B) Agarose gel
electrophoresis of linearized plasmid DNA purified both from 0.250 μg/ml ATc-treated
(+ATc) and untreated (–ATc) cultures at the indicated time points. Size markers of 10
kb, 5 kb and 4 kb are indicated. Picture is representative of a single technical replicate.
(C) Concentration (CFU / ml) of colonies recovered upon plating of the cultures
analyzed in ‘B’ at each time point. Cultures were plated with selection for either CmR
CFUs (green) or CmR+ErmR CFUs (blue) as indicated. Targeting of the pWJ153 plasmid
via induction with ATc (filled circles) is accompanied by a severe drop in ErmR CFUs
relative to untreated cultures (open circles). Error bars, mean ± s.d. (n = 3, technical
replicates).
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of its Pxyl/tet* promoter onto a pE194-based plasmid, creating pWJ153. This proved
fruitful; the target plasmid was indeed stable in the absence of ATc, and could be cured
by pGG3 upon induction (Figure 2-29). Although this was only demonstrated for one
target orientation, it provided a final confirmation of in vivo DNA targeting by a type
III-A system in S. aureus. Whereas growth was essentially halted upon induction in my
chromosomal targeting assays (Figure 2-20), Wenyan found that growth could continue
during plasmid targeting, and thereby allow cells to lose their target plasmid’s DNA
(Figure 2-29B) and its associated resistance (Figure 2-29C) over time. Growth was not
completely unperturbed, however; increases in the number of CmR CFUs were delayed
upon ATc treatment. This is probably due, at least in part, to the generalized toxicity
associated with ATc at this concentration (0.250 μg/ml). However, the possibility that
this was also the result of side effects or toxicity associated with targeting should not be
ruled out, in light of recent evidence concerning the potential for collateral RNA
degradation by HEPN-containing Cas nucleases (Shmakov et al., 2017). I elaborate on
this point in Chapter 3.

2.6

Proposed implications of transcription-dependent targeting and conditional
tolerance by type III-A CRISPR-Cas systems

The work described in Chapter 2 illustrates how transcription-dependent targeting by a
type III-A CRISPR-Cas system offers a mechanism for conditional tolerance of genetic
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elements in S. aureus hosts. In particular, my experiments with temperate phages
indicated that conditional tolerance engenders several consequences for the type III-A
systems that target temperate phages, as well as their host population(s). For one,
tolerance helps ensure the genetic stability of these CRISPR-Cas systems during
temperate phage infection, given that pressure to integrate prophages in the presence of
intolerant spacers was found to select for genetic CRISPR-Cas inactivation (Figures 2-4,
2-12, & 2-24)—similar to what has been reported in the context of plasmid uptake
(Fischer et al., 2012; Gudbergsdottir et al., 2011; Jiang et al., 2013b). In other words,
conditionally tolerant spacers ensure that type III-A systems can provide CRISPR-Cas
immunity to lytic infections without compromising their own stability in the event of
lysogenization. An important consequence of this is that lysogenized lineages can
maintain type III-A immunity to lytic infection by heteroimmune phages if the
heteroimmune phages also contain a matching target for the conditionally tolerant
spacer (Figures 2-11 & 2-22). This implies, moreover, that type III-A immunity operates
via transcription-dependent targeting of transcribed elements in cis (because lysogenic
cells survive infection by the heteroimmune phage despite the presence of their
prophage with a matching target). I corroborated this in two assays. Firstly, I monitored
growth of ɸNM1γ6-infected strains harboring my second-generation, inverted attP
integrative vectors at high-resolution in the absence of ATc. Growth was essentially
unperturbed relative to uninfected cultures for the strains that harbored the spacer 43T
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Figure 2-30. Type III-A immunity to a transcribed target element does not result in
detectable targeting of repressed DNA target elements in trans.
(A) Growth of the indicated ‘Inv-attP’ chromosomal insertion strains from Figure 2-20
harboring either spacer 43T or pGG3 CRISPR plasmids, monitored at high-resolution in
the absence (dotted lines) or presence (solid lines) of ɸNM1γ6 addition at an MOI of
~10. Black arrow denotes the time of phage addition; no ATc was used in this assay. The
presence of a chromosomal target for spacer 43T has no discernable effect on culture
growth during spacer 43T-mediated immunity to ɸNM1γ6 (compare green and blue
solid lines). The strain harboring the pGG3 plasmid serves as a sensitive control (clayred lines). (B) Schematic representation of the plasmid components used in the plasmidcuring experiment of panel ‘C’. The pGG8 CRISPR-Cas plasmid harbors a spacer in
position 2 that matches to the nes-γB target sequence inserted downstream of the Pxyl/tet*inducible promoter of pWJ153γ. In pG0mut, the nes-γB target is thought to be lacking
antisense transcription, because it is not targeted by pGG8 in conjugation assays.
Induction of the target in pWJ153γ produces the same RNA that would result from
antisense transcription of the nes-γB target in pG0mut. Also depicted on pWJ153 is the
ermC cassette conferring resistance to erythromycin, as well as the tetR gene encoding
the inducible promoter’s repressor. The pG0mut plasmid confers resistance to
mupirocin. (C) Concentration (CFU / ml) of colonies recovered upon plating of cultures
either treated (filled circles) or untreated (open circles) with ATc at 0.125 μg/ml.
Cultures were plated with selection for either CmR CFUs (green), CmR+ErmR CFUs
(blue), or CmR+MupR CFUs (purple) as indicated. Relative to untreated cultures (open
circles), targeting of the pWJ153γ plasmid via induction with ATc (filled circles) is
accompanied by a severe drop in the number of CmR+ErmR CFUs, but not CmR+MupR
CFUs. After plating of untreated cultures at time zero, only the 2-hour and 6-hour time
points were plated. Additional replicates were not performed under these assay
conditions.
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CRISPR-Cas plasmid, regardless of whether they bore a matching target in the
chromosome as well (Figure 2-30A). In another assay, I attempted to detect loss of
mupirocin resistance associated with pG0mut while curing a modified version of
pWJ153 (pWJ153γ) with a target for the nes-γB spacer (Figure 2-30B). In pWJ153γ, the
nes target of pWJ153 was replaced with the nes-γB sequence which is not normally
targeted by pGG8 in pG0mut (Figure 2-14). Again, immunity appeared to be
specifically directed at the transcribed target element upon induction of antisense
transcription (in cis), because I still did not detect targeting of pG0mut by the nes-γB
spacer in trans while curing the pWJ153γ plasmid (Figure 2-30C).
If confirmed for other type III systems, the capacity for conditional tolerance
might be particularly vital to the stability of type III systems in general, since type III
targeting in archaea has been shown to provide immunity despite up to 15 spacer-target
mismatches (Manica et al., 2013). Evidence for type III immunity occurring within
staphylococcal hosts despite the presence of spacer-target mismatches was provided in
this work (Figures 2-8, 2-11, & 2-22), and also in three subsequent works (Cao et al.,
2016; Jiang et al., 2016; Maniv et al., 2016). Therefore, without the potential for phages to
readily evade targeting via point mutation that is seen for type I and type II systems
(Deveau et al., 2008; Semenova et al., 2011), transcription-dependent type III-A targeting
offers an alternative route to lysogenization that need not provide selection for mutants.
In addition, the ability of the type III-A system to provide immunity in the presence of
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spacer-target mismatches appears to result in more stringent selection against phage
mutants during lytic infections. For example, ɸNM1 escapers were not observed with
our spacer 43T type III CRISPR-Cas plasmid (Figure 2-2), while they were observed
with the 43B-tII type II CRISPR-Cas plasmid (Figure 2-24)—despite the fact that its 3’most 12 bp (and ‘AGG’ PAM) are contained within the 36 bp of the type III target.
However, with other type III spacers where the target sequences were apparently nonessential for lytic infection, escapers were observed. For three such spacers, preliminary
characterization (section 2.2) indicated that target site deletions are the dominant route
of escape in these cases (Figures 2-7 & 2-13). Where microhomologies (< 20 bp) could be
identified flanking the deletions, I speculate that deletion may have occurred through a
recA-independent pathway (Bzymek and Lovett, 2001; Chayot et al., 2010), since the
minimum homology for efficient recA-dependent recombination is thought to be closer
to ~30 bp (Martinsohn et al., 2008; Shen and Huang, 1986). It’s also possible that our
lambdoid Newman phages encode lambda red-like homologs that can facilitate these
deletions (Datta et al., 2008). For example, the Newman phage annotations include
ORFs encoding SSB-like proteins which might provide a recombinase function.
However, the efficiency of red-mediated recombination was also shown to drop
drastically for homologies shorter than ~30 bp (Yu et al., 2000). Whether the activity of
Cas nucleases during immunity stimulates one or more of these pathways remains to be
determined. On this note, the type of CRISPR-Cas system used for targeting could
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potentially influence the sequence or frequency of deletions that arise, even when the
same site is targeted (e.g., if different Cas nuclease lesions produce different substrates
that favor deletion via one pathway over another). Evidently, certain type III spacers
can also be escaped by mutants that reduce transcription of their target sequences
during lytic infection (Figure 2-10). However, this was presumably enabled by the fact
that those spacers were engineered to target lysogenization genes. Targeting of lytic
genes should not be readily escaped in this manner, since reduced transcription of lytic
genes would simultaneously compromise phage viability.
Although a few spacers targeting putative or confirmed lysogenization genes did
not provide tolerance (Figures 2-6, 2-12, & 2-22), it is important to note that these genes
only constitute a small portion of the phage genome. Hence, spacers targeting these
regions should be acquired less frequently, even if spacer acquisition occurs randomly
without an additional mechanism for distinguishing tolerant from intolerant spacers
during acquisition. Interestingly, our survey of sequenced staphylococcal type III
spacers showed that naturally acquired spacers with known target sequences produced
crRNAs complementary to the non-template strand of predicted ORFs in nine out of ten
cases (Figure 2-31). This bias suggests negative selection on non-functional spacers
targeting template strands. Alternatively, type III systems may utilize an unknown
mechanism to discriminate template and non-template strands during spacer
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Figure 2-31. Survey of unique spacers associated with staphylococcal type III-A
systems possessing known targets with five or fewer mismatches.
(A) Spacer-containing organisms and target elements are listed in the left column; the
sequence of each spacer and its complementary target are provided in the middle
column. Right column indicates whether the target strand is a template or non-template
strand, inferred from annotated open reading frames. In cases where additional target
elements were identifiable for a given spacer, a target element with the most available
matches was chosen arbitrarily.
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acquisition. Moreover, the temperate-phage-targeting spacers that we identified were
found to match to lytic regions. A recent study corroborated our in silico findings, and
expanded the analysis to include sequences from six additional S. aureus isolates with
type III-A systems which were previously unavailable (Cao et al., 2016).
Finally, conditional tolerance by type III-A systems ensures that a host
population can efficiently sample phenotypes that result from prophage integration
(i.e., lysogenic conversion phenotypes)—and again whilst maintaining immunity to
lytic infection. However, prophage induction was found to be disrupted by type III-A
targeting in lysogenized lineages that maintain conditional tolerance (Figure 2-23).
Therefore, it is worth noting here that lysogenic conversion phenotypes which depend
on processes which occur via prophage induction, including rapid lysis of induced cells,
might also be curbed by conditional tolerance in lysogenized lineages. As discussed in
section 1.4.2, the ability of a helper prophage to mobilize a resident SaPI via prophage
induction could be considered a lysogenic conversion phenotype. In Chapter 3, I
present my preliminary evidence indicating that this too can be disrupted in lysogens
where the helper prophage is targeted by a type III-A CRISPR-Cas system.
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2.7

Tables associated with Chapter 2

Table 2-1. Spacers tested in Chapter 2.
(a)

Spacer
old
2T
2T
2B
4T
4B
4B-tII
16T
16B
16B-tII
17T
17B
19T
19B
32T
A
32T*
32B
43T
43B
43B-tII
56T
56B
61T-1
61B-1
61T-2
61B-2
nes-γB
nes-γT
nes(-R)
B
32T*
B
32T* (-R)

(b)

Sequence (5’-3’)
TTTTTAATTTAAGTTCTTGTTCATCGTCATAAATA
AATTTTTAATTTAAGTTCTTGTTCATCGTCATAAA
TATTTATGACGATGAACAAGAACTTAAATTAAAAA
AATTTCGAGGAAGTTGCAATTGATAATGAAAAATT
AATTTTTCATTATCAATTGCAACTTCCTCGAAATT
GAAATTTCCAGCAGAAACTTTACCGAAATA
CATTTTGTTTCTGTTCATGCCTCTGCCGACTGCT
AGCAGTCGGCAGAGGCATGAACAGAAACAAAATG
AGACCTGGCACATTATGAAGCAGTCGGCAG
TAATAAGTTTTATGCTCCTCAGTTTTTAAATCACTT
AAGTGATTTAAAAACTGAGGAGCATAAAACTTATTA
TTTTTAAAAATTCTTTGGTTACCATGCATCTCGCT
AGCGAGATGCATGGTAACCAAAGAATTTTTAAAAA
TTAAATCTTTGATTGCTCTTAGCTCTAGTTATGTAT
GTAAACCTTTGATTGCTCTTAGCTCGAGTTATGTGC
ATACATAACTAGAGCTAAGAGCAATCAAAGATTTAA
ATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAA
TTATTGATTTAGAGGCATTACTTGAAGATGACGAAT
ACTTCACACAAGATAACATTATTGATTTAG
GCATGCACCTTGCCTGAATGTTTTAAAAATTCATT
AATGAATTTTTAAAACATTCAGGCAAGGTGCATGC
ATGTCACCTAAGTCAACACCATCATTTTTTATTCT
CTTAGGTGACATTGGCTGTCGATTTTACACTGAAG
TTATGATTTTTTGGAGCATATAAATCATTTAGTGT
CAGAAAGTGTATTGCAACAGATTGGCTCAAAAGTT
ATAAATATGTATAAGGAAAATGAAAGACTATATGA
TCATATAGTCTTTCATTTTCCTTATACATATTTAT
ACGTATGCCGAAGTATATAAATCATCAGTACAAAG
GTAAACCTTTGATTACTCTTAGCTTTAGTTATGTGT
GTAAACCTTTGATTACTCTTAGCTTTAGTTATGTGT
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(c)

Coordinates
1317-1351
1319-1353
1317-1351
2706-2740
2706-2740
2735-2764
8527-8560
8527-8560
8509-8538
9045-9080
9045-9080
11293-11327
11293-11327
15352-15387
15352-15387
15352-15387
22411-22446
22411-22446
22393-22422
34512-34546
34512-34546
39013-39047
39036-39070
39949-39983
39884-39918
9232-9266
9232-9266
8174-8208
15256-15291
15256-15291

Gene
(d)
product
Excisionase
Excisionase
Excisionase
Repressor
Repressor
Repressor
Hyp. protein
Hyp. protein
Hyp. protein
Hyp. protein
Hyp. protein
Replication
Replication
Hyp. protein
Hyp. protein
Hyp. protein
Head protein
Head protein
Head protein
Hyp. protein
Hyp. protein
Tail fiber
Tail fiber
Tail fiber
Tail fiber
Nickase
Nickase
Nickase
Hyp. protein
Hyp. protein

Plasmid
Name
pGG34
pGG52
pGG9
pGG31
pGG30
pGG51
pGG19
pGG4
pGG33
pGG60
pGG59
pGG53
pGG10
pGG12
pGG13
pGG36
pGG41
pGG40
pGG37-full
pGG54
pGG11
pGG17
pGG15
pGG18
pGG16
pGG8
pGG24
pGG25
pGG14
pGG22

Table 2-1. Spacers tested in Chapter 2 (continued).

(a) Numbers refer to the nearest ORF designation for the closest ɸNM1 target match,
where applicable; crRNA complementarity to the ‘Top’ or ‘Bottom’ strand is
denoted with a ‘T’ or ‘B’. Type II spacers are specified with a ‘-tII’ suffix.
(b) Type III spacers were chosen to avoid homology between the 5’ crRNA tag and
the target flanking sequences, which was shown to prevent immunity in S.
epidermidis (Marraffini and Sontheimer, 2010b). Type II spacers match the nearest
sequence with a ‘NGG’ PAM motif flanking the target’s 3’ end, required for
Cas9-mediated immunity (Deveau et al., 2008; Jiang et al., 2013a).
(c) Numbers reflect the coordinates of target regions for each spacer in the ɸNM1
(NC_008583.1), pGO1 (NC_012547.1), or ɸNM4 (NC_028864.1) genomes.
(d) Predicted gene product of the nearest ORF for each target, according to the NCBI
annotations for ɸNM1, pGO1, or ɸNM4.
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Table 2-2. Oligos used in Chapter 2.
Name

Sequence

oGG6
oGG7
oGG8
oGG9
oGG10
oGG11
A10
L55
L6
L50
oGG12
oGG13
oGG18
oGG19
oGG20
oGG21
oGG22
oGG23
oGG24
oGG46
oGG47
oGG48
oGG49
oGG56
oGG72
oGG84
oGG85
oGG91
oGG101
oGG115
oGG121
oGG122
oGG123
oGG175
oGG176
oGG177
oGG178
oGG179
oGG180
oGG225
oGG226
oGG227
oGG228
oGG58
oGG61
oGG74
L342
L343
W18
W122
L362
W278
W270
W282
oGG82
oGG83
oGG86
oGG87
oGG89
oGG90
B220
B334
L448
B333
oGG148
oGG149
oGG166
oGG167
oGG191
W277
oGG206
W276
L8
L86

TACCCTAGTTAACGTCTCTTG
GATATCAACTTGTAGTGCATCG
TTGTAGCAAATCAAGAATTGACAG
CTAATTCATCTTGATTAGACATCTC
GCTGACTTACAAGAAGGTGGAC
GTTGTAATTGGATTAAATTCAGTC
CTTTGTACTGATGATTTATATACTTCGGCATACG
TAAATCTAACAACACTCTAA
AAAGGTACCAAATTTAATGCTATTTTCCTTCGC
AAAAGATCTAATAATGTATTTACGCTGGGGC
GTTCTCGTCCCCTTTTCTTCGGGGTGGGTATCGATCCTTTGTACTGATGATTTATATACTTC
AGCAGTCGGCAGAGGCATGAACAGAAACAAAATGTAAATCTAACAACACTCTAAAAAATTG
ATAAATATGTATAAGGAAAATGAAAGACTATATGATAAATCTAACAACACTCTAAAAAATTG
TATTTATGACGATGAACAAGAACTTAAATTAAAAATAAATCTAACAACACTCTAAAAAATTG
AGCGAGATGCATGGTAACCAAAGAATTTTTAAAAATAAATCTAACAACACTCTAAAAAATTG
AATGAATTTTTAAAACATTCAGGCAAGGTGCATGCTAAATCTAACAACACTCTAAAAAATTG
TTAAATCTTTGATTGCTCTTAGCTCTAGTTATGTATTAAATCTAACAACACTCTAAAAAATTG
GTAAACCTTTGATTGCTCTTAGCTCGAGTTATGTGCTAAATCTAACAACACTCTAAAAAATTG
GTAAACCTTTGATTACTCTTAGCTTTAGTTATGTGTTAAATCTAACAACACTCTAAAAAATTG
CTTAGGTGACATTGGCTGTCGATTTTACACTGAAGTAAATCTAACAACACTCTAAAAAATTG
CAGAAAGTGTATTGCAACAGATTGGCTCAAAAGTTTAAATCTAACAACACTCTAAAAAATTG
ATGTCACCTAAGTCAACACCATCATTTTTTATTCTTAAATCTAACAACACTCTAAAAAATTG
TTATGATTTTTTGGAGCATATAAATCATTTAGTGTTAAATCTAACAACACTCTAAAAAATTG
CATTTTGTTTCTGTTCATGCCTCTGCCGACTGCTTAAATCTAACAACACTCTAAAAAATTG
TCATATAGTCTTTCATTTTCCTTATACATATTTATTAAATCTAACAACACTCTAAAAAATTG
AATTTTTCATTATCAATTGCAACTTCCTCGAAATTTAAATCTAACAACACTCTAAAAAATTG
AATTTCGAGGAAGTTGCAATTGATAATGAAAAATTTAAATCTAACAACACTCTAAAAAATTG
TTTTTAATTTAAGTTCTTGTTCATCGTCATAAATATAAATCTAACAACACTCTAAAAAATTG
ATACATAACTAGAGCTAAGAGCAATCAAAGATTTAATAAATCTAACAACACTCTAAAAAATTG
ATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAATAAATCTAACAACACTCTAAAAAATTG
TGAGACCAGTCTCGGAAGCTCAAAGGTCTCTTAAATCTAACAACACTCTAAAAAATTG
GAACTTATTGATTTAGAGGCATTACTTGAAGATGACGAAT
TTTAATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAA
GAACAATTTTTAATTTAAGTTCTTGTTCATCGTCATAAA
TTTATTTATGACGATGAACAAGAACTTAAATTAAAAATT
GAACTTTTTAAAAATTCTTTGGTTACCATGCATCTCGCT
TTTAAGCGAGATGCATGGTAACCAAAGAATTTTTAAAAA
GAACGCATGCACCTTGCCTGAATGTTTTAAAAATTCATT
TTTAAATGAATTTTTAAAACATTCAGGCAAGGTGCATGC
GAACAAGTGATTTAAAAACTGAGGAGCATAAAACTTATTA
TTTATAATAAGTTTTATGCTCCTCAGTTTTTAAATCACTT
GAACTAATAAGTTTTATGCTCCTCAGTTTTTAAATCACTT
TTTAAAGTGATTTAAAAACTGAGGAGCATAAAACTTATTA
GAAGAAAAGGGGACGAGAACTAAATCTAACAACACTCTAAAAAATTG
GGGGTGGGTATCGATCACACATAACTAAAGCTAAGAGTAATC
GGGGTGGGTATCGATCCTTTGTACTGATGATTTATATACTTC
AAAGGGCCCAAATAATATTTTCATTATAGCACCTC
AAACGGCCGGAAAAAAATAAGGAATTTAAAGAGC
TATTCTGAAAAGGTCAATCAAGG
AGGTGTTTGTATATTAAGACGTAC
AAACTCGTGGATTCTGTGATTTGGATCCTTCC
AAAAAGATCTTATGACTGTTATGTGGTTATCG
AAAAAGATCTTGCATAATTCACGCTGACCTC
AAAACACGAGCGTTTGTTGAACTAATGGGTGC
AACATTGCCGATGATAACTTGAG
GTTTTGGGACCATTCAAAACAGCATAGCTCTAAAACCTCGTAG
TGAAGCAGTCGGCAGAACATTGCCGATGATAACTTGAGAAAG
TAATGTGCCAGGTCTGTTTTGGGACCATTCAAAACAGCATAG
TTTGAATGGTCCCAAAACAACATTGCCGATGATAACTTGAGAAAG
ACAGCATAGCTCTAAAACCTGCCGACTGCTTCATAATGTGC
AAAAAGCGCAAGAAGAAATCAACCAGCGCACTCGTAGACTATTTTTGTCTAAA
ACACTGAGACTTGTTGAGTTCAAACGAAAATTGGATAAAGTGGG
ATTATTTCTTAATAACTAAAAATATGG
CTTTATCCAATTTTCGTTTGAACTCAACAAGTCTCAGTGTGCTG
AAACACTTCACACAAGATAACATTATTGATTTAGG
AAAACCTAAATCAATAATGTTATCTTGTGTGAAGT
AAACGAAATTTCCAGCAGAAACTTTACCGAAATAG
AAAACTATTTCGGTAAAGTTTCTGCTGGAAATTTC
GAAGCTTTAGCTTTGCAGTGG
CTGTAATAGACATCGTTCGCAG
GCTACATTAATTATAGGGAATCTTAC
TCCTAACAGAAATTGCGTTAAAG
TTTTATACAATACTATTTATAAGTGC
CATATAGTTTTATGCCTAAAAACC

Primary Purpose
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Specific identification of ɸNM1
Specific identification of ɸNM1
Specific identification of ɸNM2
Specific identification of ɸNM2
Specific identification of ɸNM4
Specific identification of ɸNM4
Construction of pGG3 control/parent vector
Construction of pGG3 control/parent vector
Type III CRISPR array verification
Type III CRISPR array verification
Common primer for spacer cloning via PCR
Construction of pGG4
Construction of pGG8
Construction of pGG9
Construction of pGG10
Construction of pGG11
Construction of pGG12
Construction of pGG13
Construction of pGG14
Construction of pGG15
Construction of pGG16
Construction of pGG17
Construction of pGG18
Construction of pGG19
Construction of pGG24
Construction of pGG30
Construction of pGG31
Construction of pGG34
Construction of pGG36
Construction of pGG41
Construction of pGG3-BsaI
Construction of pGG40
Construction of pGG40
Construction of pGG52
Construction of pGG52
Construction of pGG53
Construction of pGG53
Construction of pGG54
Construction of pGG54
Construction of pGG59
Construction of pGG59
Construction of pGG60
Construction of pGG60
Construction of pGG22/pGG25
Construction of pGG22
Construction of pGG25
Construction of pGG41Δcsm6
Construction of pGG41Δcsm6
pGG41Δcsm6 ligation junction verification
pGG41Δcsm6 ligation junction verification
Construction of pWJ40
Construction of pWJ40
Construction of pWJ40
Construction of pWJ40
Construction of pGG32
Construction of pGG32
Construction of pGG33s
Construction of pGG33s
Construction of pGG33
Construction of pGG33
Construction of pDB184
Construction of pDB184
Construction of pDB184
Construction of pDB184
Construction of pGG37-full
Construction of pGG37-full
Construction of pGG51
Construction of pGG51
ɸNM1(-Erm) attL junction verification
ɸNM1(-Erm) attL junction verification
ɸNM1(-Erm) attR junction verification
ɸNM1(-Erm) attR junction verification
RT-PCR
RT-PCR

Table 2-2. Oligos used in Chapter 2 (continued).
L87
L484
L485
L482
L483
oGG108
oGG109
oGG110
oGG111
oGG112
oGG113
oGG124
oGG125
oGG126
oGG127
oGG64
oGG88
oGG102
oGG103
oGG104
oGG105
oGG50
oGG51
oGG96
oGG25
oGG26
oGG38
oGG39
oGG40
oGG52
oGG53
oGG233
oGG234
W176
W234
W235
oGG229
oGG230
oGG241
oGG245
oGG181
oGG182
oGG183
oGG184
oGG185
oGG186
L29
oGG192
L325

ATATATTTATTTGGCTCATATTTGC
AAACTCGAGCGCGCAAGCTGGGGATCCG
AAACTCGAGTAGGTACTAAAACAATTCATCCAG
AAACTCGAGCTGAGAGTGCACCATATGCGG
AAACTCGAGCTTAATAGCTCACGCTATGCCG
TAATTCCTCCTTTTTGTTGACATTATATCATTGATAGAGTTATTTG
ACTCTATCAATGATATAATGTCAACAAAAAGGAGGAATTAATGATG
TGACACTCTATCATTGATAGAGCATAATTAAAATAAGCTTGATATC
AAGCTTATTTTAATTATGCTCTATCAATGATAGAGTGTCAATATTT
TTGATAGAGTGATATCGAATTCGGAGGCATATC
TGATAGAGAGCTTATTTTAATTATGCTCTATC
GATCTCAAGATAACATTATTGATTTAGAGGCATTACTTGAAGATGACGAATTAGAAGCAAACCGC
GGTTTGCTTCTAATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAATGTTATCTTGA
GATCTTTTGCTTCTAATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAATGTTATCTTGCCGC
GGCAAGATAACATTATTGATTTAGAGGCATTACTTGAAGATGACGAATTAGAAGCAAAA
TCTTATTCAAGACAACACTTACAC
ATCTAACATCTCAATGGCTAAGG
CCACATACCTATATCTGCCCTTTTTCTGCCCTTTTTTATTTTTAAAG
GTGTACTAAAAGGTAATCGATACGGTTATATTTATTCCC
GGCAGAAAAAGGGCAGATATAGGTATGTGGTTTTGTATTGG
TATAACCGTATCGATTACCTTTTAGTACACAAGTTTTTC
GTTAATGTTACGAATGATGAACC
TTGGCAAGTTCTGCACCTTTAC
AAGATGCAACAATGGGAACCAAG
CTAAATGTGATATAATAAAATAAAAAG
ATAAAGACACCGATTCAACTATG
AAGATAAAGAATTTGCTCAAGACG
TTCATCAGCTGACATTAACTCAC
ACCATTAAAACTCGTCATTCTTTC
GGTGCTAGCTTCGTAAGAAAGG
CAGCTTACAACGAACATAACCAG
GCAAGAGAGTTAAAAGGTATACG
CTGTATATCCTTGTATCAACTATC
CCTATCTGACAATTCCTGAATAG
GCTTATTAACGATTCATTATAACC
TCATAAAGTCTAACACACTAGAC
TCCTTATACATATTTATAGGTGTTACATGTTCATATTTATCAGAGCTCGTG
AAATGAAAGACTATATGATTTAAAACAAGATCTCCTAGGTCATTTGATATGC
CGTTTCGGTACTTATTTCAACAC
GTTAATTCTATGTCCATTTGTAACC
GGGGACAAGTTTGTACAAAAAAGCAGGCTATTCGAAATTGTACCTGTTTCATCTC
CGAAAAAAGAGTGTCTTGTGATGGTATCATATCGGTATCAAATAAC
TGATACCGATATGATACCATCACAAGACACTCTTTTTTCGCACC
CTATGAACATATTTGATTAACGTATATAGATTTCATAAAGTCTAAC
CTTTATGAAATCTATATACGTTAATCAAATATGTTCATAGCTTGATG
GGGGACCACTTTGTACAAGAAAGCTGGGTCATTAGATATAAAGATGTATACGG
TACGACTCACTATAGGGG
TCTACTTAATCTGATAAGTGAGC
AAACCCGGGACGCAAACCGCCTCTCCCC
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RT-PCR
Construction of pKL55-iTET-B
Construction of pKL55-iTET-B
Construction of pKL55-iTET-B
Construction of pKL55-iTET-B
Construction of pKL55-iTET-RC12
Construction of pKL55-iTET-RC12
Construction of pKL55-iTET-RC12
Construction of pKL55-iTET-RC12
Construction of pKL55-iTET-RC12
Construction of pKL55-iTET-RC12
‘Forward’ target insertion
‘Forward’ target insertion
‘Reverse’ target insertion
‘Reverse’ target insertion
Verification of inducible target insertions
Verification of inducible target insertions
attP inversion
attP inversion
attP inversion
attP inversion
ɸNM4 and pKL55-iTET attL junction
ɸNM4 and pKL55-iTET attR junction
ɸNM4 and pKL55-iTET attL/R junctions
Spacer 2B (xis) target verification
Spacer 2B (xis) target verification
Spacer 32T target verification
Spacer 32T target verification (ɸNM1/ɸNM2)
Spacer 32T target verification (ɸNM4)
Spacer 61T-1 target verification
Spacer 61T-1 target verification
Spacer 43B-tII target amplification
Spacer 43B-tII target amplification
Type II CRISPR array amplification
Partial sequence verification of pWJ153(γ)
Partial sequence verification of pWJ153(γ)
Construction of pWJ153γ
Construction of pWJ153γ
43B-tII target deletion escaper mapping
Deletion junction sequencing
ɸNM1-Erm construction
ɸNM1-Erm construction
ɸNM1-Erm construction
ɸNM1-Erm construction
ɸNM1-Erm construction
ɸNM1-Erm construction
ɸNM1-Erm sequencing
ɸNM1-Erm sequencing
ɸNM1-Erm sequencing

2.8

Materials and methods used in Chapter 2

Bacterial strains and growth conditions.
Cultivation of S. aureus RN4220 (ref. (Nair et al., 2011)), TB4 (ref. (Bae et al., 2006)) and
derivative strains was done in TSB media (BD) at 37 °C, except when phage infections
were performed, or when otherwise noted (see below). Whenever applicable, media
were supplemented with chloramphenicol at 10 μg ml-1 to ensure CRISPR plasmid
maintenance. Selection for MupR strains possessing pG0400 or pG0mut was carried out
with mupirocin at 5 μg ml-1. RN4220 strains harboring pCL55-derived insertion vectors
were grown similarly, but kanamycin was provided at 25 μg ml-1 except during reculture for competent cell preparation. E. coli DH5a was grown in LB Broth (BD)
supplemented with kanamycin at 25–50 μg ml-1 to maintain pCL55-derived plasmids.
Selection for ɸNM1-ErmR lysogens with resistance to erythromycin (10 μg ml-1) was
only applied during the lysogenization protocol as described below, and, where
applicable, during the subsequent ɸNM2 sensitivity assays. Soft agar lawns were
composed of 50% HIB-agar (BD) supplemented with 5 mM CaCl2 (and chloramphenicol
at 10 μg ml-1 where applicable) and 100 μl of an overnight culture, and poured over
similarly supplemented 100% HIB-agar plates. High-titer phage lysates were harvested
from infected soft agar lawns that were sufficiently lysed via overnight growth at 37 °C.
Within 72 hours of storage at 4 °C, soft agar was hydrated with 600 μl fresh HIB,
scraped and decanted into a 50 ml conical-bottom Falcon tube, supplemented with an
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additional 600 μl fresh HIB, and then centrifuged at 4303g for 8-10 min. Filtered
supernatants containing the phage particles were stored in autoclaved 1.5 ml tubes
(Eppendorf) at 4 °C.

Estimation of phage lysate titers.
Serial dilutions were prepared in triplicate and plated on soft agar lawns of RN4220
(technical replicates). Plates were incubated at 37 °C for 16–24 h after drying at room
temperature (25 °C).

DNA preparation and cloning.
Plasmid DNA was purified from 2 to 6 ml of E. coli DH5a or S. aureus RN4220 overnight
cultures. For preparation from S. aureus cultures, cells were pelleted, re-suspended in
100 μl TSM buffer (50 mM Tris-HCl pH7.5, 10 mM MgCl2, 0.5 M sucrose) then treated
with 5 μl lysostaphin (2 mg ml-1) at 37 °C for 1.5 h before treatment with plasmid
miniprep reagents from Qiagen. Purification used Qiagen or EconoSpin columns.
Restriction enzymes were obtained from New England Biolabs (NEB).
Cloning in S. aureus used RN4220 electrocompetent cells unless otherwise stated.
For most type III CRISPR plasmids, scarless addition of repeat-spacer units to the pGG3
parent vector was accomplished by ‘round-the-horn PCR (ref. (Moore and Prevelige,
2002)) followed by blunt ligation, using common primer oGG12 and spacer-specific
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oligonucleotides listed in Table 2-2. The pGG3 vector was itself constructed by ‘roundthe horn PCR using primers L55 and A10 to remove extraneous repeat-spacer elements
from the pWJ30β CRISPR array. Construction of pWJ30β was described previously:
“pcrispr” (Hatoum-Aslan et al., 2013). To construct pGG22, the pGG14 plasmid was
used as a template for ‘round-the-horn PCR using oligos oGG58 and oGG61. The
pGG25 plasmid was constructed similarly, except that the oGG74 primer was used with
oGG58, and the pGG3 plasmid was used as a template. For construction of the
remaining type III CRISPR-Cas plasmids, a modified parent vector (pGG3-BsaI) was
created by introducing a placeholder spacer harboring two BsaI restriction sites, to
facilitate scarless cloning of spacers by replacement with annealed oligonucleotide pairs
possessing BsaI-compatible overhangs. Type III-A CRISPR arrays were amplified with
primers L50/L6 and sequenced by Sanger using either forward or reverse primers. The
pGG41Δcsm6 plasmid was obtained via intramolecular ligation of doubly digested PCR
products amplified from pGG41 by ‘round the horn PCR with the primer pair
L342/L343. PspOMI/EagI restriction enzymes were used for digestion, and clones were
verified using primers W18/W122 to PCR-amplify and Sanger sequence the ligation
junction. The BsaI cloning method was also used to construct type II CRISPR plasmids
from the pDB184 parent vector, a modified version of pWJ40 with only the single
placeholder spacer. Type II CRISPR arrays were amplified with primers L448 and
W176, and sequenced by Sanger using L448. After the cloning of each spacer, plasmid
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sizes were verified by restriction digest with BssSI for type III plasmids or BtgI for type
II plasmids. The pC194-derived pWJ40 vector contains the full S. pyogenes SF370 type II
CRISPR-Cas system and was constructed by amplifying S. pneumoniae LAM226
genomic DNA with oligonucleotides L362/W278 and pC194 (ref. (Horinouchi and
Weisblum, 1982a)) with oligonucleotides W270/W282, followed by digestion of the PCR
products with BglII and BssSI and a subsequent ligation. pDB184 was created via
Gibson assembly (Gibson et al., 2009) of two PCR fragments: a pWJ40 backbone
amplified using primers B220/B334, and a CRISPR array amplified from pCas9 (ref.
(Jiang et al., 2013a)) using primers L448/B333.
For construction of pCL55-iTET-derived inducible target vectors, cloning used
chemically competent DH5a cells. Briefly, the chloramphenicol resistance cassette was
first replaced with a kanamycin resistance cassette amplified from S. pneumoniae
LAM202-3 using primers L484/L485. This was accomplished by ‘round-the-horn PCR
on the pCL55-iTET parent vector using primers L482/L483, followed by blunt ligation
with the PCR-amplified resistance cassette to create the new pKL55-iTET(-B) parent
vector (first-generation). Directionality of the insertion was verified afterwards with an
analytical restriction digest using BtgI. Modification of the Pxyl/tet and PtetR promoters in
accordance with pRAB12 (ref. (Helle et al., 2011)) architecture was achieved via three
steps. First, two consecutive overlap PCR steps were used to introduce point mutations
with oligonucleotide pairs oGG108/oGG109 and oGG110/oGG111, creating the pKL55-
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iTET-R and pKL55-iTET-RC intermediates, respectively. The third step involved
‘round-the-horn PCR using oligonucleotides oGG112 and oGG113, followed by blunt
ligation, to introduce the downstream operator sequence. The resulting pKL55-iTETRC12 parent vector (second-generation) harboring the Pxyl/tet* modifications was used for
downstream manipulations. For forward and reverse target insertions, annealed
oligonucleotide pairs (oGG124/oGG125 and oGG126/oGG127, respectively) with
appropriate overhangs were ligated into the multiple cloning site after digesting the
vector with BglII and SacII restriction enzymes. Target insertions were verified by PCR
amplification and Sanger sequencing using the primers oGG64 andoGG88. Inversion of
the attP motif for both forward and reverse target vectors, and for the targetless (pKL55iTET-RC12) parent vector, was achieved by Gibson assembly of two PCR fragments,
using oligonucleotides oGG102/oGG103 for the attP motif and oGG104/oGG105 for the
backbones. Directional integration into the RN4220 chromosome was verified by
amplification of either the attL or attR junctions using primer pairs oGG50/oGG96 and
oGG51/oGG96, respectively. The pWJ153-inducible target vector is a pKL55-iTET-RC12and pE194- (ref. (Horinouchi and Weisblum, 1982b)) derived plasmid constructed via
multiple steps of either ‘round-the-horn PCR followed by blunt ligation or Gibson
assembly. A region that contains the Pxyl/tet* inducible promoter components and the nes
target was sequenced by Sanger using forward (W234) and reverse (W235) primers that
flank the region. The expected sequence of pWJ153, including this Sanger-verified
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region, was included as a supplementary sequence in the published work (Goldberg et
al., 2014). The pWJ153γ plasmid is a derivative of pWJ153 that was constructed by
replacing the nes protospacer with the nes-γB target via ‘round-the-horn PCR followed
by blunt ligation using primers oGG229 and oGG230. Clones were checked by PCRamplifying the ligation junction using the W234/W235 primers, and Sanger sequencing
with W234.
Construction of the ɸNM1-ErmR lysogen was achieved via pKOR allelic exchange
(Bae and Schneewind, 2006). Homology arms (~1 kb) were amplified from the
chromosome of S. aureus RN4220::ɸNM1 using primer pairs oGG181/oGG182 and
oGG185/oGG186, while the ~1.25 kb ermC resistance cassette was amplified from a
pE194 plasmid preparation using primers oGG183 and oGG184. An ~3.25 kb fragment
was assembled by SOEing PCR (Horton, 1993) using external primers oGG181 and
oGG186 with clonase (QuikChange) attB adapters that allowed directional integration
into the pKOR vector (Bae et al., 2006). Sequence integrity of the ~3.25 kb insertion was
verified by Sanger using primers L29, oGG191, oGG192, W277 and L325.

Preparation of electrocompetent S. aureus cells.
S. aureus RN4220, TB4, or derivative strains were grown overnight in TSB medium,
diluted 1:100 in fresh medium without antibiotics, then allowed to grow to an
attenuance (D600 nm) reading of 0.8–1.0 for RN4220 or 0.7–0.9 for TB4. Measurements
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were taken using a NanoDrop 2000c Spectrophotometer (Thermo Scientific) and
disposable polystyrene cuvettes. After re-culture, cells were pelleted at 4 °C, and two or
three washes were performed using chilled, sterile dH2O or 10% glycerol. Cells were
ultimately re-suspended in 1/100th volume of chilled, sterile 10% glyercol and 50 ml
aliquots were distributed for storage at –80 °C.

Conjugation assays.
Conjugation assays were carried out by the filter mating method essentially as
described previously (Marraffini and Sontheimer, 2008), except that TSB and TSA
media were used throughout, overnight cultures were mixed directly in 5 ml fresh
broth at approximately 1:1 attenuances (D600 nm), and growth was carried out at 30 °C for
approximately 24 hours following the serial dilution and plating step. Recipients and
transconjugants were quantified as the number of CmR CFUs or CmR+MupR CFUs,
respectively, scored by eye. Conjugation efficiencies were subsequently calculated as
the ratio of transconjugants to recipients.

Efficiency of plaquing assays.
High-titer lysates (~1011 PFU ml-1) of either ɸNM1, ɸNM1γ6 or ɸNM2 were serially
diluted in triplicate and applied to RN4220 or TB4 soft agar lawns harboring different
CRISPR-Cas plasmids, including pGG3 or pDB184 non-targeting control lawns infected
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in parallel (technical replicates). Plates were incubated at 37 °C for 18 h. After
incubation, plates were monitored at bench top for up to 24 h to facilitate quantification
of plaque-forming units. Efficiency ratios were calculated as the number of plaques
formed on a lawn of interest divided by the number of plaques formed on the nontargeting control lawn infected in parallel.

Isolation of type III CRISPR-escape mutant phages.
Soft agar lawns of TB4 harboring a CRISPR-Cas plasmid of interest were infected with
high-titer lysates (~1011 PFU ml-1) of ɸNM1, ɸNM2, or ɸNM4 either by spotting on the
lawn or mixing with cells prior to pouring. Plaques that escape targeting were picked,
resuspended in a small volume of HIB broth, and subjected to at least one additional
round of counter-selection on lawns with the same CRISPR-Cas plasmid. Subsequent
propagation on non-targeting lawns initially used TB4 lawns harboring the pGG3
plasmid. High-titer phage lysates were ultimately harvested from sufficiently lysed soft
agar lawns, as described in the “Bacterial strains and growth conditions” section above.

Quantification of erythromycin-resistant lysogens.
Overnight cultures of RN4220 with respective CRISPR-Cas plasmids were inoculated in
triplicate from single colonies in HIB medium supplemented with chloramphenicol
(biological replicates). After chilling at 4 °C, 1:10 dilutions were prepared in 1 ml fresh
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HIB supplemented with chloramphenicol and 5mM CaCl2. Diluted cultures were
infected with ɸNM1-ErmR at ~MOI 10 and incubated on ice for 30 min. After incubation
on ice, cultures were transferred to a 37 °C incubator for 30 min with shaking. Serial
dilutions from each culture were then applied to HIB-agar plates supplemented with
chloramphenicol, erythromycin and 5 mM CaCl2 for quantification of lysogenic colonyforming units. In selected cases, type III-A CRISPR locus and target sequence integrity
was verified by colony PCR after re-streaking single colonies using primer pairs L6/L50
(CRISPR array) and oGG25/oGG26 (ORF 2) or oGG38/oGG39 (ORF 32). Where
applicable, Sanger sequencing of PCR products was also performed using these
primers. When verifying type II lysogenization isolates, the spacer 43B-tII target
region was amplified using primers oGG233 and oGG234, and the type II CRISPR
array was amplified using L448 and W176. The presence of integrated ɸNM1 or
ɸNM1-ErmR prophages was confirmed by colony PCR using primer pairs oGG191/
W277 and oGG206/W276 to amplify the attL and attR junctions, respectively. To
estimate the total number of recipient cells, serial dilutions of untreated overnight
cultures were plated on TSB- or HIB-agar supplemented with chloramphenicol.

Streak-test (phage-sensitivity) assays.
High-titer phage lysates (~1011 PFU ml-1) were applied to the surface of a pre-dried HIBagar plate supplemented with 5 mM CaCl2 and appropriate antibiotics, then allowed to
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dry for an additional ~30 min at room temperature (25 °C). Single colonies isolated from
egg yolk screens, CRISPR-Cas plasmid transformations, or ɸNM1-ErmR lysogeny
experiments were streaked through the phage-seeded region using a sterile plastic loop,
then incubated for ~12-16 h at 37 °C.

Quantification of PFU in lysogenic culture supernatants or other lysates.
Overnight cultures of either RN4220::ɸNM1-ErmR or RN4220::ɸNM1 lysogens
harboring targeting or non-targeting CRISPR-Cas plasmids were inoculated in
triplicate from single colonies in HIB media supplemented with chloramphenicol
(biological replicates). After overnight growth, cells were transferred to 4 °C then
pelleted by centrifugation at 4696g for 5 min. Supernatants were filtered, and 100 μl
from each lysate was mixed with 100 μl of either an indicator strain or targeting
strain overnight culture for plating by the soft agar method. After drying at room
temperature (25 °C), plates were incubated for 18 h at 37 °C. When quantifying plaqueforming potential (PFU / ml) from high-titer lysates of ɸNM1, ɸNM2, or ɸNM4 raised
on lawns of TB4 harboring the pGG3 plasmid, 5 ul of diluted or undiluted lysate was
spotted and dripped on an uninfected lawn of interest after drying at room temperature
(25 °C), and then incubated for 18 h at 37 °C.
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Screens for lipase-negative ɸNM4 lysogens.
An overnight culture of S. aureus TB4 harboring the spacer 32T or spacer 61T-1 CRISPRCas plasmid was re-cultured to log phase growth in HIB medium supplemented with 5
mM CaCl2. Re-cultures were treated with ɸNM4 at ~MOI 50 after measurement of
attenuance (D600 nm) to approximate cell densities. After incubation with phage for 1 h,
cells were plated on TSA supplemented with 5% egg yolk emulsion. After ~24 h
incubation at 37 °C, approximately 1,000 colonies were inspected for lipase secretion.
Lipase-negative candidates were re-streaked to single colonies for PCR analysis and
functional testing.

Phage DNA isolation and deep sequencing.
Samples of high-titer phage lysates (~1011 PFU ml-1) were treated with DNase and RNase
to a final volume of 150 μl for 1 h at 37 °C. Samples were treated with EDTA (pH 8.0) to
a final concentration of 20mM, followed by treatment with SDS to a final concentration
of 0.5% and 2 μl proteinase K. Samples were incubated for 1 h at 65 °C, then subjected
to a PCR purification protocol (Qiagen). Paired-end library preparation was performed
on purified phage DNA using a Nextera Tagmentation protocol (Illumina), and samples
were pooled for multiplexed sequencing on a MiSeq (Illumina). De novo assembly
of phage genomes used ABySS (Simpson et al., 2009).
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RNA preparation for reverse transcription PCR and RNA sequencing.
For reverse transcription PCR (RT-PCR), overnight cultures were diluted 1:20 in 25 ml
fresh media and grown for 2.5 h at 37 °C with shaking. After re-culture, cells were
pelleted and washed twice in 1 ml ice cold TSM buffer, then treated with 3 μl
lysostaphin (2 mg ml-1) for 20 min at 37 °C in 500 μl TSM buffer. Treated cells were
pelleted then re-suspended in 750 μl cold TRIzol Reagent (Life Technologies) after
discarding the supernatant. The following chloroform extraction and precipitation
was performed according to the manufacturer’s protocol. After resuspension in dH2O,
samples were treated with Qiagen DNase I for 45 min at 30 °C, then re-purified using
RNeasy Cleanup columns (Qiagen). In some cases, it was necessary to repeat this
step a second time to ensure the complete removal of DNA. After cleanup, all samples
were again treated with DNase I (Sigma-Aldrich) for 30–45min at 30 °C, before
use in the reverse transcription reaction.
For RNA sequencing, overnight cultures were diluted 1:100 in fresh HIB
supplemented with chloramphenicol and 500 μM CaCl2, and grown for 1.5 h
(approximately mid-log phase) at 37 °C with shaking. Cultures were removed, infected
at MOI ~20 then split into 10 ml portions for an additional 6, 15, 30 or 45 min of growth.
Immediately following incubation, samples were mixed with 10 ml of a 1:1
acetone/ethanol solution and transferred to –80 °C. The ɸNM1 lysogen was grown
similarly, except without antibiotics, and harvested immediately after the 1.5 h re-
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culture at 37 °C. After at least one overnight at –80 °C, samples were thawed on ice and
pelleted by centrifugation at 4696g for 10 min. After two washes of 1 ml TE buffer, cells
were re-suspended in 1 ml RLT buffer (Qiagen) supplemented with BME, and
transferred to 2-ml tubes pre-loaded with ~0.5–1 cm3 of 0.1 mm glass beads (BioSpec).
Samples were processed in a Mini-Beadbeater instrument (BioSpec) three times for 10 s
at 4,200 oscillations per minute, with 40 s of chilling on ice between runs. After
beadbeating, samples were spun down for 2 min at 16,100g in a refrigerated
microcentrifuge. Supernatant (750 μl) was transferred to a clean tube for mixing with
500 μl of 100% ethanol, and the following RNeasy purification was done according to
the manufacturer’s protocol (Qiagen). After elution, samples were treated with either
Qiagen or Sigma-Aldrich DNase I for 30–45 min at 30 °C, then re-purified using
RNeasy cleanup columns. In some cases, it was necessary to repeat this step a second
time to ensure the complete removal of DNA. rRNA-depleted samples were
subsequently generated using the RiboZero Magnetic Kit for bacteria (Epicentre),
according to the manufacturer’s protocol.

RNA preparation for reverse transcription PCR and RNA sequencing.
Reverse transcription used M-Mulv Reverse Transcriptase (NEB), with DNA-free total
RNA isolated from RN4220 cultures harboring either the pNes(wt-d) or pNes(wt-i)
plasmids as templates for cDNA synthesis. For pNes(wt-d), reverse transcription used
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either the L8 or L86 primers in two separate 30 ml reactions, alongside mock reactions
(–RT enzyme). For pNes(wt-i), the same was done using primers L8 or L87. After
incubation, 1 μl of each reaction was used as a template for PCR, with respective primer
pairs for each sample.

Phage transcriptome analysis and visualization.
Reads were aligned to reference genomes using Bowtie and sorted using Samtools.
Using a custom script, sorted reads were accessed via Pysam, normalized as reads per
million values, and plotted in log scale as the average over consecutive windows of 500
base pairs using matplotlib tools for IPython.

Transformation assays.
S. aureus RN4220 plasmid preparations were dialyzed on 0.025 μm nitrocellulose filters
(Millipore) then quantified using a NanoDrop 2000c Spectrophotometer (Thermo
Scientific). Aliquots (50 μl) of electrocompetent cells were transformed in triplicate with
80 ng dialyzed miniprep DNA per transformation (or as otherwise noted in figure
legends) using a Gene Pulser Xcell (BioRad) with the following parameters: 2900 V, 25
μF, 100 Ω, 2 mm (technical replicates). After electroporation, cells were immediately resuspended in TSB to a final volume of 200 μl and recovered at 30 °C for 2 h with
shaking. Serial dilutions were then prepared for plating with appropriate antibiotics.
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For targeting of iTET insertion vectors, additional plating in the presence of ATc at a
final concentration of 0.5 μg ml-1 was performed in parallel using the same dilutions.
Plates were incubated at 37 °C for 18–24 h.

Plate reader high-resolution growth curves.
For ATc induction experiments, overnight cultures were launched from single colonies
in triplicate (or as otherwise noted in the figure legend) and diluted 1:200 in TSB broth
(biological replicates). After 1 h of growth, ATc was added at a final concentration of 0.5
μg ml-1 where applicable. Measurements were taken every 5 min. For mitomycin C
induction experiments, overnight cultures were launched from single colonies in
duplicate and diluted 1:100 in HIB broth (biological replicates). After 1.5 h of growth,
mitomycin C was added at a final concentration of 0.5 μg ml-1 where applicable.
Measurements were taken every 10 min. For ɸNM1 infections, overnight cultures were
launched from single colonies in triplicate and diluted 1:100 in HIB broth supplemented
with CaCl2 5 mM (biological replicates). After 1 h 25 min of growth, attenuance (D600 nm)
was measured for three representative cultures to estimate MOI. Aliquots were then
loaded into 96-well plates along with ɸNM1 at the appropriate MOI (10 or 100), where
applicable. Measurements were taken every 5 min. For ɸNM1γ6 infections, overnight
cultures were launched from single colonies in triplicate and diluted 1:200 in HIB
supplemented with CaCl2 5 mM (biological replicates). An average attenuance (D600 nm)
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measurement was taken after 1 h of growth, and ɸNM1γ6 was added at an MOI of 10
on the basis of this value, where applicable. Measurements were taken every 5 min.

Plasmid-curing assays.
RN4220 strains harboring the CRISPR-Cas plasmid (pGG3 or pGG8) and the target
plasmid (pWJ153 or pWJ153γ) were cultured in TSB supplemented with
chloramphenicol (10 μg ml-1) to an attenuance (D600 nm) of 0.45. Strains harboring the
pGG8 and pWJ153γ combination also harbored the pG0mut plasmid as a bystander
plasmid to assay for targeting in trans. After splitting the cultures in two, transcription
across the target was induced for one of the cultures via the addition of ATc to a final
concentration of 0.250 μg ml-1 or 0.125 μg ml-1 as noted in the figure legends. Where
applicable, aliquots of cells from each culture were harvested before (0) and after (1, 2,
3, 4, 5 and 6 h) the time of induction for miniprepping of plasmids. In parallel, serial
dilutions of both cultures were prepared in triplicate for each time point and plated on
TSA plates supplemented with chloramphenicol and erythromycin or chloramphenicol
alone, for quantification of antibiotic-resistant CFU (technical replicates). In experiments
with pG0mut, serial dilutions for each time point were also plated on TSA plates
supplemented with chloramphenicol and mupirocin. After miniprepping, plasmids
were linearized with the common single cutter BamHI and subjected to agarose gel
electrophoresis.
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CHAPTER 3: INVESTIGATION OF PHENOTYPIC CONSEQUENCES
ASSOCIATED WITH MAINTENANCE OF CONDITIONAL TOLERANCE IN
LYSOGENIZED S. AUREUS LINEAGES

The work described in Chapter 2 established key insights into the targeting mechanism
of a type III-A CRISPR-Cas system, and thereby provided a foothold for understanding
the biology of these systems in the context of temperate phage infections. Prior to that
work, it was unclear whether stable co-existences between active CRISPR-Cas systems
and their temperate phage targets could occur, because CRISPR-Cas targeting was
shown to resist lysogenic infections by phage lambda (Edgar and Qimron, 2010). This
finding, however, made use of a particular transcription-independent type I-E CRISPRCas system in E. coli. While I observed similar results with a transcription-independent
(type II-A) CRISPR-Cas system in S. aureus, the type III-A system I tested, in contrast,
was found to prevent temperate phage propagation when targets are transcribed
during lytic infection or prophage induction, and tolerate prophages in cases where
targets are sufficiently repressed in the chromosome (Goldberg et al., 2014). Thus, this
work provided the first demonstration that a temperate phage which was otherwise
targeted by a CRISPR-Cas system could be acquired via lysogeny without mutating its
target, and even in the absence of CRISPR-Cas inactivation via inhibition (BondyDenomy et al., 2013) or mutation. Unlike inactivation of transcription-independent
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CRISPR-Cas systems by temperate-phage-encoded targeting inhibitors (Bondy-Denomy
et al., 2013; Pawluk et al., 2014), conditional tolerance via transcription-dependent
targeting ensures that the host can maintain type III-A resistance to subsequent lytic
infections by heteroimmune phages that bear a matching target. Another consequence
of transcription-dependent targeting is that tolerance breaks down during prophage
induction, when the lytic cycle reinitiates and target sequences are transcribed.
However, additional consequences for the lysogenic hosts that maintain conditional
tolerance have not been described.
In preliminary attempts to determine the effect of prophage induction on
RN4220::ɸNM1 lysogens harboring the spacer 43T CRISPR-Cas plasmid, I found no
evidence that these conditionally tolerant lysogens survived better than non-targeting
lysogens following treatment with MMC, even at a sub-inhibitory concentration of 0.5
μg/ml (data not shown). Therefore, an a priori reason to suspect that conditional
tolerance could provide a direct advantage to lysogenized lineages was, in my view,
still lacking. In fact, the scarcity of type III-A systems observed among staphylococcal
isolates seemed to argue the opposite: that these systems might be too detrimental—or
at least insufficiently advantageous—to be maintained in those populations.
Furthermore, given that conditional tolerance contributes to the genetic stability of the
type III-A CRISPR-Cas system itself, it could be viewed as a paradigm of genetic
‘selfishness’ (Doolittle and Sapienza, 1980; Orgel and Crick, 1980) first and foremost—
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and perhaps should be. The stabilizing effects of conditional tolerance, for example,
might be sufficient to explain why this phenomenon has also evolved as an emergent
property of other phage defense mechanisms, such as SaPI interference (Ram et al.,
2014) and abortive infection (Depardieu et al., 2016). Viewing conditional tolerance in a
selfish light makes it easier to envision a scenario where negative side-effects associated
with its maintenance over the long term could provide pressure to abandon the phagedefense system responsible—despite the short-term stabilizing effects it can afford. For
example, considering that type III-A targeting was found to occur during prophage
induction (which, can occur spontaneously even in growing populations), it seemed
plausible to me that maintenance of conditionally tolerant type III-A systems in
lysogenized lineages could be accompanied by unforeseen phenotypic consequences.
The work described in Chapter 3 was designed to investigate this possibility. An
understanding of such phenotypes, in turn, could offer valuable insight into factors that
influence the stability and distribution of type III-A systems among natural,
lysogenization-prone populations of S. aureus (Aanensen et al., 2016; Cao et al., 2016;
Goerke et al., 2009).
In an effort to emulate natural systems more closely, I once again began using the
Newman phages’ native host background, TB4, as a model host for investigating the
biology of type III-A temperate phage targeting in clinically-relevant strains of S. aureus.
Various mutations had been identified previously (Nair et al., 2011) in the genome of S.
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aureus RN4220, including mutations in DNA repair and housekeeping genes, which
could potentially have an impact during CRISPR-Cas targeting (although not
necessarily). Moreover, I resolved to exclusively work with wild type CRISPR array
architectures where spacers are flanked by repeats on both sides. To facilitate the
cloning of such CRISPR-Cas systems, I constructed a new set of BsaI-based parent
vectors. The pGG-BsaI-R parent vector was constructed by adding a repeat downstream
of the BsaI placeholder spacer in pGG-BsaI (Samai et al., 2015), and is suitable for
constructing single-spacer arrays with the ‘R-S-R’ architecture. However, after a slew of
inefficient cloning attempts with this vector, I endeavored to improve the cloning
efficiency by eliminating a base pair from the 3’ end of the BsaI placeholder spacer to
produce different downstream overhangs upon restriction digest. Aside from this
change, the resulting pGG78 plasmid is otherwise identical to pGG-BsaI-R. The pGG79
parent vector, also constructed at this time, is a variant of pGG78 with the nes spacer
still present in position 1, and was derived from pGG3-BsaI (Figure 3-1). Whether or not
the placeholder spacer modification was effective in improving the cloning efficiency
was not rigorously determined, and remains unclear to me. In any event, I began using
the pGG79 vector for downstream manipulations, because I decided that it might still
on occasion be useful to assay whether the backbone is functional via the nes spacer in
position 1 (independently of the variable spacers I introduce at position 2). Such
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functional testing became even easier after my colleague, Dr. Varble, engineered a
variant of ɸNM4γ4 with the 32T spacer’s target replaced by the nes protospacer. Indeed,

Figure 3-1. Generation of a modified BsaI parent vector for cloning of type III-A
CRISPR-Cas plasmids with wild type CRISPR architecture.
(A) Schematic representations of the pGG3-BsaI (left) and pGG79 (right) type III-A
CRISPR-Cas plasmids. pGG3-BsaI harbors the type III-A system from S. epidermidis
RP62a, including its conserved leader sequence (‘L’, dark grey box), but with a modified
CRISPR array containing only two spacers. The wild type nes spacer is located at
position 1, while its 30 bp placeholder spacer (green) containing BsaI restriction sites to
facilitate oligo cloning is located at position 2. To construct pGG79, an additional
CRISPR repeat was added downstream of the BsaI placeholder spacer in pGG3-BsaI
(middle). pC194 backbones include a chloramphenicol acetyltransferase (cat) gene
conferring resistance to chloramphenicol, which is also depicted alongside cas genes in
the plasmid diagrams.

CRISPR-Cas-mediated resistance to this phage, which we called ɸNM4γ4α2, could be
assayed with a simple streak-test if needed.
Now that I was testing various lysogenic derivatives of TB4, it became more
efficient to introduce plasmids via generalized transduction rather than transformation.
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Transformation required that I would have to prepare different batches of competent
cells for each strain, and then transform them with each (miniprepped) plasmid.
Transduction only required that a single transducing lysate was prepared per plasmid,
which could then be used to deliver the plasmid to each strain directly during log-phase
growth. One potential obstacle here is that preparation of the transducing lysate
requires efficient lysis of the CRISPR-Cas plasmid’s host by a phage; i.e., the phage
should not harbor a target for the CRISPR-Cas system. However, I now had various
clear-plaque phages at my disposal, so I could readily transduce each CRISPR-Cas
plasmid by simply lysing its host with a suitable phage that lacks a target. In addition, I
had at my disposal a tetM-marked SaPI—SaPI1tst::tetM (Lindsay et al., 1998) —which
our lab had received from the Novick group. This SaPI confers resistance to tetracycline
upon delivery and integration into a suitable host chromosome, and its transfer can
therefore be readily monitored using standard transduction protocols. In the first
section of this chapter, I describe some experiments illustrating how the mobilization of
this SaPI in lysogenic hosts can be impeded by type III-A targeting of its helper phage(s)
during prophage induction.
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3.1

Conditionally tolerant type III-A CRISPR-Cas systems that target helper
prophages can impede SaPI mobilization in lysogenic hosts

The SaPI1(tst::tetM) element can be mobilized by various helper phages, including 80α
and ɸNM1 (Dearborn and Dokland, 2012; Lindsay et al., 1998). SaPI1 induction by 80α
requires the Sri antirepressor protein (Tormo-Mas et al., 2010), and induction by ɸNM1
is thought to be licensed by its homolog in ɸNM1 (Dearborn and Dokland, 2012). The
ORF encoding this sri homolog is missing from the original ɸNM1 annotation
(NC_008583.1), but is located roughly between ORFs 19 and 20. To facilitate lysogen
strain construction, I used an ErmR-marked derivative of ɸNM1 (ɸNM1-ErmR2) as my
helper phage of interest (such that I could readily select for lysogens on the basis of
erythromycin resistance). The ɸNM1-ErmR2 phage (Figure 3-2A) is a derivative of
ɸNM1-ErmR (Goldberg et al., 2014) that I constructed in an effort to improve plating
efficiency during lysogenization assays. Its ermC insertion was trimmed upstream of the
5’ UTR and contains the tyc-1 allele SNP that was shown to improve constitutive
expression of this cassette in B. subtilis (Gryczan et al., 1980). After lysogenizing TB4 (or
derivatives of TB4 harboring CRISPR-Cas plasmids), the SaPI1tst::tetM element was
introduced into lysogens via transduction. I first confirmed that the presence of the SaPI
alone did not appreciably alter lysis profiles mediated by ɸNM1-ErmR2 during MMCstimulated prophage induction: as expected, lysis was still observed (Figure 3-2B). For
comparison, I tested TB4 derivatives lysogenized with ɸ11, which is not a helper phage
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Figure 3-2. Effects of helper phage targeting in conditionally tolerant, SaPIcontaining lysogens.
(A) Schematic representation of the ɸNM1-ErmR2 prophage genome, with ORFs (thick
arrows) scaled by length in accordance with the ɸNM1 annotation (NC_008583.1). The
ermC(tyc-1) insertion (blue) is located immediately downstream of the ɸNM1 integrase.
The sri antirepressor ORF (green) is located between ORFs 19 and 20 in the original
ɸNM1 annotation. Precise locations of the target sites for the gp16 and gp43ori spacers
tested in this chapter are also shown above their respective color-coded ORFs.
Divergently oriented grey bent arrows signify the presence of PcI and Pcro promoters in
the ELCR. (B) Quantification of PFU concentrations (PFU / ml) in filtered supernatants
from overnight cultures of TB4::ɸNM1-ErmR2 lysogens with the indicated CRISPR-Cas
plasmid, grown in TSB supplemented with chloramphenicol for 14 hours. Lysogens
with the control CRISPR-Cas plasmid are either lacking (C/S-) or harboring (C/S+) the
SaPI1tst::tetM element. Horizontal bars emphasize the measurement from a single
experiment, plotted as a black dot in each column. Dashed line represents the limit of
detection under these assay conditions. (C) High-resolution growth curves of
TB4::ɸNM1-ErmR2 or TB4::ɸ11 lysogens either lacking or possessing the SaPI1 element
as indicated, with MMC added at the indicated time point (black arrow). Solid lines
represent attenuance (D600 nm) measurements from single biological replicates in the
presence of MMC; for comparison, attenuance measurements from the same biological
replicate grown in the absence of MMC is plotted for two strains (dashed lines). (D)
Quantification of STU and PFU concentrations (STU /ml or PFU / ml) in filtered
supernatants from subcultures of TB4::ɸNM1-ErmR2 lysogens harboring the SaPI and a
CRISPR-Cas plasmid as indicated, four hours post-treatment with MMC at 2.0 μg/ml.
After 95 minutes of growth and immediately prior to treatment, subculture attenuances
(D600 nm) were normalized to ~0.5. The pGG115 plasmid was used as the non-targeting
control (C) in this assay. Additional biological replicates were not performed. (E) Same
as in ‘C’, except with TB4::ɸNM1-ErmR2 lysogens that harbor both the SaPI and a
CRISPR-Cas plasmid as indicated, and all three untreated curves were plotted. The
pGG115 plasmid was also used as the non-targeting control (C) in this assay. (F)
Schematic diagram summarizing the multiplex PCR reaction that allows for a coarsegrained assessment of integrated and excised SaPI1 genome relative abundances. The
attC and attS junctions are only present when the SaPI is excised by a helper phage.
Primers ‘1’ through ‘4’ correspond to oGG338 through oGG341. Features are scaled
arbitrarily. (G) Multiplexed PCR amplification with the oGG338-oGG341 primer set and
one of 6 colony lysate templates. Templates 1 through 4 were from TB4::ɸNM1-ErmR2
lysogens harboring the pGG79, gp16, gp16(csm6*), or gp43ori CRISPR-Cas plasmids (in
that order). Templates 5 and 6, respectively, were from TB4::ɸNM1 and TB4::ɸ11
lysogens lacking CRISPR-Cas plasmids. All lysogens harbored the SaPI. Size markers of
1 kb and 0.5 kb are indicated, along with the expected banding position for the intact
attC, attR, attL, and attS junction amplicons. Additional technical replicates were not
performed on these templates, but similar banding patterns were observed for the gp16
and gp43ori strains in a separate biological replicate (not shown).
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for SaPI1tst::tetM (Lindsay et al., 1998). Meanwhile, the presence of the SaPI was
sufficient to reduce spontaneously induced PFU from ɸNM1-ErmR2 lysogens harboring
a non-targeting CRISPR-Cas plasmid (Figure 3-2C), presumably as a result of SaPImediated interference. For comparison, spontaneous induction was measured under the
same assay conditions for TB4::ɸNM1-ErmR2 lysogens lacking the SaPI but harboring
conditionally tolerant type III-A CRISPR-Cas plasmids with either the gp16 or gp43ori
spacers. The gp43ori spacer harbors the same 36 bp sequence as the 43T spacer published
previously (Goldberg et al., 2014), and is identical to the 35 bp variant published as
‘gp43’ (Jiang et al., 2016) aside from the one bp at its 3’ end. For the next experiments, I
introduced the gp16 or gp43ori CRISPR-Cas plasmids into TB4::ɸNM1-ErmR2 lysogens
harboring the SaPI. The presence of these conditionally tolerant type III-A systems
prevented lysis when prophage induction was stimulated with MMC (Figure 3-2D). To
demonstrate that type III-A targeting during prophage induction could impede SaPI
transfer, I next measured the number of SaPI transfer units (STUs) in supernatants of
lysogenic cultures after a four-hour treatment with MMC. For comparison, PFU were
also measured. By interfering with lysis during prophage induction, type III-A plasmids
are expected to prevent release of STU and PFU altogether. Indeed, the concentration of
STUs and PFUs in culture supernatants were both reduced appreciably for strains
harboring conditionally tolerant type III-A plasmids, four hours post-induction (Figure
3-2E). To determine whether intracellular mobilization of the SaPI was also reduced by
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either of these spacers, I designed a multiplex PCR reaction for amplifying across
excised and integrated SaPI attachment junctions (Figure 3-2F). The presence of an attS
and/or attC amplicon indicates that the SaPI genome is excised (and possibly already
replicated or packaged). Meanwhile, only the attL and attR junctions can be amplified if
the SaPI is stably integrated. PCR was performed on single colony lysates to probe the
effects of helper prophage targeting during spontaneous induction. Whereas excised
SaPIs were detectable in TB4::ɸNM1-ErmR2 lysogens harboring the non-targeting parent
vector, this was not the case for lysogens harboring the gp16 CRISPR-Cas plasmid
(compare to control amplification from TB4::ɸ11 lysogens harboring a non-helper
prophage, Figure 3-2G). Interestingly, excised SaPIs were still detectable with the gp43ori
CRISPR-Cas plasmid. In fact, the attC amplicon appeared to be slightly enriched relative
to non-targeting lysogens (Figure 3-2G). I speculate that this enrichment results from
the accumulation of replicated SaPI genomes in cells which cannot lyse via prophage
induction, due to targeting by the gp43ori spacer. Previously published work (Jiang et al.,
2016) from my colleagues showed that immunity licensed by the gp43 spacer allows for
intracellular accumulation of phage DNA because its target is transcribed late during
the lytic cycle, when replication is already under way. In contrast, phage DNA
accumulation was not observed when an early-transcribed ORF (gp14) was targeted,
presumably because the phage could be cleared before replication (Jiang et al., 2016).
Given that the sri antirepressor ORF falls within an early transcribed region upstream of
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gp43ori, it could presumably be expressed before targeting by gp43ori occurs. Similarly,
the effect on intracellular SaPI mobilization observed with the gp16 spacer—which also
targets an early transcribed ORF—might be explained by the location of the gp16 target
upstream of the sri ORF (Figure 3-2A). In other words, type III-A targeting at the gp16
ORF during prophage induction might prevent intracellular SaPI mobilization by
interfering with expression of the downstream sri ORF. I also tested a variant of the
gp16 CRISPR-Cas plasmid with catalytic site mutations in csm6 that abolish its HEPN
domain’s non-specific RNase activity (Jiang et al., 2016), in order to rule out the
possibility that the effects observed with gp16 were due to this activity operating on
phage, SaPI, or host transcripts at other loci during targeting. As expected for a spacer
matching to an early-transcribed region of ɸNM1, the RNase activity of Csm6 appeared
to be dispensable for targeting effects (Figures 3-2C, D, E, & G). Whether or not the
gp43ori spacer allows intracellular accumulation of intact SaPI particles was not assessed,
and it’s possible that targeting of the head protein disrupts intracellular packaging in
addition to preventing completion of the lytic cycle. Extraction of intracellular particles
via mechanical or chemical lysis could help to clarify these points. Interactions between
a phage-encoded type I-F CRISPR-Cas system and an ~18-kb element, resembling a
SaPI-like phage-inducible chromosomal island (PICI), were previously described in
Vibrio cholerae (Seed et al., 2013). In that work, however, the CRISPR-Cas system
directly targeted the PICI-like element, and therefore did not interfere with completion
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of the helper phage’s lytic cycle. Type III-A systems that directly target SaPIs might be
similarly expected to allow a helper phage to complete its lytic cycle, by neutralizing the
SaPI, but it is unclear if such systems could evolve naturally.
The results described above indicate that targeting of helper prophages by
conditionally tolerant type III-A CRISPR-Cas systems can impede the transfer of SaPI
particles from lysogens via prophage induction. Similar outcomes would be expected
during lytic infections by heteroimmune helper phages bearing a target for the type IIIA system, although this was not tested. By preventing the transfer of genes carried
directly on the SaPI genome, and perhaps also by limiting the transfer of host genes via
island-mediated (or by extension, phage-mediated) generalized transduction (Chen et
al., 2015b), phage targeting by type III-A systems could be detrimental in natural
populations of S. aureus that thrive off such forms of HGT. In turn, the loss of type III-A
CRISPR-Cas systems from S. aureus genomes might help to ensure that such
populations remain adaptive in rapidly changing environments, and/or that they can
readily resist Muller’s ratchet mechanism (Muller, 1932, 1964) over the long term.
However, the possibility that maintenance of conditionally tolerant type III-A systems
in lysogenic populations could impact host fitness more directly has not been ruled out.
In the remainder of this chapter, I provide evidence that conditionally tolerant type IIIA systems can impose constitutive fitness costs on lysogenic hosts which lack SaPIs
altogether.
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3.2

Detection of incomplete prophage tolerance by type III-A CRISPR-Cas

systems in lysogenic hosts
In Chapter 2, the CRISPR-Cas system of S. epidermidis RP62a was re-engineered to
contain spacers targeting the temperate phages of S. aureus Newman, and introduced
into heterologous RN4220 (Nair et al., 2011) or TB4 hosts (Bae et al., 2006) on pC194based plasmids (Horinouchi and Weisblum, 1982a). The spacers were all introduced
into the CRISPR loci of my original parent vectors (pGG3 or pGG3-BsaI), and many of
them were found to license conditional tolerance. However, a small-colony phenotype
was clearly apparent when the spacer 2T CRISPR-Cas plasmid was introduced into
RN4220::ɸNM1 lysogens. As explained in section 2.4, this was assumed to result from
slightly elevated rightward transcription across the prophage’s xis target ORF, relative
to other target regions (Figure 2-17). In other words, this result seemed to suggest that
leaky prophage transcription could license an incomplete tolerance phenotype. Once I
began working with pGG79-derived CRISPR-Cas plasmids, and also primarily TB4
lysogens, it became clear that this incomplete tolerance phenotype was more common
than previously expected. For example, a small-colony phenotype was clearly apparent
when the pGG79-derived gp32* CRISPR-Cas plasmid was introduced into TB4::ɸNM1
lysogens (Figure 3-3A). A colony size reduction, albeit less pronounced, was also
observed with the mismatched gp32 variant of this spacer. Hypothesizing that these
phenotypes reflect a general growth rate reduction relative to non-targeting lysogens, I
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Figure 3-3. Maintenance of conditionally tolerant type III-A CRISPR-Cas systems in
lysogenic hosts can incur fitness costs.
(A) Colony size comparison of TetR-marked TB4::ɸNM1 single lysogens harboring
CRISPR-Cas plasmids containing either non-targeting spacers alone (C), the perfectly
matched gp32 spacer (gp32*), or the originally identified gp32 spacer with 5 mismatches
(gp32). Picture is representative of a biological replicate for each strain plated in the
presence of chloramphenicol to select for the CRISPR-Cas plasmids. (B) Pairwise
competition experiments with the gp32* spacer that licenses conditional tolerance of
ɸNM1. An ErmR-marked control lysogen harboring the parent vector with nontargeting spacers was competed against the TetR-marked conditionally tolerant lysogen.
Relative frequencies (y-axis) are plotted against the number of transfers (x-axis), with
one transfer per day. Individual values from each biological replicate are depicted in
black as a triangle, circle, or rhombus. Solid lines represent the average change in
relative frequency across the three replicates, and share color coding with the target
ORF indicated in Figure 3-4A. (C) Same as in ‘B’, except that the TetR-marked
conditionally tolerant lysogen used for competitions harbored the gp32 (partially
mismatched) spacer. (D) Schematic summary of pairwise competition assays used in
this work to assess the relative fitness of antibiotic resistance-marked TB4 lysogens.
Lysogens harboring CRISPR-Cas plasmids with either non-targeting or targeting
spacers were mixed ~1:1 and passaged daily, with selective plating at each interval to
calculate relative abundances as the ratio of TetR CFUs over total (TetR + ErmR) CFUs.
Chloramphenicol was also maintained in all media and plates to ensure selection for
CRISPR-Cas plasmids. Falcon tube graphic adapted from an online source:
https://clipartfest.com/download/c8aa2089bcf055d864c0317e14ff369ded0b3d10
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sought to quantify them more precisely in terms of a fitness cost. This was
accomplished by marking the TB4::ɸNM1 lysogens with small plasmids (Horinouchi
and Weisblum, 1982b; Khan and Novick, 1983) conferring resistance to either
tetracycline (Tet) or erythromycin (Erm), and measuring their relative abundances over
time in pair-wise competition co-cultures (Figure 3-3D). As anticipated, the relative
abundance of lysogens with the perfectly matching gp32* spacer declined more rapidly
than lysogens with the mismatched spacer, when competed against control lysogens
containing the parent vector with non-targeting spacers (Figures 3-3B & C). Fitness
costs were quantified in terms of a selection coefficient, s, based on instruction from
Robert Heler on how to calculate these values for a set of competition data points, using
formulas in Microsoft Excel. Table 3-1 lists the calculated values for all competition
experiments performed in this work. To probe the generality of spacer-dependent
fitness costs, I tested four additional spacers with perfect identity to sequences within
gp5, gp8, gp16, and gp43 of ɸNM1 (Figure 3-4A), and assayed them for relative fitness
using the same setup. In three cases, a decline in relative abundance was clearly
apparent (Figures 3-4B, C, & D), whereas no change in relative abundance was found in
control co-cultures where competing lysogens harbored the same non-targeting parent
vector (Figure 3-4E).
Previous studies have demonstrated that chromosomal targeting by CRISPR-Cas
systems in bacteria is severely detrimental to growth and potentially lethal
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Figure 3-4. Incomplete prophage tolerance by type III-A systems can be licensed by
prophage-internal promoter activity.
(A) Schematic representation of the integrated ɸNM1 prophage genome, with ORFs
(thick arrows) scaled by length according to the annotation (NC_008583.1). The gp5, gp8,
gp16, gp32, and gp43 ORFs are colored to denote inclusion of a target sequence for one
or more spacers tested in this work. Grey bent arrow indicates the position of ɸNM1’s
early lytic promoter (Pcro). LLCR denotes the location of an intergenic region in ɸNM1
with homology to regulatory sequences reported to control late gene expression for
related phages (Ferrer et al., 2011; Quiles-Puchalt et al., 2013). (B) Pairwise competition
experiments for testing the perfectly matching gp5 spacer in marked single lysogens of
TB4::ɸNM1, performed as described in Figure 3-3. (C) Same as in ‘B’, except the
perfectly matching gp16 spacer was tested. (D) Same as in ‘B’, except the perfectly
matching gp43 spacer was tested. (E) Control co-culture competition experiment; same
as in ‘B’, except that both ErmR- and TetR-marked TB4::ɸNM1 lysogens harbored the
non-targeting pGG79 parent vector. (F) Sequences of the Pcro promoter in wild type
ɸNM1 or its inactive variant in ɸNM1Pcro-, with point mutations (red lettering) in the -10
element. The location of Pcro, along with the approximate position of its transcriptional
start site (+1), was inferred from RNA-sequencing analysis of ɸNM1 during lytic
infections (Goldberg et al., 2014). This designation is further supported by research on
S. aureus temperate phages with related lambdoid regulatory architecture (Ganguly et
al., 2009; Iandolo et al., 2002; Quiles-Puchalt et al., 2013). (G) Pairwise competition
experiments for testing the perfectly matching gp5 spacer in marked single lysogens of
TB4::ɸNM1Pcro-, performed as described in Figure 3-3. Individual values from each
biological replicate are depicted in grey with black outlines as a triangle, circle, or
rhombus. (H) Same as in ‘G’, except the perfectly matching gp16 spacer was tested. (I)
Same as in ‘G’, except the perfectly matching gp43 spacer was tested.
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(Jiang et al., 2013b; Vercoe et al., 2013), even in cases where prophage loci are targeted
(Cady et al., 2012; Edgar and Qimron, 2010; Goldberg et al., 2014). In light of these
findings, I hypothesized further that the spacer-dependent fitness costs result from
growth defects associated with incomplete prophage tolerance, licensed by leaky
transcription across targets from one or more promoter within the prophage. To explore
this possibility, I introduced inactivating mutations into the early lytic promoter
upstream of ɸNM1’s cro-like regulator, encoded by gp5 (Figure 3-4F). Mutation of this
promoter (ɸNM1Pcro-) virtually abolished the fitness cost associated with the gp5 spacer
(Figure 3-4G). Interestingly, the cost associated with the gp16 spacer was only partially
reduced (Figure 3-4H), suggesting that downstream promoters might license different
growth defects in the absence of a dominant promoter upstream. In support of this
notion, I observed a clear discrepancy in the magnitude of the costs associated with the
gp5 or gp16 spacers compared to that of the gp43 spacer in wild type lysogens (Figures
3-4B, C, & D), despite their similar capacities to disrupt phage lytic propagation via
spontaneous or MMC-stimulated prophage induction (Figures 3-5A & B). The gp43
target, unlike the gp5 and gp16 targets, is located within a gene cluster that is
transcribed late during the lytic cycle of ɸNM1 (Goldberg et al., 2014). In staphylococcal
phages with related genomic architecture, this cluster lies downstream of a regulatory
region that was shown to contain a conserved transcriptional terminator (Ferrer et al.,
2011), and I identified such a region (LLCR) in ɸNM1 between gp36 and gp37 (Figure 3-
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Figure 3-5. Prophage inducibility is not a prerequisite for incomplete tolerance by
type III-A systems.
(A) Quantification of PFU concentrations (PFU / ml) in filtered supernatants from
overnight cultures of TetR-marked TB4::ɸNM1 single lysogens harboring CRISPR-Cas
plasmids with one of several targeting spacers, or the control parent vector with nontargeting spacers (C). Horizontal bars indicate the mean value of three biological
replicates, plotted as black dots in each column. TetR-marked lysogens harboring the
control parent vector and mutant prophages ɸNM1Pcro- or ɸNM1ind- were also tested, and
plaques were only detected in one of the replicates for ɸNM1ind-. Dotted line represents
the limit of detection under these assay conditions. (B) High-resolution growth curves
of TetR-marked TB4::ɸNM1 single lysogens harboring the CRISPR-Cas plasmids tested
in panel ‘A’. Solid lines represent the average attenuance (D600 nm) measured from three
biological replicates with MMC added at the indicated time point (black arrow), and are
colored to match the target ORFs highlighted in Figure 3-4A or black for the control
parent vector. A dotted line is used for the gp32 (mismatched) spacer, but note that
individual dots do not correspond to measurements taken every 10 minutes. For
comparison, average attenuance measured from three biological replicates in the
absence of MMC is plotted for two strains (dashed lines). (C) Same as in ‘B’, except
using TetR-marked TB4::ɸNM1Pcro- lysogens with select CRISPR-Cas plasmids. (D) Same
as in ‘B’, except using TetR-marked TB4::ɸNM1ind- lysogens with select CRISPR-Cas
plasmids; a TetR-marked TB4 non-lysogen harboring the pGG79 parent vector was also
tested (grey lines). (E) Schematic diagram illustrating different outcomes expected for
the wild type ɸNM1 prophage (left) or the ɸNM1ind- prophage mutant (right) in
response to a canonical SOS-inducing signal. Monomers of CI-like repressor are
depicted as black bar bells, with green spots for the ɸNM1ind- mutant indicating the
presence of a S124A substitution in the C-terminal serine protease domain. When intact
repressors are present, only leaky transcription originates from the regulated promoter
(dashed grey bent arrows). Under inducing conditions, autoproteolysis of wild type
repressor is stimulated by the presence of activated RecA (RecA*) and allows
transcription required for the lytic cycle (solid black bent arrow), while ɸNM1ind- mutant
repressor remains intact and continues to allow only leaky transcription. (F) Pairwise
competition experiments for testing the perfectly matching gp16 spacer in marked single
lysogens of TB4::ɸNM1ind-, performed as described in Figure 3-3. (G) Same as in ‘F’,
except the perfectly matching gp43 spacer was tested.
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4A). Conceivably, the magnitude of the gp43 spacer’s fitness cost is determined by one
or more late promoters that are insulated from upstream transcription during the noninducing conditions of lysogeny, perhaps in part due to this regulatory region. In order
to better assess the plausibility of this surmise, I used an online promoter prediction
tool to identify putative promoters upstream of my targets (Table 3-2). Candidates were
selected from among the initial hits by cross-referencing with the position of relative
transcriptional peaks identified along the traces of non-averaged plots from a stranded
RNA-seq dataset collected previously (Goldberg et al., 2014). Particularly when
considering the relative peaks observed 6 minutes post-infection with ɸNM1 (Figure 36A), it is apparent that there are multiple regions that display a dip in coverage
followed by a peak, which could thus indicate the presence of a promoter. However,
although this stranded RNA-seq dataset distinguished between the directionality of
transcription, it did not distinguish transcriptional start sites from processed or cleaved
RNA ends (which could also manifest as a local dip in coverage). Additional analyses
would therefore be required to confirm the presence of bona-fide promoters at these
sites. Note that the magnitudes of rightward transcription observed in the
RN4220::ɸNM1 lysogen dataset (Figure 3-6B) should be interpreted with caution,
because rightward transcription may be derived from a subset of the cells in the
population undergoing spontaneous prophage induction, in addition to the stably
lysogenic cells. Note, also, that both of these expression profiles were measured with
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Figure 3-6. Location of ɸNM1 promoter candidates inferred from promoter
predictions and stranded RNA-seq profiles.
(A) Schematic representation of the ɸNM1 genome as presented in Figure 3-4A, aligned
with ɸNM1’s rightward transcription profile (solid green line), obtained six minutes
after infection of sensitive RN4220/pGG3 cells. Values are plotted in reads per million
(RPM), but were not averaged over a 500 bp sliding-window as displayed previously
(Goldberg et al., 2014). Vertical dashed lines below grey bent arrows represent the
position of candidate promoters as indicated. Their sequences are listed in Table 3-2.
(B) Same as in ‘A’, except that data was collected from a logarithmically growing
RN4220::ɸNM1 lysogen.
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the RN4220 host background. Nevertheless, I speculate that leaky transcription from at
least some of these candidates—in addition to Pcro—could license incomplete prophage
tolerance and a concomitant fitness reduction for the lysogen. Consistent with this
notion, the ɸNM1Pcro- mutation had no discernible effect on the cost associated with the
gp43 spacer (Figure 3-4I). Furthermore, this mutation was found to completely abolish
the lysogen’s capacity for detectable prophage induction in two assays (Figures 3-5A &
C). This suggests that the costs I’ve observed do not require transcription derived from
lytic propagation. In further support of this idea, fitness costs associated with the gp32*
spacer in the ɸNM1Pcro- background were comparable to that observed in the wild type
background prior to day 3, and in fact somewhat elevated (Table 3-1). However, a
fitness equilibrium plateau was not reached at this point when Pcro was mutated in the
ɸNM1Pcro- background (Figure 3-7). Evidently, the pronounced curing of the wild type
ɸNM1 prophage detectable by day 3 with the gp32* spacer (data not shown) requires
that the prophage’s lytic capabilities are intact, although the fitness costs per se do not.
In fact, by eliminating the target sequence, prophage curing apparently has the effect of
rapidly extinguishing the fitness cost associated with maintenance of this CRISPR-Cas
system. Meanwhile, prophage curing was not observed with the gp5, gp16, and gp43
spacers in wild type ɸNM1 lysogens, or the gp32* spacer in ɸNM1Pcro- lysogens, where
genetic escape via CRISPR-Cas plasmid inactivation was instead apparent by day 6
(data not shown). The reason for this discrepancy between the gp32* spacer and the
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Figure 3-7. An intact ɸNM1 prophage is required for high-frequency genetic escape
of gp32*-dependent fitness costs observed in TB4::ɸNM1 lysogens.
(A) Pairwise competition experiments for testing the perfectly matching gp32* spacer in
marked single lysogens of TB4::ɸNM1, performed as described in Figure 3-3. (B) Same
as in ‘B’, except that the perfectly matching gp32* spacer was tested in marked single
lysogens of TB4::ɸNM1Pcro-, and individual values from each biological replicate are
depicted in grey with black outlines as a triangle, circle, or rhombus.

other perfectly matching spacers in wild type lysogens is still unclear to me. I speculate,
however, that the unique position of its target within the prophage genome, and the
dispensability of the gp32 ORF (based on homology to ɸNM2 and ɸNM4; see Chapter 2)
for lytic infections, might be responsible. In temperate phages of Pseudomonas
aeruginosa, accessory genes have been identified at an analogous region upstream of
late-transcribed phage structural genes (Bondy-Denomy et al., 2013; Pawluk et al.,
2014), and they are thought carry their own promoters (Pawluk et al., 2014). It is
possible that this region in ɸNM1 also encodes accessory genes with their own
promoters, and that the regulation of these promoters is relatively uncoordinated with
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the phage’s other promoters. In turn, such unregulated transcription might allow for
bursts of targeting at opportune times during prophage induction, and targeting of this
region would not necessarily disrupt the early lytic functions required for curing
(because they are located upstream). It is also interesting to note that the fitness plateau
was reached within a mixed population where non-targeting (ErmR-marked) lysogens
release normal levels of infective phage particles. CRISPR-Cas immunity to lytic
infection licensed by the gp32* spacer therefore appears to be sufficient to maintain the
fitness of TetR-marked non-lysogens alongside control lysogens, at least under the
growth conditions tested.
In order to further demonstrate that these spacer-dependent fitness costs arise
independently of prophage induction, I disrupted ɸNM1’s SOS-inducibility without
altering its promoters by introducing a serine to alanine missense mutation in the
catalytic domain of its cI-like repressor (Figures 3-5D & E). The CI-like repressors of
lambdoid phages possess a serine protease activity that is required for prophage
induction via RecA*-stimulated autoproteolysis and de-repression (Erill et al., 2007;
Livny and Friedman, 2004; Mo et al., 2014). Spontaneous prophage induction was
almost undetectable for this ɸNM1ind- mutant as well (Figure 3-5A). A previous report
with phage lambda showed that when the primary recA-dependent pathway of
prophage induction is prevented, rare spontaneously induced plaques can be found
with compensatory mutations in either cI or its operator region that destabilize the
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repression circuit (Little and Michalowski, 2010). I therefore used PCR and Sanger
sequencing to check this region in the five plaques I detected, and confirmed that the
plaques were indeed created by mutants of ɸNM1ind- that harbor additional SNPs
(Figure 3-8). I next tested the marked TB4::ɸNM1ind- lysogens in pairwise competition
assays. For reasons unclear, I was not able to isolate stable transductants of
TB4::ɸNM1ind- harboring the gp5 CRISPR-Cas plasmid. I speculate that, in the absence of
RecA*-stimulated repressor cleavage, the stability of the repression circuit in ɸNM1indmay be more prone to fluctuations that increase transcription of its gp5 (cro-like) ORF.
In lambda, CI represses its own promoter at higher concentrations in a negative
feedback loop (Ptashne, 2011). Therefore, if CI-like repressors accumulate to high
concentrations more readily in the ɸNM1ind- background, they may in turn repress their
own promoter more frequently than in wild type (and thus allow for more frequent
bursts of gp5 transcription). Notwithstanding, when the gp16 and gp43 spacers were
tested with this prophage mutant in competition assays, no reduction in their fitness
costs was observed (Figures 3-5F & G). Taken together, these results demonstrate that
conditionally tolerant type III-A systems can impose spacer-dependent fitness costs
even if their target prophages are not inducible, and thus suggest that the costs arise
from transcription of prophage targets within otherwise stably lysogenic cells.
Supporting this view, I did not find the relative fitness of conditionally tolerant
lysogens at steady state to be correlated with their ability to survive brief MMC
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Figure 3-8. Characterization of five ɸNM1ind- spontaneous induction escapers.
(A) Schematic diagram depicting a relevant genomic region of the ɸNM1ind- prophage
delimited by gp3 and gp7, according to the ɸNM1 annotation (Accession: NC_008583.1).
Green vertical line denotes location of the engineered missense mutation in ɸNM1indthat causes a SerineAlanine substitution at residue 124 of its CI-like repressor gene
product. Dashed line denotes the location of Sanger-sequenced PCR products (1355 bp)
amplified from the five spontaneously induced PFUs using primers oGG31 and oGG33.
Grey bent arrow indicates the position of the inferred Pcro transcriptional start site. (B)
Sequence of the Pcro promoter region in ɸNM1ind-/op*. Whereas the putative Pcro -35 and -10
elements (underlined) are intact, a point mutation (red lettering) was found within a
putative operator binding site that partially overlaps these elements (dashed blue box).
This point mutation appears to diminish the palindromy of this sequence (consult Table
3-2 for the wild type sequence), and was found in 2/5 plaques. (C) Sequence of the first
18 codons in the mutant cI-like repressor gene of ɸNM1ind-/cI*. The TC missense
mutation (red lettering) within codon 17 is expected to produce a SerineProline
substitution. This mutation was found in 3/5 plaques.
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treatments at a subinhibitory concentration (Figure 3-9A). For example, although fitness
costs were undetectable with conditionally tolerant lysogens harboring the gp8 spacer
(Figure 3-9B), they survived MMC treatment worse than conditionally tolerant lysogens
with the gp43 spacer for which a fitness cost was observed (Figure 3-4D). Given that
completion of the lytic cycle is not required for a decline in viability associated with
lambdoid prophage induction (Livny and Friedman, 2004), and that CRISPR-Cas
targeting of induced prophages could potentially occur prior to excision from the

Figure 3-9. Survival of conditionally tolerant lysogens following MMC-stimulated
prophage induction is not a predictor of relative fitness in untreated cultures.
(A) Percent survival of TetR-marked TB4::ɸNM1 lysogens harboring the indicated
conditionally tolerant CRISPR-Cas plasmid or the pGG79 parent vector (C/L+),
following a 45-minute treatment with MMC at a subinhibitory concentration (0.5
μg/ml). Survival of a TetR-marked TB4 non-lysogen harboring the pGG79 parent vector
is also shown (C/L-). (B) Pairwise competition experiments for testing the perfectly
matching gp8 spacer in marked single lysogens of TB4::ɸNM1, performed as described
in Figure 3-3.
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chromosome, it is expected that prophage induction might still have a lethal outcome
even when targeting spacers are present.

3.3

Contributions of type III-A targeting nucleases

Having demonstrated that lysogenic hosts which maintain type III-A systems can incur
spacer-dependent fitness costs, I sought to clarify whether this phenomenon reflects
CRISPR-Cas targeting. To this end, I tested my gp16 spacer with mutations in Cas
nuclease active sites previously implicated in targeting by the S. epidermidis type III-A
system (Figure 3-10A). Mutation of Csm3 (D32A) was previously shown to abolish the
targeting complex’s capacity for specific cleavage of complementary RNAs, while
mutation of Cas10’s palm polymerase domain (D586A,D587A) was shown to abolish
the complex’s capacity for transcription-dependent cleavage of DNA on the nontemplate strand (Samai et al., 2015). Furthermore, mutations in the HEPN domain of
Csm6 (R364A,H369A) were shown to abolish its RNase activity and eliminate its
contributions to phage defense (Jiang et al., 2016). I first assessed the targeting capacity
of mutant CRISPR-Cas plasmids during prophage induction. When csm3, csm6, or both
RNases were mutated, spontaneous release of plaque forming units (PFUs) from
overnight cultures was reduced to a similar degree as wild type, with individual
replicates exhibiting as much as 3.2- to 4-log reductions relative to the average
measured for lysogens harboring the non-targeting parent vector (Figure 3-10B). In

188

Figure 3-10. Effect of targeting nuclease active site mutations on conditional tolerance
and spacer-dependent fitness costs associated with type III-A systems.
(A) Schematic diagram summarizing the arrangement of CRISPR-Cas loci used
throughout the work, with position 2 of the CRISPR array occupied by the gp16 spacer
(purple rectangle) in this example. The naturally occurring nes spacer (white rectangle)
from S. epidermidis RP62a is maintained at position 1 in all cases. ORFs encoding Cas
nucleases implicated in targeting are highlighted in blue with green outline (cas10), red
(csm3), or yellow (csm6), and the positions of their active site mutations are labeled to
scale within each ORF. Other features of the diagram are not drawn to scale. (B)
Quantification of PFU concentrations (PFU / ml) in filtered supernatants from overnight
cultures of TetR-marked TB4::ɸNM1 single lysogens harboring mutant or wild type
CRISPR-Cas plasmids with the gp16 spacer, or the wild type pGG79 parent vector with
non-targeting spacers (C). Horizontal bars indicate the mean value of three biological
replicates, plotted as black dots in each column. (C) High-resolution growth curves of
TetR-marked TB4::ɸNM1 single lysogens harboring the mutant or wild type CRISPRCas plasmids tested in panel ‘B’. Solid lines represent the average attenuance (D600 nm)
measured from three biological replicates with MMC added at the indicated time point
(black arrow), and are colored to match the cas gene ORFs highlighted in panel ‘A’ for
each mutant, or otherwise green for the cas10HD mutant, blue for the cas10DD palm
domain mutant, orange for the csm3*/csm6* double mutant plasmid, purple for the wild
type gp16 plasmid, or black for the non-targeting pGG79 plasmid. For comparison,
average attenuance measured from three biological replicates in the absence of MMC is
plotted for two strains (dashed lines). (D) Pairwise competition experiments with
marked TB4::ɸNM1 single lysogens, performed as described in Figure 3-3, except that
the targeting strain harbored the gp16(csm3*) mutant CRISPR-Cas plasmid. (E) Same as
in ‘D’, except with the gp16(cas10HD) mutant plasmid. (F) Same as in ‘D’, except with the
gp16(cas10DD) palm domain mutant plasmid. (G) Same as in ‘D’, except with the
gp16(csm6*) mutant plasmid. (H) Same as in ‘D’, except with the gp16(csm3*/csm6*)
double mutant plasmid.
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contrast, spontaneously induced PFU were never reduced more than ~1.3 logs among
replicates with the cas10DD mutant, indicating that its targeting is partially impaired.
Similar results were obtained in high-resolution growth curves following treatment
with MMC, where partial lysis could be detected with the cas10DD mutant, but not with
either or both of the RNAses mutated (Figure 3-10C). These results corroborate
previous findings which demonstrated that both the Csm3 and Csm6 RNAse activities
are dispensable for immunity during the lytic cycle when the target falls within an
early-transcribed region of the phage genome such as this (Jiang et al., 2016).
Recent reports on type III systems from other groups have shown that the HD
domain of Cas10 proteins is required for RNA-activated cleavage of ssDNA in vitro
(Elmore et al., 2016; Estrella et al., 2016; Han et al., 2017; Kazlauskiene et al., 2016; Park
et al., 2017), although a requirement for cleavage of the non-template DNA strand in a
transcription-coupled assay has yet to be demonstrated. Moreover, while mutation of
the HD domain was not found to abolish anti-plasmid immunity by the type III-A
system of S. epidermidis RP62a in a pG0400 conjugation assay (Hatoum-Aslan et al.,
2014), the effect of this mutation on type III-A targeting in lysogens has not been
explored. I first tested the cas10HD mutant in prophage induction assays. Interestingly,
while this mutant still appeared to be largely capable of preventing lysis in highresolution growth curves following MMC-stimulated prophage induction, almost no
reduction in spontaneously released PFUs was observed in this background. The reason
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for this discrepancy is currently unclear, but I speculate that the HD domain’s DNase
activity might be required to prevent phage DNA from being packaged efficiently, and
yet not per se required to prevent completion of the lytic cycle. Additional insight could
perhaps be obtained by quantifying the number of PFUs released (or produced
intracellularly) at different time points after induction with MMC in this mutant
background. For example, it’s possible that a residual targeting activity—potentially
derived from one or both of the type III-A system’s RNases—could be delaying lysis
without degrading phage DNA or sufficiently preventing its packaging. I further
speculate that the residual targeting observed in high-resolution growth curves reflects
the same activity or activities that allow for immunity to pG0400 conjugation via the
native nes spacer in this background (Hatoum-Aslan et al., 2014), because the immunity
to pG0400 licensed by this spacer was, incidentally, found to depend on csm6 (HatoumAslan et al., 2014). Testing of double or triple mutants with the HD domain and one or
both RNase functions mutated would likely clarify this point.
I next measured the relative fitness of lysogens harboring mutant CRISPR-Cas
plasmids. The fitness cost associated with the gp16 spacer was not reduced by the csm3*
mutation (Figure 3-10D), and perhaps only slightly reduced by the cas10HD mutation
(Figure 3-10E). Meanwhile, the fitness cost appeared to be completely abolished by the
cas10DD palm domain mutation (Figure 3-10F). Interestingly, both the csm6* and
csm3*/csm6* mutants also displayed a strongly reduced fitness cost (Figures 3-10G &
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H). This finding implies that the RNase activity of Csm6 can contribute to growth
defects associated with chromosomal targeting, although the mechanism for this
remains to be elucidated. An important caveat of these nuclease mutant data is that
isogenic plasmid backbones were not used when measuring relative fitness in the
competition experiments; as such, the observed reduction in gp16-associated fitness
costs could in fact reflect reduced general toxicity associated with expression of the
intact nucleases, rather than reduced targeting at prophage loci. To rule this out, mutant
CRISPR-Cas plasmids with the gp16 spacer should be tested against their respective
non-targeting mutant parent vectors. Notwithstanding, my results suggest that costs
associated with incomplete prophage tolerance by type III-A systems may depend on
the activity of at least one Cas nuclease implicated in transcription-dependent targeting.

3.4

Consequences of conditionally tolerant type III-A systems in polylysogens

Clinical isolates of S. aureus are seldom found to possess CRISPR-Cas systems (Cao et
al., 2016), and in many cases are polylysogens harboring more than one prophage
(Aanensen et al., 2016; Goerke et al., 2009). The clinical isolate S. aureus Newman, for
example, does not harbor an endogenous CRISPR-Cas system but harbors four
heteroimmune lambdoid prophages (Bae et al., 2006). However, among the
staphylococcal type III-A CRISPR-Cas systems which have been identified so far, some
spacers have been found to match conserved temperate phage lytic genes, at least
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partially (Cao et al., 2016; Goldberg et al., 2014). These observations prompted us to
investigate the consequences of maintaining type III-A systems in a polylysogenic
scenario where more than one prophage can be targeted. This was accomplished using
ɸNM1 and ɸNM4, which integrate into distinct chromosomal loci but share regions of
sequence homology, including a perfectly conserved target for the gp16 spacer (Figure
3-11A). Provided that each target sequence falls within lytic gene clusters which are
sufficiently repressed during lysogeny, I anticipated that polylysogeny would be
tolerated even in the presence of perfectly matching spacers. To confirm this,
TB4::ɸNM4 lysogens harboring CRISPR-Cas plasmids with spacers matching to ɸNM1’s
gp5, gp16, or gp43 targets were infected with an erythromycin resistance-conferring
derivative of ɸNM1 (ɸNM1-ErmR2) that allows quantification of newly formed lysogens.
Lysogens with singly (gp5, gp43) and doubly (gp16) targeting spacers tolerated
secondary lysogenization by ɸNM1-ErmR2 at a comparable frequency as control
lysogens harboring a fully mismatched (35 mm) spacer (Figure 3-11B), while plaque
formation on the same hosts was reduced only in the presence of targeting spacers
(Figure 3-11C). However, differences in colony size phenotype were clearly discernible
among the resulting double lysogens (Figure 3-11D). Relative to double lysogens with
the control spacer, double lysogens with the gp5 or gp43 spacers which do not target
ɸNM4 had a less severe colony size reduction than lysogens with the gp16 spacer
targeting both prophages. This trend was likewise observed with unmarked

194

Figure 3-11. Type III-A systems which target multiple temperate phages can impose
greater fitness costs in polylysogenic hosts.
(A) Schematic representation of the integrated ɸNM1 (NC_008583.1) and ɸNM4
(NC_028864.1) prophage genomes. ORFs (thick arrows) were scaled in accordance with
their annotated lengths. Colored ORFs denote the presence of a target sequence for one
or more spacer tested in section 3.4. ɸNM1’s gp16 ORF includes a target that is found
with 100% conservation in gp17 of ɸNM4, as indicated by color-matched ORFs (purple).
(B) Secondary lysogenization of TB4::ɸNM4 with ɸNM1-ErmR2 in the presence of the 35
mm, gp5, gp16, or gp43 CRISPR-Cas plasmids as indicated. The ‘35 mm’ spacer is a fully
mismatched variant of the gp16 spacer that serves as a non-targeting control.
Lysogenization was quantified as the concentration (CFU / ml) of CmR+ErmR CFUs in
each culture following treatment with ɸNM1-ErmR2. For comparison, total recipients
were quantified as the concentration (CFU / ml) of CmR CFUs in each untreated culture.
Error bars, mean ± s.d. (n = 3, biological replicates). (C) Plaquing efficiency of ɸNM1ErmR2 on TB4::ɸNM4 lysogens harboring the different CRISPR-Cas plasmids tested in
panel ‘B’, as indicated by the labels. Dotted line represents the limit of detection under
these assay conditions. Error bars, mean ± s.d. (n = 3, technical replicates). (D) Colony
size comparison of TB4::ɸNM4+ɸNM1-ErmR2 double lysogens harboring the different
CRISPR-Cas plasmids tested in panel ‘B’, as indicated by the labels above. Picture is
representative of a biological replicate for each strain plated in the presence of
chloramphenicol to maintain CRISPR-Cas plasmids. (E) Batch competition experiment
with unmarked TB4::ɸNM1+ɸNM4 double lysogens harboring the different CRISPRCas plasmids tested in panel ‘B’. As outlined in the methods, deep sequencing was used
to determine targeting spacer frequencies relative to the 35 mm non-targeting spacer
within the sample (y-axis), and plotted against the number of transfers (x-axis, one
transfer per day). Dashed lines illustrate the change in relative frequency across time
points, and are color-coded for their targets according to the schematic in panel ‘A’.
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TB4::ɸNM4+ɸNM1 double lysogens when the same CRISPR-Cas plasmids were
introduced via transduction (data not shown). To determine whether these phenotypes
reflect discrepancies in relative fitness, I performed pairwise competition assays with
marked double lysogens harboring either the gp5 spacer, the gp16 spacer, or the gp43ori
spacer. A control co-culture experiment where differentially marked double lysogens
both harbored the same pGG79 parent vector was also performed. Surprisingly, the
TetR-marked double lysogens had an apparent advantage even in control co-cultures
(data not shown). Furthermore, although the double lysogens with the gp16 spacer
indeed declined the most rapidly at the outset, all of the fitness costs were offset, and
the relative abundance of TetR-marked lineages would even increase by the end of the
six-day experiment in cases where sufficient genetic inactivation of the conditionally
tolerant CRISPR-Cas plasmid had presumably occurred (data not shown). I speculate
that the pE194 plasmid is less stable in this doubly lysogenic background, perhaps due
to synergistic or additive effects of harboring both prophages. For example, harboring
both prophages might provide additional opportunities for leaky expression of
prophage terminase proteins that could license off-target cleavage of plasmids. In this
scenario, specific loss of the pE194 plasmid rather than pT181 could be explained by
intrinsic terminase sequence preferences (Chen et al., 2015b). Note, however, that
neither of these prophages were sufficient to license this effect on their own (Figures 34E & 3-12A). In order to circumvent this technical constraint, and also to assess the
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relative fitness of multiple strains in a less cumbersome manner, I mixed unmarked
double lysogens harboring each of the four spacers (35 mm, gp5, gp16, or gp43) into a
single batch and competed them in liquid culture for three days. After each day, and
also at time ‘zero’ before the first transfer, spacer abundances were measured by deep
sequencing, and the frequency of each targeting spacer was calculated relative to the 35
mm spacer’s frequency in the sample. Deep sequencing in a single MiSeq run was
performed on small PCR amplicons spanning the spacer of interest, alongside two
additional series of three-day batch competitions described later in this chapter. This
was enabled by independently barcoding each of the 12 PCR samples, with advice on
barcode design provided by Dr. Modell. Spacer quantification was subsequently
performed with a sequence-matching Python script that I designed to tally reads
containing each of the expected sequences with 100% identity (including their expected
barcode sequences). Troubleshooting of the script was carried out with mini files
containing a subset of the reads (to reduce processing times). I generated these mini
files using another Python script, provided by Phil Nussenzweig and Dr. Varble, which
pulls out a user-specified range of reads. During the troubleshooting process, I also
generated modified scripts for sampling and tallying aberrant reads (including barcode
cross-contaminants that were likely generated during the library preparation steps),
which allowed me to confirm that these reads contributed negligibly to my primary
tallies. Ultimately, a representative dataset was manually compiled and plotted using
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Microsoft Excel. My analysis indicates that the dual-targeting gp16 spacer declined
more rapidly than the spacers targeting only ɸNM1 (Figure 3-11E), and its rate of
decline was more than double that observed in pairwise competitions with either of the
marked TB4::ɸNM1 or TB4::ɸNM4 single lysogens (Figures 3-4C & 3-12B). Importantly,
this was not observed for double lysogens where only ɸNM1 was targeted with the gp5
or gp43 spacers (Figure 3-11E), which declined at rates similar to those observed in their

Figure 3-12. Fitness costs associated with conditional tolerance in marked TB4::ɸNM4
single lysogens harboring the gp16 CRISPR-Cas plasmid.
(A) Pairwise competition experiments for measuring the relative fitness of differentially
marked TB4::ɸNM4 lysogens each harboring the non-targeting pGG79 plasmid,
performed as described in Figure 3-3. (B) Same as in ‘B’, except that the perfectly
matching gp16 spacer was tested, and the solid line shares color coding with the ɸNM4
target ORF indicated in Figure 3-11A. (C) High-resolution growth curves of TetRmarked TB4::ɸNM4 single lysogens harboring either the gp16 or non-targeting pGG79
CRISPR-Cas plasmid. Solid lines represent the average attenuance (D600 nm) measured
from three biological replicates with MMC added at the indicated time point (black
arrow), and are colored to match the target ORFs highlighted in Figure 3-11A, or black
for the non-targeting vector. For comparison, average attenuance measured from three
biological replicates in the absence of MMC is plotted for two strains (dashed lines).
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respective pairwise competitions using marked TB4::ɸNM1 single lysogens (Figures 34B & D and Table 3-1). Thus, in spite of their capacity for conditional tolerance, type
III-A CRISPR-Cas systems can become a greater fitness liability if they target multiple
temperate phages. It should be pointed out, however, that these broadly targeting
systems are expected to confer superior short-term advantages when guarding against
lytic infection by heteroimmune phages.
The results described above confirmed the expectation that conditional tolerance
can operate independently on heteroimmune temperate phages during infection.
However, the effects of targeting in double lysogens, for example during prophage
induction, were not explored. To investigate this, I first measured the number of PFUs
released from unmarked doubly lysogenic cultures four hours post-induction with
MMC, and plated supernatants on lawns of TB4::ɸNM1, TB4::ɸNM4, and TB4, in order
to determine the relative proportion of ɸNM1 and ɸNM4 particles out of the total. For
comparison, PFUs were also measured under these assay conditions from unmarked
single lysogens of TB4::ɸNM1 and TB4::ɸNM4 harboring the non-targeting (35 mm)
CRISPR-Cas plasmid. When double lysogens harboring this non-targeting plasmid are
induced, ɸNM1 makes up the majority of the phage particles recovered (Figure 3-13A).
Such asymmetries have also been observed during induction of E. coli double lysogens
harboring heteroimmune lambdoid prophages, and are likely the result of intracellular
competition (Refardt, 2011). For reasons unclear, ɸNM1 PFUs were specifically depleted
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Figure 3-13. Conditionally tolerant type III-A systems can display prophage targeting
specificity within double lysogens undergoing induction.
(A) Quantification of PFU concentrations (PFU / ml) in filtered supernatants from
subcultures of unmarked TB4::ɸNM1+ɸNM4 double lysogens harboring one of the
CRISPR-Cas plasmids tested in Figure 3-11, four hours post-treatment with MMC at 2.0
μg/ml. For comparison, single lysogens of TB4::ɸNM1 and TB4::ɸNM4 harboring the 35
mm CRISPR-Cas plasmid were also tested under these assay conditions. All lysates
were spotted on TB4 lawns to measure total PFU, as well as TB4::ɸNM1 and TB4::ɸNM4
lawns to measure the fraction of ɸNM4- and ɸNM1-derived PFUs, respectively. Dashed
line represents the limit of detection under these assay conditions. Error bars, mean ±
s.d. (n = 3, biological replicates). (B) High-resolution growth curves of unmarked
TB4::ɸNM1+ɸNM4 double lysogens harboring the gp5, gp16, gp43ori, or 35 mm CRISPRCas plasmids. Solid lines represent the average attenuance (D600 nm) measured from three
biological replicates with MMC added at the indicated time point (black arrow), and are
colored to match the target ORFs highlighted in Figure 3-11A, or black for the nontargeting vector. For comparison, average attenuance measured from three biological
replicates in the absence of MMC is plotted for two strains (dashed lines). (C) Same as
in ‘B’, except that the gp5(csm6*), gp16(csm6*), and gp43ori(csm6*) mutant CRISPR-Cas
plasmids were tested. For comparison, data from experiments with the 35 mm wild
type CRISPR-Cas plasmid are also plotted.
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from the total by approximately one order of magnitude even when both prophages
were targeted with the gp16 spacer. Potentially, ɸNM4 simply fairs better during
induction under the gp16 targeting conditions, but neither prophage was particularly
proliferative; PFU measurements were approaching my limit of detection in these
experiments. Nevertheless, a much more pronounced effect was observed when only
ɸNM1 was targeted with either the gp5 or gp43 spacers: ɸNM1 PFUs were specifically
depleted from the total by about 3 orders of magnitude in each case. The absolute
number of PFUs released during induction was lower with the gp43 spacer than with
the gp5 spacer. This was initially puzzling, but high-resolution monitoring of these
cultures during induction provided some additional insight. Whereas the dualtargeting gp16 spacer prevented lysis, the gp5 and gp43ori spacers did not (Figure 313B)—presumably because ɸNM4 is allowed to complete its lytic cycle when it is not
targeted. However, lysis profiles were more noticeably perturbed by the gp43ori spacer
than by the gp5 spacer. The effect was similarly observed in a triplicate experiment with
unmarked double lysogens harboring the gp43 CRISPR-Cas plasmid (data not shown).
This perturbation—suggestive of a simple delay in ɸNM4-mediated lysis—might
explain why I recovered fewer particles overall with the gp43 spacer, four hours postinduction. Assessing the number of particles released at a later time point could help to
clarify this point. Nevertheless, given that ɸNM1 was specifically depleted to the same
extent by the gp5 spacer without a concomitant strong reduction in total PFUs, the lysis

203

perturbation I observed with gp43ori likely reflects a non-specific effect encountered
during targeting. Given, also, mounting evidence which suggests that the HEPN RNase
domain of type VI effector nucleases—and perhaps other Cas nucleases—can license
off-target effects (Jiang et al., 2016; Shmakov et al., 2017), I tested whether an intact
HEPN domain active site in Csm6 was required for the lysis perturbations in this assay.
Whereas the gp16 spacer still prevented lysis even in the csm6-mutant background
(csm6*), lysis profiles in double lysogens with the gp5(csm6*) and gp43ori(csm6*) CRISPRCas plasmids were essentially indistinguishable from double lysogens with the nontargeting plasmid (Figure 3-13C). Taken together, these results demonstrate that
conditionally tolerant type III-A systems can display prophage targeting specificity
within double lysogens. However, the RNase activity of Csm6 can apparently license
off-target effects during induction, and potentially perturb lysis by another prophage
that is not targeted. Additional insight into the specificity of the type III-A targeting
complex during induction could be provided by measuring PFUs derived from csm6*mutant cultures. For example, it would be interesting to see if the remaining nuclease
activities associated with Cas10 and Csm3 are sufficient to license a specific reduction in
ɸNM1-derived PFUs.
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3.5

Effects of spacer-target mismatches in single and double lysogens

The above results confirmed that type III-A systems which target multiple temperate
phages are not a barrier to polylysogenization per se, even if they possess perfectly
matching spacers. However, natural examples of prophage targets and type III-A
systems with perfectly matching spacers co-existing within staphylococcal isolates have
yet to be reported. Having found that the mismatched gp32 spacer in single lysogens is
associated with a lower fitness cost than its perfectly matched gp32* variant but is still
capable of targeting during the lytic cycle (Figures 3-3 & 3-5), I wondered if spacertarget mismatches could likewise help to stabilize conditionally tolerant systems in
polylysogenic populations. To investigate this, I constructed a series of mismatched
spacers based around the gp16 spacer, which targets an identical sequence found in
both ɸNM1 and ɸNM4. It was previously shown that mismatches most readily abrogate
type III targeting when they’re distributed at both the 5’ and 3’ ends of the spacer (Cao
et al., 2016; Manica et al., 2013). Accordingly, I introduced increasing numbers of
mutations at both ends of the gp16 spacer in an effort to sample a range of targeting
potentials with a minimal number of mismatches (Figure 3-14A). The resulting CRISPRCas plasmids were then transduced into unmarked TB4::ɸNM4+ɸNM1 double lysogens,
as well as unmarked TB4::ɸNM1 single lysogens for comparison. First, I examined the
targeting potential of each spacer in single and double lysogens during MMCstimulated prophage induction. In both cases, PFU induction was reduced to a similar
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Figure 3-14. Effects of spacer-target mismatches in single and double lysogens
harboring type III-A CRISPR-Cas systems with dual-targeting potential.
(A) Sequence summary of the gp16 spacer and its mismatched variants. Black lettering
indicates sequences found in the parental gp16 spacer; red lettering indicates mutated
base pairs. A subset of transversion mutations were used to avoid introducing G:U
pairing when complementarity between the crRNA and transcribed target RNA is
considered. (B) Quantification of PFU concentrations (PFU / ml) in filtered supernatants
from subcultures of single (TB4::ɸNM1) or double (TB4::ɸNM1+ɸNM4) lysogens
harboring the spacers depicted in panel ‘A’, four hours post-treatment with MMC at 1.0
μg/ml. Error bars, mean ± s.d. (n = 3, biological replicates). (C) Batch competition
experiment with unmarked TB4::ɸNM1 single lysogens harboring CRISPR-Cas
plasmids with the perfectly matched gp16 spacer or one of several mismatched
derivatives shown in panel ‘A’. As outlined in the methods, deep sequencing was used
to determine targeting spacer frequencies relative to the 35 mm spacer within the
sample (y-axis), and plotted against the number of transfers (x-axis, one transfer per
day). Dashed lines illustrate the change in relative frequency across time points, and are
color-coded according to the labeled inset. (D) Same as in panel ‘C’, except that
unmarked TB4::ɸNM1+ɸNM4 double lysogens were used in the experiment.
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degree by spacers with 6 or fewer mismatches, while targeting was undetectable with 8
or more mismatches (Figure 3-14B). I next tested each group of single or double
lysogens in batch competition experiments lasting three days. Again, spacer
abundances were measured by deep sequencing at each time point, and the frequency
of each spacer was calculated relative to the 35 mm spacer’s frequency in the sample.
My analysis indicates that the spacers with 4 and 6 mismatches declined less rapidly
than the spacers with 0 or 2 mismatches within their respective populations (Figures 314C & D). Meanwhile, no decline was discernible for the spacers with 8 or more
mismatches in either population, consistent with the complete lack of detectable
targeting by these spacers in the prophage induction assay. Furthermore, I observed a
similar rate of decline for the perfectly matching gp16 spacer across experiments with
marked and unmarked single lysogens (Figures 3-4C & 3-14C), which served to
validate my usage of the method in assessing relative fitness. I also found that the costs
associated with dual-targeting spacers possessing either 4 or 6 mismatches (Figure 314D) were comparable to that of the perfectly matched gp5 spacer targeting only ɸNM1
in double lysogens (Figure 3-11E). Thus, mismatches which alleviate fitness costs may
help to ensure that spacers targeting multiple prophages are not always more
burdensome to their polylysogenic hosts than singly targeting spacers. Moreover, this
feature of type III-A systems might improve the long-term stability of spacers that
guard against lytic infection by a range of heteroimmune phages with partially
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divergent target sequences, given that the 4 and 6 mismatches did not abrogate
targeting outright.

3.6

Discussion points and additional proposed experiments

I report here that S. aureus lysogens which maintain type III-A CRISPR-Cas systems can
incur constitutive fitness costs, despite the genetic stability generally afforded by
conditional tolerance. The costs depend on the presence of certain prophage-targeting
spacers, and likely result from incomplete prophage tolerance by the system’s
transcription-dependent targeting machinery. Several lines of evidence support this
interpretation.
Previously, transcription-dependent chromosomal targeting by the type III-A
system of S. epidermidis RP62a was found to cause severe growth defects (Goldberg et
al., 2014; Jiang et al., 2016), and similar effects have been observed with other types of
CRISPR-Cas systems (Edgar and Qimron, 2010; Jiang et al., 2013b; Vercoe et al., 2013).
At least in part, this appears to result from toxicity associated with frequent nicking or
cleavage of the host’s chromosomal DNA. Minor growth defects, in line with the fitness
costs described in this work, might instead be expected if type III-A chromosomal
targeting were infrequent; e.g., licensed by transcription in a sufficiently small
subpopulation of cells. When lambdoid lysogens are cultured under standard growth
conditions, transcription from lytic promoters can occur in a subpopulation of cells
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undergoing the lytic cycle via spontaneous prophage induction (Nanda et al., 2015). For
SOS-inducible lambdoid phages, the frequency of spontaneous prophage induction in
the population depends almost entirely on the host’s SOS responsiveness (Fuchs et al.,
1999; Little and Michalowski, 2010; Nanda et al., 2015), and this is presumably
unaltered by the presence or absence of conditionally tolerant spacers. Given that
prophage induction leads to lysis in the absence of targeting spacers, the fitness of
conditionally tolerant lysogens would not necessarily be impaired relative to nontargeting lysogens if spontaneous prophage induction events were strictly required for
toxicity. Indeed, even when ɸNM1’s capacity for detectable spontaneous prophage
induction was nearly completely eliminated by mutations in its cI-like repressor
(Figures 3-5A & 3-8), fitness costs were not alleviated (Figures 3-5F & G). This suggests
that the fitness costs might depend instead on leaky transcription of prophage targets
occurring within stably lysogenic cells (Figure 3-5E); in other words, targeting occurring
in a subpopulation of cells that is not undergoing spontaneous prophage induction.
Consistent with a requirement for transcription at prophage target loci, costs associated
with the gp5 spacer were virtually undetectable when the Pcro promoter immediately
upstream of its target was inactivated (Figure 3-4G). Meanwhile, mutation of Pcro did
not eliminate fitness costs associated with spacers that target other prophage loci
(Figures 3-4H & I), despite preventing detectable prophage induction (Figures 3-5A &
C).
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The potential for prophage lytic loci to be de-repressed independently of
spontaneous prophage induction is not unprecedented for lambdoid temperate phages,
and was previously demonstrated using a genetic reporter system (Livny and
Friedman, 2004). In this study, furthermore, the authors detected slight de-repression
above background even when prophages carried a non-inducible cI allele similar to that
of my ɸNM1ind- mutant. Conceivably, leaky transcription arising in this manner may
license the fitness costs I’ve detected. This model could also account for the
discrepancies I observed with spacers matching to different regions of the ɸNM1
prophage in single lysogens (Figure 3-4). For example, different promoters in each
region might produce distinct patterns of leaky transcription within stably lysogenic
cells, even if upregulation of the promoters is normally coordinated by extrinsic
factors—such as the host’s SOS response—within cells undergoing prophage induction.
Moreover, this model could explain why a combined effect of having both ɸNM1 and
ɸNM4 was observed in double lysogens with the dual-targeting gp16 spacer (Figure 311E), even though induction of heteroimmune prophages can be coordinated in
polylysogens by the SOS response (Refardt, 2011). In this scenario, if instances of leaky
transcription in each prophage are poorly correlated within cells that are not
undergoing induction, the combined effect of having both targets might be essentially
additive at the population level. The cost observed with the gp16 spacer in double
lysogens was indeed comparable to the sum of that observed with single lysogens of
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ɸNM1 and ɸNM4 alone (Figures 3-4C & 3-12B). Regarding the potential for
uncorrelated leaky expression from distinct chromosomal loci in bacteria, there is
precedent here as well. It was previously demonstrated that cell-cell variability becomes
elevated under transcriptionally repressed conditions, even when expression from two
loci with identical promoters and identical repressors is compared (Elowitz et al., 2002).
Similar single-cell approaches could be used to clarify whether expression of each
prophage is occasionally uncoupled from one another, and from the host’s SOS
response. The combined effect I observed could also be synergistic, at least in part,
particularly if transcription were found to occur simultaneously at both loci in certain
cells. Cells which are targeted at both loci within a sufficiently small timeframe might
experience more severe toxicity. In this scenario, however, it is assumed that a subset of
the target’s transcription events do not produce lethal outcomes; otherwise, if a single
transcription event at the target site were always sufficient to license lethality, it is
difficult to imagine how synergy would arise. Testing the effects of CRISPR arrays with
more than one prophage-targeting spacer could perhaps help to clarify whether or not
this is the case. I’m proposing, for example, to construct a conditionally tolerant
TB4::ɸNM1 single lysogen with a CRISPR array that has two spacers targeting nearby
sequences within the gp16 ORF. If transcriptional surveillance by the type III-A system
were saturating with a single spacer, we might find that the presence of the
downstream spacer incurs no additional fitness cost. Such a result would imply that all
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of the target’s transcription events lead to lethal outcomes. Expanded CRISPR arrays
could also be used to investigate the effects of targeting at different loci within the same
prophage. For example, if transcription of the gp5 and gp43 loci were poorly
coordinated within single cells of TB4::ɸNM1, we might expect a CRISPR array
possessing both the gp5 and gp43 spacers to license more severe fitness costs (again,
perhaps essentially equal the sum of the gp5- and gp43-associated fitness costs alone).
It is still unclear to me why the fitness cost associated with the gp16 spacer was
reduced in the ɸNM1Pcro- background (Figure 3-4). One interpretation follows that a
weaker downstream promoter which is coordinately transcribed with Pcro in wild type
ɸNM1 could license these residual fitness costs in the absence of Pcro (e.g., if
transcription from Pcro is effectively ‘dominant’ to transcription from this downstream
promoter, and yet not strictly required for it). Based on my RNA-seq and promoterprediction analyses (Figure 3-6 and Table 3-2), one such downstream promoter might
be located within the annotated gp9 ORF. In this scenario, leaky transcriptional readthrough of gp16 from Pcro would explain the higher fitness cost observed in the wild
type ɸNM1 background, and potentially also explain why the gp5 and gp16 fitness costs
were so similar in magnitude. Arguing against this, however, a spacer which targets the
intervening gp8 ORF was not associated with a detectable fitness cost (Figures 3-4A &
3-9B). An alternative interpretation follows that leaky transcription from Pcro terminates
before gp8 in the lysogenic populations, but gives rise to one or more immediate early
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gene products which can partially enhance transcription from a downstream promoter,
such as the putative promoter in gp9. In this scenario, leaky transcription from Pcro and
the downstream promoter is not necessarily well-coordinated, and the similarity
between the fitness costs observed with the gp5 and gp16 spacers in wild type ΦNM1
lysogens is simply fortuitous. Again, testing of a CRISPR-Cas plasmid with multiple
ΦNM1-targeting spacers (e.g., targeting both gp5 and gp16), could potentially prove
insightful, and help to distinguish between these interpretations.
Additional evidence pointing to transcription-dependent chromosomal targeting
as the source of the fitness costs was provided by experiments with mutant type III-A
Cas nucleases. Ablation of csm3’s RNase activity did not reduce fitness costs (Figure 310D). Given its role in specific cleavage of target RNAs by type III systems, this was
perhaps expected (Tamulaitis et al., 2017); knockdown of prophage lytic transcripts
should not be toxic to lysogenic cells per se. Meanwhile, fitness costs appeared to be
completely abolished by mutation of cas10’s palm polymerase domain (Figure 3-10F). In
addition, whereas this cas10DD palm domain mutation strongly impaired targeting with
the gp16 spacer in prophage induction assays, ablation of the csm3 and csm6 RNase
activities did not (Figures 3-10B & C). These data were in line with past reports
indicating that both transcription-dependent DNA degradation and robust immunity to
lytic infections by this system requires an intact palm polymerase domain (Samai et al.,
2015), and that its RNase activities are not required to disrupt the lytic cycle if the
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phage’s target falls within an early-transcribed region, such as gp16 (Jiang et al., 2016).
However, although the cas10DD palm domain mutation was not found to prevent target
RNA cleavage by the type III-A complex in vitro (Samai et al., 2015), the possibility that
this mutation could have pleiotropic effects in vivo has not been ruled out. Perhaps less
expected was the finding that mutation of csm6’s HEPN RNase domain almost
completely eliminated the costs associated with the gp16 spacer (Figures 3-10G & H).
This RNase function is not strictly required to elicit severe growth defects associated
with transcription-dependent chromosomal targeting, or targeting of DNA elements in
general (Jiang et al., 2016). Hence, the nature of Csm6’s contribution to the growth
defects described in this work remains unclear. Of potential relevance here, it was
recently demonstrated that the HEPN RNase domains of RNA-guided type VI effector
nucleases can mediate cleavage of non-target RNAs in trans, or ‘collateral’ RNA
cleavage, upon binding of target RNAs (Shmakov et al., 2017). Furthermore, it was
shown that type VI systems can cause growth defects in the presence of target RNAs,
and this was proposed to result from off-target cleavage of cellular transcripts
(Abudayyeh et al., 2016; Smargon et al., 2017). It’s possible that I’m observing a similar
phenomenon in my experiments (and the results presented in Figure 3-13 would
support this notion), but an analogous mechanism for coupling Csm6’s activity to
transcription-dependent targeting by the type III-A complex has yet to be established.
Current evidence suggests that binding of nascent target transcripts in cis is a pre-
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requisite for both localizing type III complexes to specific DNA elements and for
regulating their DNase activity (Estrella et al., 2016; Goldberg et al., 2014; Kazlauskiene
et al., 2016; Samai et al., 2015). Binding of target RNAs, nascent or otherwise, could
likewise be a pre-requisite for recruitment or regulation of Csm6’s RNase activity, and
this recruitment or regulation would presumably involve biophysical (and/or
biochemical) interactions between Csm6 and the Cas10-Csm complex during targeting
(Jiang et al., 2016). Meanwhile, such interactions—if confirmed—might feed back on in
vivo DNA targeting by the Cas10-Csm complex in a more direct manner. In other
words, the partially Csm6-dependent fitness costs I’m observing might result from
enhanced degradation of chromosomal DNA licensed by Csm6-mediated feedback on
the complex (at least in instances where nascent target RNAs are bound in cis)—rather
than Csm6-dependent collateral RNA degradation effects per se. Arguing against this,
however, I found almost no reduction in the gp16 spacer’s fitness cost upon mutation of
the cas10 HD domain (Figure 3-10E). HD domain mutations are thought to specifically
inactivate the DNase activity of Cas10 proteins (Estrella et al., 2016; Kazlauskiene et al.,
2016). Testing of a cas10HD/csm6* double mutant would confirm whether the residual
fitness costs observed in the csm6* mutant background are due to the HD domain’s
DNase activity (and thus presumably the direct result of chromosomal degradation).
Note that, in each scenario described above, transcription is assumed to be a prerequisite for the Csm6- and Cas10-dependent effects, so that the wild type system
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would still be expected to tolerate sufficiently repressed prophage targets. However,
given the potential for incomplete tolerance of leaky targets, it is tempting to speculate
that further layers of regulation could evolve to fine-tune type III-A targeting nuclease
activities and provide more complete prophage tolerance while still ensuring robust
immunity during lytic infections.
The results presented in this work suggest that, among natural lysogenizationprone lineages of S. aureus (Aanensen et al., 2016; Goerke et al., 2009), enrichment for
certain temperate-phage-targeting spacers could serve as an ad hoc mechanism of
evolutionary fine-tuning for type III-A CRISPR-Cas systems. Different fitness costs were
observed for spacers matching different regions of the ɸNM1 prophage (Figures 3-3, 34, & 3-9B) and fitness costs were potentially more severe in double lysogens if the
spacer targeted both prophages (Figure 3-11E). Presumably, this latter phenomenon
would be particularly relevant in natural environments where encounters with
heteroimmune phages are common. Under these conditions, CRISPR-adapted lineages
could gain a short-term survival advantage over non-adapted lineages (lysogenic or
otherwise) when the population is infected by heteroimmune phages with identical or
partially divergent target sequences. However, as my results illustrate, CRISPR-adapted
cells that become lysogenized or polylysogenized during these subsequent infections
may also incur constitutive fitness costs. In one case, a perfectly matching spacer was
found to license curing of its ɸNM1 prophage target (Figure 3-7). This effectively
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remedied the host’s immunopathology in a manner that did not compromise the
CRISPR-Cas system itself. While a phenomenon such as this could be detrimental in
environments where the host relies on its prophage(s) for beneficial traits, it might
enhance the stability of a CRISPR-Cas system in environments where immunity to lytic
infection conferred by its spacer(s) is sufficient for survival. In contrast, I found that the
other CRISPR-Cas systems with perfectly matching spacers eventually succumbed to
genetic inactivation (data not shown). Finally, the prophage-curing phenomenon could
also promote the stability of a CRISPR-Cas system by preventing the accumulation of
target prophages, which—as I’ve demonstrated (Figures 3-11E & 3-14D)—may further
jeopardize host fitness.
Importantly, costs were found to be reduced in the presence of sufficient spacertarget mismatching, and in certain cases even when the mismatching did not abrogate
immunity during the lytic cycle (Figures 3-3, 3-5A, 3-5B & 3-14). For these reasons, I
speculate that conditionally tolerant lysogens harboring mismatched spacers could be
generally more stable in natural populations than those with perfectly matched spacers.
In line with this possibility, a putative conditionally tolerant isolate of S. aureus was
recently identified, and it contains mismatches in each prophage target relative to a
spacer in its type III-A CRISPR-Cas system (Cao et al., 2016). Type III-A systems have
also been found to display signatures of horizontal acquisition within S. aureus genomes
(Cao et al., 2016; Golding et al., 2010; Kinnevey et al., 2013). Hence, I further speculate
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that the genetic stability afforded by conditional tolerance, and by extension spacertarget mismatches, could facilitate horizontal dissemination of prophage-targeting type
III-A systems throughout natural lysogenic populations. Currently, it is unclear to me
why the type III-A CRISPR-Cas plasmids employed in this work do not undergo
detectable CRISPR adaptation, despite various conditions tested by me and other
members of the lab (data not shown). Once rectified, investigation of type III-A CRISPR
adaptation could be useful in clarifying the extent to which spacer diversity and
incomplete prophage tolerance influence the stability of these systems in temperatephage-infected populations at large.
Lastly, it should be emphasized that additional phenotypic consequences of
conditional tolerance, or of incomplete tolerance, have not been ruled out. For example,
it was previously found that low-grade chromosomal targeting by a type I CRISPR-Cas
system, made possible by certain spacer-target mismatches, is sufficient to trigger a
host-controlled response in Pseudomonas aeruginosa PA14 which prevents biofilm
formation without an overt growth defect (Heussler et al., 2015). This phenotype was
originally identified using a lysogenic derivative where the target was chromosomally
integrated via a prophage, although these mismatches also abolished immunity during
lytic infections (Cady et al., 2012; Cady et al., 2011). It remains to be seen whether
immunopathological ‘costs’ associated with type III-A systems in lysogenic hosts could
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be similarly exploited to provide a phenotype in certain environments, without
necessarily compromising resistance to lytic infections.
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3.7

Tables associated with Chapter 3

Table 3-1. Selection coefficients determined in fitness assays.
(a)

(b)

(c)

Prophage(s)

Spacer

Figure

Mean s

s.d.

Median s

ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1PcroɸNM1PcroɸNM1PcroɸNM1indɸNM1indɸNM1PcroɸNM1PcroɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4
ɸNM4
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1
ɸNM4+ɸNM1

gp32*
gp32 [5 mm]
gp5
gp16
gp43
Parent vector
gp5
gp16
gp43
gp16
gp43
gp32*
gp32*
gp8
gp16 (csm3)
gp16 (cas10HD)
gp16 (cas10DD)
gp16 (csm6)
gp16 (csm3/csm6)
gp5
gp16
gp43
gp16
gp16
gp16
gp16 [2 mm]
gp16 [4 mm]
gp16 [6 mm]
gp16 [8 mm]
gp16 [10 mm]
gp16 [12 mm]
gp16 [14 mm]
gp16 [16 mm]
gp16
gp16 [2 mm]
gp16 [4 mm]
gp16 [6 mm]
gp16 [8 mm]
gp16 [10 mm]
gp16 [12 mm]
gp16 [14 mm]
gp16 [16 mm]

3-3B
3-3C
3-4B
3-4C
3-4D
3-4E
3-4G
3-4H
3-4I
3-5F
3-5G
3-7B
3-7B
3-9B
3-10D
3-10E
3-10F
3-10G
3-10H
3-11E
3-11E
3-11E
3-12A
3-12B
3-14C
3-14C
3-14C
3-14C
3-14C
3-14C
3-14C
3-14C
3-14C
3-14D
3-14D
3-14D
3-14D
3-14D
3-14D
3-14D
3-14D
3-14D

0.1088
0.0522
0.1036
0.0822
0.0327
0.0077
0.0137
0.0531
0.0334
0.1029
0.0356
0.1449
0.1051
0.0045
0.0745
0.0667
0.0055
0.0113
0.0258
0.1059
0.3341
0.0581
-0.0030
0.0868
0.1080
0.0722
0.0115
0.0268
-0.0191
0.0002
0.0038
-0.0206
0.0056
0.2155
0.2090
0.0812
0.0494
-0.0192
-0.0089
0.0201
-0.0212
-0.0145

0.0561 (n = 3)
0.0476 (n = 3)
0.0394 (n = 6)
0.0663 (n = 6)
0.0283 (n = 6)
0.0344 (n = 6)
0.0256 (n = 6)
0.0098 (n = 6)
0.0262 (n = 6)
0.0498 (n = 6)
0.0118 (n = 6)
0.0644 (n = 3)
0.0682 (n = 6)
0.0074 (n = 6)
0.0504 (n = 6)
0.0166 (n = 6)
0.0170 (n = 6)
0.0177 (n = 6)
0.0189 (n = 6)
0.0441 (n = 3)
0.0775 (n = 3)
0.0528 (n = 3)
0.0262 (n = 6)
0.0209 (n = 6)
0.0404 (n = 3)
0.0320 (n = 3)
0.0474 (n = 3)
0.0163 (n = 3)
0.0355 (n = 3)
0.0111 (n = 3)
0.0147 (n = 3)
0.0393 (n = 3)
0.0139 (n = 3)
0.0780 (n = 3)
0.0289 (n = 3)
0.0224 (n = 3)
0.0238 (n = 3)
0.0201 (n = 3)
0.0043 (n = 3)
0.0604 (n = 3)
0.0216 (n = 3)
0.0139 (n = 3)

0.1162
0.0530
0.1062
0.0680
0.0192
0.0005
0.0168
0.0557
0.0373
0.0981
0.0335
0.1117
0.1078
0.0047
0.0844
0.0681
0.0083
0.0088
0.0233
0.1288
0.3396
0.0300
0.0045
0.0919
0.1076
0.0689
0.0198
0.0210
-0.0133
0.0003
0.0110
-0.0122
0.0115
0.1902
0.1949
0.0939
0.0604
-0.0098
-0.0090
-0.0051
-0.0181
-0.0117
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Table 3-1. Selection coefficients determined in fitness assays (continued).
(a) For spacers possessing mismatches relative to their prophage target, the number
of mismatches (mm) is written in brackets. For spacers present in CRISPR-Cas
plasmids with one or more mutant cas genes, the mutated gene is written in
parentheses.
(b) Selection coefficients, ‘s’, determined from the change or average change (where
available) in relative frequency after each transfer interval in fitness assays.
Values were extracted from the equation, dq/dt = –q(1 – q)s, where q is the relative
frequency of the spacer being assayed, and t = 9.97 generations is assumed for
1:1000 dilutions at each transfer interval. Positive selection coefficients (s > 0)
suggest that the spacer is associated with a fitness cost.
(c) Standard deviation.
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Table 3-2. Sequences of putative ɸNM1 promoter elements depicted in Figure 3-6.
Promoter
Pcro
Pssb(1)
Pssb(2)
Prep
Pdut
PterS
Pportal
Pcapsid

(a)

(b)

Sequence (5’-3’)
AAAATAATTACGAAAAATACTTGCAATCGTATTCTAATTACGATATACTTTGATCAGAACTTAA
AGTCACGATCTAAAAGATATTTAACTGTATTCAAAATTTTCATATCTTGTTGAGCTTTTAAGC
TTTCCAAGAAAAACAATTGATTGAATTAGTTACTCGATTAGGTATTAAGTTAAATCTTCCTAG
TTAAATTGTTCTTTGAATTTTTCAAATTCTACTTCTCTTTGATAAATAACTTTATCCACATAA
ACCAACAAGCAATTGTTATAGTGATAGACATAGCTTACAACTTATATTCTATCGACCAACTCA
TGACAGTAAAATGACAGTTTTTGACACCTATAACGAGGTATTATGATAGCGTAAGATATTGA
GAAAAAGAAGTTATACATCATTGAAGAGTATGTTAAACAAGGTATGCTGAATGATGAAATAGC
ACAGCGTAAGGTCGGCAGTATTAGCCGATAAAGAAAAATCGAAATATAATGAACCTCTCTTTTAA

(a) Promoters are named after the nearest encompassing or downstream ORF with a
known or predicted function, according to the ɸNM1 annotation (Accession:
NC_008583.1).
(b) Candidates were selected from among prokaryotic promoters predicted using a
neural network promoter prediction (Reese, 2001) tool available online at:
http://www.fruitfly.org/seq_tools/promoter.html. Published E. coli promoter
consensuses (Shimada et al., 2014; Shultzaberger et al., 2007) were consulted for
additional reference to manually curate the initial hits. Putative -35 and -10
elements are underlined. A putative operator binding site palindrome is
italicized in the Pcro promoter. Putative RinA-interacting direct repeat elements
(Ferrer et al., 2011; Quiles-Puchalt et al., 2013) adjacent to the PterS promoter are
bold-faced.
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Table 3-3. Spacers tested in Chapter 3.
(a)

Spacer
Parent vector
gp5
gp8
gp16
gp32 [5 mm]
gp32*
ori
gp43
gp43
gp16 [35 mm]
gp16 [2 mm]
gp16 [4 mm]
gp16 [6 mm]
gp16 [8 mm]
gp16 [10 mm]
gp16 [12 mm]
gp16 [14 mm]
gp16 [16 mm]

(b)

Sequence (5’-3’)
TGAGACCAGTCTCGGAAGCTCAAAGGTCTC
ATGTCTTAGCAATTCTAAAAGCATCTCTAGGTTTA
TTGCCAGGTTCACTACGTTGAATCATTGCAATCTC
TAGAACAGTCGCGCAGACTGATTTCTTCATAACCT
TTAAATCTTTGATTGCTCTTAGCTCTAGTTATGTAT
GTAAACCTTTGATTGCTCTTAGCTCGAGTTATGTGC
ATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAA
ATTCGTCATCTTCAAGTAATGCCTCTAAATCAATA
GCTCCACTGATATACTCAGTCGGGAGGACGCCAAG
TCGAACAGTCGCGCAGACTGATTTCTTCATAACAT
TCGCACAGTCGCGCAGACTGATTTCTTCATACCAT
TCGCAAAGTCGCGCAGACTGATTTCTTCAGACCAT
TCGCAAATTCGCGCAGACTGATTTCTTAAGACCAT
TCGCAAATTAGCGCAGACTGATTTCGTAAGACCAT
TCGCAAATTAGAGCAGACTGATTGCGTAAGACCAT
TCGCAAATTAGAGAAGACTGAGTGCGTAAGACCAT
TCGCAAATTAGAGAATACTTAGTGCGTAAGACCAT

Plasmid Name
pGG79
pGG126
pGG124
pGG102
pGG122
pGG100
pGG104
pGG165
pGG153
pGG154
pGG155
pGG156
pGG157
pGG158
pGG160
pGG161
pGG162

(a) ‘gp’ numbers correspond to open reading frames with a matching target
sequence in ɸNM1 (Accession: NC_008583.1). Mismatched variants are also
listed, with the number of mismatches (mm) denoted within brackets. Each
spacer is located between repeats 2 and 3 of the CRISPR array. A placeholder
sequence with two opposing BsaI restriction sites is present at this position in the
parent vector.
(b) In order to avoid excessive matching between the 5’ crRNA tag and the target’s
corresponding flanking sequence, which has been shown to abrogate DNA
targeting by the type III-A system (Marraffini and Sontheimer, 2010b; Samai et
al., 2015), spacer-target combinations were selected such that no more than 1 bp
of complementarity was present at flanking sequences in each case.
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Table 3-4. Oligonucleotides used in Chapter 3.
Name Sequence

Primary Purpose

oGG281
oGG282
oGG330
oGG331
oGG332
oGG333
oGG334
oGG335
oGG351
oGG352
oGG385
oGG386
oGG393
oGG394
oGG397
oGG398
oGG435
oGG436
oGG437
oGG438
oGG439
oGG440
oGG441
oGG442
oGG443
oGG444
oGG445
oGG446
oGG447
oGG448
oGG449
oGG450
oGG451
oGG452
oGG461
oGG462
oGG320
oGG321
oGG432
oGG433
L6
L50
PS153
PS154
PS465
PS466
W852
W614
PS565
PS566
oGG457
oGG458
oGG424
oGG425
oGG270
L36
W14
W15
W16
W19
PS566
W125
PS557
PS556
W762
W1169
W1170
JW398
JW399
JW443
JW444
oGG387
oGG388
AV205

Construction of pGG79 control/parent vector
Construction of pGG79 control/parent vector
Construction of pGG100
Construction of pGG100
Construction of pGG102
Construction of pGG102
Construction of pGG104
Construction of pGG104
Construction of pGG115
Construction of pGG115
Construction of pGG122
Construction of pGG122
Construction of pGG124
Construction of pGG124
Construction of pGG126
Construction of pGG126
Construction of pGG153
Construction of pGG153
Construction of pGG154
Construction of pGG154
Construction of pGG155
Construction of pGG155
Construction of pGG156
Construction of pGG156
Construction of pGG157
Construction of pGG157
Construction of pGG158
Construction of pGG158
Construction of pGG160
Construction of pGG160
Construction of pGG161
Construction of pGG161
Construction of pGG162
Construction of pGG162
Construction of pGG165
Construction of pGG165
Construction of pGG91
Construction of pGG91
Construction of pGG152
Construction of pGG152
Type III CRISPR array sequence verification
Type III CRISPR array sequence verification
Construction of pPS95
Construction of pPS95
Construction of pPS95
Construction of pPS95
Construction of other mutant type III plasmids
Construction of other mutant type III plasmids
Construction of pGG99 and pGG89
Construction of pGG99 and pGG89
Construction of pGG167
Construction of pGG167
Construction of pGG139
Construction of pGG139
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Additional type III plasmid sequencing
Construction of pAV71
Construction of pAV71
Construction of pAV71
Construction of pAV71
Construction of pWJ291
Construction of pWJ291
Construction of JW233’s type III plasmid
Construction of JW233’s type III plasmid
Sequencing of the ɸ11γ2 deletion
Sequencing of the ɸ11γ2 deletion
Sequencing of the ɸ11γ2β1 deletion
Sequencing of the ɸ11γ2β1 deletion
Construction of pAV43

GTATCGATCGAGACCTTTGAGCTTCCGAGAC
CCACCCCGAAGAAAAGGGGACGAGAACTAAATCTAACAACACTCTAAAAAATTG
GAACGTAAACCTTTGATTGCTCTTAGCTCGAGTTATGTGCG
CGATCGCACATAACTCGAGCTAAGAGCAATCAAAGGTTTAC
GAACTAGAACAGTCGCGCAGACTGATTTCTTCATAACCTG
CGATCAGGTTATGAAGAAATCAGTCTGCGCGACTGTTCTA
GAACATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAAG
CGATCTTATTGATTTAGAGGCATTACTTGAAGATGACGAAT
GAACCAGGTGCAGTTACACCAATCATCAAACCTTTACCAAG
CGATCTTGGTAAAGGTTTGATGATTGGTGTAACTGCACCTG
GAACTTAAATCTTTGATTGCTCTTAGCTCTAGTTATGTATG
CGATCATACATAACTAGAGCTAAGAGCAATCAAAGATTTAA
GAACTTGCCAGGTTCACTACGTTGAATCATTGCAATCTCG
CGATCGAGATTGCAATGATTCAACGTAGTGAACCTGGCAA
GAACATGTCTTAGCAATTCTAAAAGCATCTCTAGGTTTAG
CGATCTAAACCTAGAGATGCTTTTAGAATTGCTAAGACAT
GAACGCTCCACTGATATACTCAGTCGGGAGGACGCCAAGG
CGATCCTTGGCGTCCTCCCGACTGAGTATATCAGTGGAGC
GAACTCGAACAGTCGCGCAGACTGATTTCTTCATAACATG
CGATCATGTTATGAAGAAATCAGTCTGCGCGACTGTTCGA
GAACTCGCACAGTCGCGCAGACTGATTTCTTCATACCATG
CGATCATGGTATGAAGAAATCAGTCTGCGCGACTGTGCGA
GAACTCGCAAAGTCGCGCAGACTGATTTCTTCAGACCATG
CGATCATGGTCTGAAGAAATCAGTCTGCGCGACTTTGCGA
GAACTCGCAAATTCGCGCAGACTGATTTCTTAAGACCATG
CGATCATGGTCTTAAGAAATCAGTCTGCGCGAATTTGCGA
GAACTCGCAAATTAGCGCAGACTGATTTCGTAAGACCATG
CGATCATGGTCTTACGAAATCAGTCTGCGCTAATTTGCGA
GAACTCGCAAATTAGAGCAGACTGATTGCGTAAGACCATG
CGATCATGGTCTTACGCAATCAGTCTGCTCTAATTTGCGA
GAACTCGCAAATTAGAGAAGACTGAGTGCGTAAGACCATG
CGATCATGGTCTTACGCACTCAGTCTTCTCTAATTTGCGA
GAACTCGCAAATTAGAGAATACTTAGTGCGTAAGACCATG
CGATCATGGTCTTACGCACTAAGTATTCTCTAATTTGCGA
GAACATTCGTCATCTTCAAGTAATGCCTCTAAATCAATAG
CGATCTATTGATTTAGAGGCATTACTTGAAGATGACGAAT
GAACGTTTTGGTCGTAGAGCACACGGTTTAACGACTTAAG
CGATCTTAAGTCGTTAAACCGTGTGCTCTACGACCAAAAC
GAACCCAGTTGCACCACATGCAATATACGATACTAGTTTG
CGATCAAACTAGTATCGTATATTGCATGTGGTGCAACTGG
AAAGGTACCAAATTTAATGCTATTTTCCTTCGC
AAAAGATCTAATAATGTATTTACGCTGGGGC
GGTAAATCAAAACTAACTAACAAATACATTAGTTTCCCACCTCTATCATC
GATGATAGAGGTGGGAAACTAATGTATTTGTTAGTTAGTTTTGATTTACC
GAATCTAGTATGATTGGAGCAATTGCTTCTCCTGTAGTTAGAGATTTGCAAACC
GGTTTGCAAATCTCTAACTACAGGAGAAGCAATTGCTCCAATCATACTAGATTC
CCAACAAACGACTTTTAGTATAACC
GGTTATACTAAAAGTCGTTTGTTGG
GTTAGAGTATTATATTTATCAAATAAGGGAG
CTCCCTTATTTGATAAATATAATACTCTAAC
GAGCACAAATTAAGTATTAAAGAAG
CTTCTTTAATACTTAATTTGTGCTC
CATATTGCCTGATGAAGTGAATAG
CTATTCACTTCATCAGGCAATATG
TAAAATGTGGTTTGACAAACGAAAATTGGATAAAGTGGG
AAAGGTACCTTATTACTACCTAAGATGATAGAGG
ATCAATTTTTGTCCCAATTTTCAG
CAAATTACTGCTATATATTCAGGC
TTAAATTTTATTATGAAGCAGGACG
CTACTTTAATAATTGAAAAAGATGG
CTCCCTTATTTGATAAATATAATACTCTAAC
ATTTAGCGTCTATAGTAAAGGTG
CCATGCACCGATTAAAAATAAAGCGGCACCGCCTGAATATATAGCAG
CTGCTATATATTCAGGCGGTGCCGCTTTATTTTTAATCGGTGCATGG
CAAATCACCTTTACTATAGACGC
CCGATTAAAAATAAAGCTGCACCGCCTGAATATATAGCAGTAATTTG
TATTCAGGCGGTGCAGCTTTATTTTTAATCGGTGCATGGGATG
GAACGTCTCATAATTTGAAATAGTAGCTTTTTTAGTGTT
TTTAAACACTAAAAAAGCTACTATTTCAAATTATGAGAC
CTTTAGGTAACTCATAAGTGAATGGTTG
GCCACTCTGTTAAATCAGTAACTTTG
GTGTTGAACTTGAACAAAGTCAC
TCATCAACTTTTATCCACGAGTC
ATACAAAACCACATACCTATCAACGTGATGAGCTTATTGGGG
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Table 3-4. Oligonucleotides used in Chapter 3 (continued).
AV202
AV203
AV185
AV186
AV204
oGG38
oGG40
oGG297
oGG298
oGG315
oGG316
oGG314
oGG317
oGG192
oGG191
W277
oGG342
oGG343
oGG338
oGG339
oGG340
oGG341
oGG6
oGG7
oGG10
oGG11
JW809
JW810
oGG467
oGG468
oGG469
oGG470
oGG471
oGG472
oGG473
oGG474
W1250
oGG455
W1245
W354
B266
W653
oGG509
oGG510
oGG32
oGG33
oGG475
oGG31

GAAGTATATAAATCATCAGTACAAAGGTTTACGTCCTGTTGAATCTTTG
GATGATTTATATACTTCGGCATACGTAGTCGTTGAGGCAGAGAGTA
CTGTTATGTGGTTATCGATTCCTAGCTTGTATGTCTGCGC
AATCGATAACCACATAACAGTCATAAAAC
ATAGGTATGTGGTTTTGTATTGGAAT
AAGATAAAGAATTTGCTCAAGACG
ACCATTAAAACTCGTCATTCTTTC
GCAAAATTCATATAAACAAATTAAAGAGGGTTATAATGAACG
CCCTCTTTAATTTGTTTATATGAATTTTGCTTATTAACGATTC
AGTGATCGTTAAATTTTAATCAAATATGTTCATAGCTTGATG
CGCATCCGATTGCAGCGATGCAGGTCTTTCTGTTGGC
AACATATTTGATTAAAATTTAACGATCACTCATCATGTTC
GAAAGACCTGCATCGCTGCAATCGGATGCGATTATTG
TCTACTTAATCTGATAAGTGAGC
GAAGCTTTAGCTTTGCAGTGG
CTGTAATAGACATCGTTCGCAG
CATCTTAAAGGAGACATAACAAATG
CCAGCTCTCGCTCACATCTG
CTTGTTCAAATTACTTTCGTCTG
CTTAAAATTATTCGTTGATGCAGG
CCTTGAACTTCCTTGATAATCTG
ATTCTCACGTTACTGAACAGATG
TACCCTAGTTAACGTCTCTTG
GATATCAACTTGTAGTGCATCG
GCTGACTTACAAGAAGGTGGAC
GTTGTAATTGGATTAAATTCAGTC
GTTGTACAAGGGTTACAATTCTTAATGC
CCATCTTCATCAGCTGACATTAGAG
AATAACTCTAATGTCAGCTGATGAAGATGGGTTTACGACCGTTAAAAGCAAATG
AGTTCTGATCAACGTACATCGTAATTAGAATACGATTGCAAG
TTCTAATTACGATGTACGTTGATCAGAACTTAACAAGGAGG
TTGCATTAAGAATTGTAACCCTTGTACAACGAAAACCCTTTAACTTTTGATGTTG
AATAACTCTAATGTCAGCTGATGAAGATGGTTCAACTACATATTTGTAGCCTTC
AATAAACGGAGATGCCATGAATAAAATACTCGCTAACGGTTC
GTATTTTATTCATGGCATCTCCGTTTATTTTTAGTGCTATAC
TTGCATTAAGAATTGTAACCCTTGTACAACGCTTTCAAAAATTCCATAAAAGAAATC
TTCAAAGAGTTGGTAGCTCAGAG
CATACCCATTCTAGGTTCAGTTC
GACAAAAATCACCTTGCGCTAATGCTCTGTTACAGCTGTTAGATTATGAAAGCCGATG
GTTTTTCAAAATCTGCGGTTGCG
TGGAATAATAGTAATATTATACAAAATGGA
ATTTACCGCTATCTTTACAGGTAC
TGGAAAGAAAAATTAGAGAGTTTGGGCGTATCTATGGC
TACGCCCAAACTCTCTAATTTTTCTTTCCAATCATTAGGAATTG
GTATTTTAAGGGTTGCAATTACG
GTATCTGTTTTCAACTACATATTTG
AATAACTCTAATGTCAGCTGATGAAGATGGCGTAGTAAATAGATGTGTAATAAATG
TACCATCAACAGTTAAAGACAATG
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Construction of pAV43
Construction of pAV43
Construction of pAV43
Construction of pAV43
Construction of pAV43
ɸNM4γ4α2 sequence verification
ɸNM4γ4α2 sequence verification
Construction of pE194-tyc1
Construction of pE194-tyc1
Construction of pGG90
Construction of pGG90
Construction of pGG90
Construction of pGG90
ɸNM1-ErmR2 sequence verification
ɸNM1-ErmR2 sequence verification
TB4::ɸ11 attL junction verification
ɸ11-specific amplification
ɸ11-specific amplification
Multiplex PCR for SaPI1tst::tetM
Multiplex PCR for SaPI1tst::tetM
Multiplex PCR for SaPI1tst::tetM
Multiplex PCR for SaPI1tst::tetM
ɸNM1 prophage genotyping
ɸNM1 prophage genotyping
ɸNM4 prophage genotyping
ɸNM4 prophage genotyping
Construction of pGG170 and pGG172
Construction of pGG170 and pGG172
Construction of pGG170
Construction of pGG170
Construction of pGG170
Construction of pGG170
Construction of pGG172
Construction of pGG172
Construction of pGG172
Construction of pGG172
pGG170/pGG172 homology arm sequencing
pGG170 homology arm sequencing
Sequencing of the repA(ts) region
Sequencing of the repA(ts) region
Sequencing of the repA(ts) region
Sequencing of the repA(ts) region
Construction of pGG170ts and pGG172ts
Construction of pGG170ts and pGG172ts
Verification of pGG172ts integrants
Sequencing of GWG7
Sequencing of GWG9
Verification of ɸNM1ind- escaper plaques

3.8

Materials and methods used in Chapter 3

Bacterial strains and growth conditions.
Unless otherwise noted, cultivation of RN4220 (Nair et al., 2011) or TB4 (Bae et al., 2006)
and their derivatives was carried out in sterile 15 or 50 ml conical-bottom Falcon tubes
(Corning) containing DifcoTM TSB liquid media from BD (volume ≤ 14% tube capacity),
or on sterile petri dish plates containing DifcoTM TSA solid media from BD. Media was
supplemented with erythromycin (Erm) at 10 μg/ml or tetracycline (Tet) at 5 μg/ml only
when streaking out single colonies of marked TB4 lysogens containing pE194
(Horinouchi and Weisblum, 1982b) or pT181 (Khan and Novick, 1983) plasmids,
respectively, and during the construction of these strains as needed. When cultivating
TetR strains that harbor the SaPI1tst::tetM element in their chromosome, media was
supplemented with tetracycline at 2.5 μg/ml instead of 5 μg/ml. All media was
supplemented with chloramphenicol (Cm) at 10 μg/ml when cultivating strains with
CRISPR-Cas plasmids. Unless otherwise noted, plates were incubated at 37 °C for 12-18
hours and then stored at 4 °C for up to a week. Overnight liquid cultures were
inoculated from single colonies (biological replicates), grown for 12-16 hours at 37 °C
with shaking, and then stored at 4 °C for 3 hours or less before briefly vortexing and
subculturing at a 1:100 dilution as needed. Where applicable, subcultures were treated
with Mitomycin C (AG Scientific) to a final concentration of either 0.5, 1.0, or 2.0 μg/ml,
as indicated in the figure legends. When the overnight cultures were to be used in
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competition experiments, 24 hours of growth was instead allowed, followed by
immediate vortexing, mixing of aliquots, and passaging at a 1:1000 dilution. When
streaking out lysogens with targeting spacers, aberrantly large colonies were presumed
to have lost conditional tolerance either via genetic inactivation of CRISPR-Cas
plasmids or prophage deletion, and not studied further in this work.

DNA preparation and cloning.
Plasmid DNA of E. coli DH5α was purified from 4-6 ml overnight cultures using
plasmid miniprep reagents from Qiagen, according to the manufacturer’s protocol.
DNA from S. aureus RN4220 or TB4 was purified similarly except that 2 ml overnight
cultures were used, and cells were treated with 10-15 μl lysostaphin (1 mg ml-1) at 37 °C
for 1.5 h immediately after resuspension in P1 buffer. Minipreps were carried out with
either Qiagen or EconoSpin columns. For PCR-based cloning procedures, DNA was
amplified with Phusion polymerase (Thermo) and purified using Qiagen reagents and
EconoSpin columns. When generating amplicons for Sanger sequencing, TopTaq
polymerase (Qiagen) was often used for amplicons smaller than 750 bp, and DNA was
not necessarily purified after the PCRs.
Electrocompetent RN4220 cells (described previously, (Goldberg et al., 2014))
were used for cloning in S. aureus. The pGG79 parent vector is a derivative of pGG3BsaI, (Goldberg et al., 2014) with the BsaI placeholder sequence at position two trimmed
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at its 3’ end by one base pair, and a CRISPR repeat inserted immediately downstream.
This was accomplished by ‘round-the-horn PCR (Moore and Prevelige, 2002) using
primers oGG281/oGG282, followed by blunt ligation. The pGG78 plasmid was
constructed similarly, except that the pGG-BsaI plasmid was used in place of pGG3BsaI to template the PCR. Their CRISPR arrays were sequenced by Sanger as described
previously (Goldberg et al., 2014), and expected plasmid sizes were verified via
analytical digestion during subsequent manipulations. The immune functionality of
pGG79 in S. aureus was later also confirmed by resistance to infection with ɸNM4γ4α2,
a derivative of ɸNM4γ4 (Heler et al., 2015) possessing a target for the nes spacer in
position 1 of its CRISPR array. Except where noted, all other CRISPR-Cas plasmids with
wild type cas genes were constructed via scarless insertion of spacers between CRISPR
repeats 2 and 3 of the parent vector, pGG79. This was accomplished by restriction
digesting the two oppositely oriented BsaI sites and then ligating them with an
annealed oligonucleotide pair possessing compatible overhangs and the desired spacer
sequence (see Supplementary Table 3). CRISPR array modifications were then verified
again as described previously (Goldberg et al., 2014). CRISPR-Cas plasmids with the
gp16 spacer and one or more cas gene mutations were also constructed by the annealed
oligo cloning method in most cases, and checked similarly, except that mutant BsaI
parent vectors were used as backbones for insertion of the spacer. The csm3* (D32A)
mutant vector, pPS95, was constructed via 2-piece Gibson assembly of PCR products
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(Gibson et al., 2009) amplified from pGG79 using primers PS153/PS465 and
PS154/PS466. The csm6* (R364A,H369A) mutant vector, pGG99, as well as the
csm3*/csm6* double mutant vector, pGG89, were also constructed via 2-piece Gibson.
For pGG99, the fragment containing the CRISPR array was amplified from pGG79
using primers W852/PS566, while the rest of the backbone including the csm6*
mutations was amplified from pWJ241 (Jiang et al., 2016) using primers PS565/W614.
The same was done for pGG89, except that pWJ242 (Jiang et al., 2016) was used for
templating the backbone with both csm3* and csm6* mutations. To construct the
pGG164 cas10HD (H14A,D15A) HD domain mutant plasmid harboring the gp16 spacer,
2-piece Gibson was performed with a CRISPR-containing fragment amplified from
pGG141 using primers W852/oGG458, and a backbone fragment amplified from pGG79
using primers oGG457/W614. The pGG167 cas10DD (D586A,D587A) palm domain
mutant plasmid harboring the gp16 spacer was constructed similarly, except that the
CRISPR-containing fragment was amplified from pGG102, and the backbone fragment
was amplified from pGG139. The pGG139 BsaI parent vector contains cas10 mutations
in both the HD (H14A,D15A) and palm polymerase (D586A,D587A) domains, and was
itself constructed via 2-piece Gibson of a fragment amplified from pGG79 with
W852/oGG425 and a fragment amplified from pAV71 using primers oGG424/W614.
Following Gibson assembly of these vectors, the expected plasmid size was confirmed
by restriction digest, and regions of interest were sequenced by Sanger using primers
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listed in Supplementary Table 3 (Gibson assembly junctions, CRISPR arrays, and in
select cases the relevant cas nuclease active sites). The pAV71 vector was constructed via
2-piece Gibson of a fragment containing the HD domain mutation amplified from
pLM546 (Hatoum-Aslan et al., 2014) with W125/PS557, and a fragment containing the
palm domain mutation amplified from pWJ291 with PS556/W762. The pWJ291 vector
was constructed via 2-piece Gibson of fragments amplified from pWJ30β (Goldberg et
al., 2014) using primer pairs W852/W1169 and W1170/W614. In turn, the pGG141
plasmid was constructed by inserting the gp16 spacer into the pGG139 vector via the
oligo cloning method described above. JW233 is a derivative of RN4220 with a type III
CRISPR-Cas plasmid that targets ɸ11’s cI-like repressor gene. This plasmid was
constructed from pGG3-BsaI according to the annealed oligo cloning procedure
described previously (Goldberg et al., 2014), using oligos JW398 and JW399 for insertion
of the spacer. The pAV43 plasmid was constructed by 3-piece Gibson assembly of two
homology fragments amplified from ɸNM4γ4 (AV205/AV202 and AV203/AV185),
along with a backbone fragment amplified from pC194 (AV186/AV204). The pE194-tyc1
plasmid was constructed by 1-piece Gibson assembly of PCR products generated with
primers oGG297/oGG298. The presence of an intact assembly junction, including the 5’
UTR SNP in ermC, was subsequently confirmed by Sanger sequencing with primers
oGG191/W235. The pGG90 plasmid was constructed by 2-piece Gibson assembly of
PCR products; its integrase homology fragment was amplified from ɸNM1 with
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primers oGG315/oGG316, while its backbone fragment including ermC homology was
amplified from pE194-tyc1 using primers oGG314/oGG317. Intact assembly junctions
were verified by PCR and Sanger sequencing with primers W234/W235.
Chemically competent DH5α cells were used for cloning pWJ327-derived vectors
in E. coli, each constructed via 3-piece Gibson assembly of PCR products. The pGG170
plasmid contains homology to ɸNM1 with mutations in the Pcro promoter, while the
pGG172 plasmid contains homology to ɸNM1 with mutations in its cI-like repressor. A
backbone fragment was amplified from pWJ327 using primers JW809/JW810, while the
homology arms were amplified from ɸNM1 using primer pairs oGG467/oGG468 and
oGG469/oGG470 for pGG170, or oGG471-oGG472 and oGG473-oGG474 for pGG172.
The expected size of the resulting plasmids was confirmed by restriction digest, and
homology arm sequences were confirmed by Sanger using primers listed in
Supplementary Table 3 (W1250, oGG455, and oGG469 or W1250, oGG471, and
oGG473). Unexpectedly, the plasmids failed to transform RN4220. PCR and Sanger
sequencing of the region encoding elements required for replication in S. aureus at 28 °C
revealed a SNP within the temperature-sensitive repA gene, resulting in a premature
stop codon. The SNP was corrected in each case to create “pGG170ts” or “pGG172ts”
via 1-piece Gibson of PCR products amplified from pGG170 or pGG172 using primers
oGG509/oGG510, followed by electroporation directly into RN4220 and plating at 28 °C.
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Estimation of phage lysate titers.
As needed, phage lysate titers were estimated according to the procedure described
previously (Goldberg et al., 2014).

Preparation of transducing lysates.
Overnight culture aliquots (100 ul) of RN4220 or TB4 derivatives harboring a plasmid of
interest were infected with ‘clear’ mutant (lytic) derivatives of either ɸNM1, ɸNM2,
ɸNM4, or ɸ11 (MOI ~0.1-10) in HIA soft agar supplemented with CaCl2 at 5mM, and
incubated overnight at 37 °C to produce a lysed lawn. Within 48 hours of storage at 4
°C, soft agar was hydrated with 600 μl fresh HIB, scraped and decanted into a 50 ml
conical-bottom Falcon tube, supplemented with an additional 600 μl fresh HIB, and
then centrifuged at 4303g for 8-10 min. Filtered supernatants containing the phage and
transducing particles were stored in autoclaved 1.5 ml tubes (Eppendorf) at 4 °C. When
the plasmid of interest carried a CRISPR-Cas system, care was taken to lyse its host with
a suitable non-targeted phage, among the following: ɸNM1γ6 (Goldberg et al., 2014),
ɸNM2γ1, ɸNM1γ6α1, ɸNM4γ4 (Heler et al., 2015), or ɸ11γ2β1. Phages not described
previously were procured via CRISPR-assisted editing as outlined below.
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CRISPR-assisted editing of phages.
Recombinant phages were isolated by using type III CRISPR-Cas plasmids to counterselect against different target sequences, essentially as described for the isolation of
CRISPR-escape mutant phages in Chapter 2. The ɸ11γ2β1 phage is a mutant of ɸ11γ2
isolated during infection of lawns harboring the pGG102 plasmid (gp16). After an
additional round of counter-selection with pGG102, the presence of a 357 bp deletion
encompassing the target site was confirmed by PCR and Sanger sequencing with
primers oGG387/oGG388. ɸ11γ2 is a clear mutant of ɸ11 that was isolated during
infection of JW233 lawns harboring a type III plasmid targeting its cI-like repressor
gene. Following plaque re-isolations, a 791 bp deletion was confirmed by PCR and
Sanger sequencing with primers JW443/JW444. The ɸNM1γ6α1 phage is a mutant of
ɸNM1γ6 that was similarly isolated while infecting lawns harboring the pGG100
plasmid (gp32*), although the presence of a target site deletion was not confirmed after
plaque re-isolations. ɸNM2γ1 is a clear mutant of ɸNM2 that was isolated during
infection of lawns harboring the pGG152 type III plasmid targeting its cI-like repressor
gene, although the presence of a target site deletion was not confirmed after plaque reisolations. The original two ɸNM2 γ-series escapers of spacer 2B described in Chapter 2
were never analyzed for plaque phenotypes, and were ultimately discarded. For
homology-directed editing of phages, we used a variation of phage editing methods
described previously (Kiro et al., 2014; Martel and Moineau, 2014). Briefly, phages were
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propagated on hosts containing homology plasmids for recombination with phage
genomes, and the resultant lysates were used to infect soft agar lawns containing a
suitable CRISPR-Cas plasmid that can counter-select against parental genotypes.
Homologies were designed such that recombinant phages would lack a target sequence
for the type III CRISPR-Cas plasmid used in counter-selection. The ɸNM4γ4α2 phage
was created by replacing a 40 bp sequence containing the gp32 spacer’s partially
matched target in ɸNM4γ4 with a perfectly matched target sequence for the nes spacer
(Marraffini and Sontheimer, 2008). ɸNM4γ4 was first propagated on lawns of RN4220
containing the homology plasmid, pAV43, and recombinants were subsequently
selected during infection of lawns containing the pGG12 (Goldberg et al., 2014) CRISPRCas plasmid. After an additional round of counter-selection with pGG12, a single
ɸNM4γ4α2 plaque was isolated, and the presence of its recombinant target was
confirmed by Sanger sequencing of PCR products generated with primers
oGG38/oGG40. The ɸNM1-ErmR2 phage was constructed similarly by first propagating
the ɸNM1-ErmR phage (Goldberg et al., 2014) on lawns containing the pGG90 homology
plasmid, which includes the tyc-1 allele SNP in the 5’ UTR of ermC, and subsequently
selecting for recombinants lacking a nearby 182 bp fragment that encompasses the
target for the pGG91 CRISPR-Cas plasmid. The presence of the recombinant sequences
in ɸNM1-ErmR2 was confirmed by PCR and Sanger sequencing with primers
oGG192/oGG191.
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Transduction.
Subcultures were grown at 37 °C in TSB supplemented with CaCl2 at 5mM for 1 hour 25
minutes (~0.5-1.0 attenuance, D600 nm), and 990 μl aliquots were subsequently mixed with
10 μl of transducing lysate containing the plasmid or SaPI of interest in autoclaved 1.5
ml tubes (Eppendorf). After 15 minutes of growth at 37 °C, infected cultures were
treated with filter-sterilized sodium citrate to a final concentration of 40 mM, and then
pelleted by centrifugation at 16100g for 2 min with refrigeration (4 °C). When
transducing pE194, pT181, or SaPI1tst::tetM, an additional 1 hour 45 minutes of growth
was allowed immediately after treatment with citrate and prior to centrifugation.
Following centrifugation, fresh TSB supplemented with sodium citrate (40 mM) was
used to resuspend and dilute pellets for plating on solid media supplemented with both
sodium citrate at 20 mM and antibiotics to select for the transductants. To avoid
residual free phage, an additional re-streak was performed on solid media in the
presence of citrate (20 mM) and antibiotics to select for the strain’s plasmid(s).

Streak-test (phage-sensitivity) assays.
Throughout cloning and strain construction procedures, or as otherwise needed, clones
were readily checked for sensitivity to a phage of interest according to the streak
method previously performed with ɸNM2 (Goldberg et al., 2014), except that clear
mutants described above were used in place of their parental temperate phages to
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facilitate scoring, and chloramphenicol-supplemented TSA without added CaCl2 was
usually used in place of HIA.

Construction of lysogens and derivative strains.
TB4::ɸNM1-ErmR2 and TB4::ɸ11 single lysogens were obtained by mixing 100 μl of a
TB4 overnight culture with either ɸNM1-ErmR2 or ɸ11 (MOI ~0.1-10) in HIA soft agar
supplemented with CaCl2 at 5mM, incubating overnight at 37 °C, and re-streaking from
the resulting turbid lysate lawns. After an additional re-streak from single colonies
(plates were supplemented with erythromycin in the case of TB4::ɸNM1-ErmR2), a clone
was selected for each and saved. The TB4::ɸ11 single lysogen was verified further via
PCR with primers oGG342 and oGG343 to amplify a specific internal sequence not
present in my other phages, and also via PCR with primers oGG191 and W277 to
amplify across its integrated attL junction. Other TB4::ɸNM1-ErmR2 single lysogens
were obtained by lysogenizing TB4 derivatives harboring CRISPR-Cas plasmids via the
erythromycin selection protocol for lysogenization described in another section below.
TB4::ɸNM1 or TB4::ɸNM4 single lysogens were likewise obtained by mixing 100 μl of a
TB4 overnight culture with either ɸNM1 or ɸNM4 (MOI ~0.1-10) in HIA soft agar
supplemented with CaCl2 at 5mM, incubating overnight at 37 °C, and re-streaking from
the resulting turbid lysate lawns. After an additional re-streak from single colonies, a
clone was selected for each, and immunity groups were confirmed by assaying for
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sensitivity to clear mutants (ɸNM1ɣ6 (Goldberg et al., 2014) or ɸNM4ɣ4 (Heler et al.,
2015)). Both clones were also typed via PCR using ɸNM1- or ɸNM4-specific primer
pairs, oGG6/oGG7 or oGG10/oGG11, respectively. The TB4::ɸNM1+ɸNM4 double
lysogen was constructed and typed similarly, except that an overnight culture of
TB4::ɸNM4 was mixed with ɸNM1 in soft agar to produce the turbid lysate lawn. ɸNM1
prophage mutants were constructed via CRISPR-assisted genome editing as outlined
below. All plasmid-containing derivatives of TB4::ɸNM1, TB4::ɸNM4, or
TB4::ɸNM1+ɸNM4 were subsequently generated via transduction.

CRISPR-assisted genome editing of S. aureus.
Homology-directed allelic exchange coupled with CRISPR-Cas counter selection was
performed essentially as described previously for the pWJ327 allelic replacement
system (Modell et al., 2017), with modifications. pWJ327-derived vectors containing
homology to ɸNM1 and the prophage mutation of interest were used to transform
electrocompetent RN4220 non-lysogens instead of RN4220::ɸ12, and a subsequent
transduction step was used to transfer the plasmids from RN4220 to TB4::ɸNM1.
Transduction was performed with ɸNM4γ4 as described above, except that transducing
lysates were raised and injected at 28 °C, with 2 hours 30 minutes of growth allowed for
the recipient subculture. After isolating putative co-integrants via two consecutive restreaks at 37 °C in the presence of chloramphenicol and verifying them with PCR using
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primers W1250/oGG7 (pGG170ts) or W1250/oGG32 (pGG172ts), clones were inoculated
overnight in plain media at 37 °C instead of 28 °C. Subcultures were grown at 28 °C in
plain media supplemented with CaCl2 at 5mM to obtain logarithmic-phase cultures for
treatment with the pWJ326 phagemid, but treated cultures were plated at 30 °C on
media containing erythromycin after 3 hours of growth at 30 °C rather than 1 hour. An
additional re-streak at 30 °C was performed in the presence of erythromycin before
clones were checked by PCR and Sanger sequencing with primers oGG455/oGG470
(pGG170ts) or oGG471/oGG474 (pGG172ts) for the presence of the desired mutation
(ɸNM1Pcro or ɸNM1ind-, respectively). Clones which had also lost the integrated pWJ327
amplicon (again determined by PCR with primers W1250/oGG7 or W1250/oGG32) were
inoculated overnight in plain media but grown at 42 °C instead of 37 °C in order to cure
the strain of pWJ326. Dilutions were plated on plain media at 37 °C, and single colonies
were replica-plated at 37 °C on both plain and erythromycin-supplemented media to
confirm plasmid loss. After re-streaking an erythromycin-sensitive clone on plain
media, a PCR amplicon spanning the entire homology region was procured with
primers oGG33/oGG7 (pGG170ts) or oGG475/oGG32 (pGG172ts), and sequenced by
Sanger using additional primers listed in Supplementary Table 3. The clone was also restreaked on media supplemented with chloramphenicol as a final check for sensitivity
to the antibiotic; and, checked for sensitivity to ɸNM1γ6 to ensure that lysogenic
immunity had not been lost. The pGG170ts- and pGG172ts-derived strains were
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renamed GWG7 and GWG9, respectively. TSB and TSA media were used in place of
BHI throughout. The pWJ326 phagemid lysate used in this work was procured using
the method described previously (Modell et al., 2017).

Enumeration of plaque-forming units liberated from lysogenic cultures.
‘Spontaneous’ particle release from single lysogens was measured essentially as
described previously (Goldberg et al., 2014), except that filtered supernatants were
collected immediately after 12 hours of growth overnight (or as otherwise noted in the
figure legend). For quantification of particles released from MMC-induced cultures,
overnight cultures were grown for 15 hours and subcultures were grown for 1 hour 15
minutes (~0.3-0.6 attenuance, D600 nm) before treatment with MMC (or as otherwise noted
in the figure legend). Following 4 hours of growth post-treatment, subcultures were
pelleted by centrifugation at 4303g for 6 min, and filtered supernatants were collected
for serial dilution and spotting on lawns of TB4 harboring the CRISPR-Cas parent
vector. Where applicable, filtered supernatants derived from double lysogens were
spotted in parallel on TB4::ɸNM4 and TB4::ɸNM1 lawns harboring the CRISPR-Cas
parent vector in order to quantify the fraction of PFU derived from ɸNM1 or ɸNM4,
respectively.
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Plate reader high-resolution growth curves.
Biological replicates were subcultured as described above, except that 200ul culture
volumes were used in 96-well microplates, and incubation at 37 °C with shaking was
performed with an Infinite M200 PRO plate reader (TECAN) measuring attenuance
(D600 nm) every 10 minutes. Following 70 minutes of growth, subcultures were treated
with MMC to a final concentration of 2.0 μg/ml. For each biological replicate, an
additional subculture was performed in parallel to monitor growth in the absence of
MMC treatment.

Pairwise competition assays with marked lysogens.
Aliquots of overnight cultures were mixed 1:1 by volume and then diluted for
passaging and selective plating on tetracycline (5 μg/ml) and chloramphenicol or
erythromycin (5 μg/ml) and chloramphenicol. Passaging and plating was repeated in
this manner every 24 hours for 6 days, and relative frequencies were calculated at each
interval as the number of TetR+CmR colony forming units (CFU) divided by the sum of
ErmR+CmR CFU plus TetR+CmR CFU.

Batch competition of unmarked lysogens for deep sequencing.
Aliquots of overnight cultures were mixed in equal proportions by volume and then
diluted for passaging as described above. The remaining culture (~2 ml) was pelleted by
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centrifugation at 4303g for 6 min. Supernatants were discarded, and pellets were stored
at -20 °C after drying for 10 min at benchtop. Passaging and storage of pellets was
repeated in this manner every 24 hours for 3 days.

Preparation of DNA for deep sequencing.
Frozen pellets were thawed on ice for 20 minutes and then miniprepped as described
above. 100 ng of miniprepped DNA from each sample was used as the template for
barcoded PCRs to amplify a region of the CRISPR array that fully spans spacer position
2, using forward and reverse primers with identical barcode pairs. Barcoded PCR
products were gel purified and then pooled at roughly equal proportions by
normalizing to the least-concentrated NanoDrop Spectrophotometer (Thermo) reading.
Library preparation was subsequently carried out on the pooled sample using a TruSeq
Nano DNA LT kit (Illumina).

Deep sequencing and analysis.
Single-read deep sequencing (321 cycles) was performed on an Illumina MiSeq
essentially as described in the manufacturer’s protocol for low-complexity amplicon
sequencing with the v3 reagent kit (~25% PhiX spike-in). Using a custom Python script,
output files (.fastq) were parsed using the Biopython package for Python, and reads
containing the expected sequences with 100% identity (either forward or reverse) were
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tallied for each barcode set. Relative frequency datapoints are plotted as the number of
reads containing a particular barcode and the perfect or partially matching spacer of
interest divided by the sum of that count plus reads containing the fully mismatched
spacer with the same barcode.

Efficiency of plaquing.
Assays were performed as described previously (Goldberg et al., 2014), except that the
sensitive control lawns were prepared with a TB4 derivative harboring the pGG79 (nontargeting) parent vector.

Lysogenization with ermC(tyc-1)-marked ɸNM1.
Lysogenization was performed essentially as described previously (Goldberg et al.,
2014), except that overnight cultures were always grown for 14 hours, TSB broth was
used in place of HIB, multiplicity of infection was ~1, and incubation times were
reduced to 10 minutes on ice and 20 minutes at 37 °C. Following the 20 minute
incubation, cultures were supplemented and plated with citrate as described for the
transduction protocol above, except that chloramphenicol was maintained in all media
and plates were also supplemented with erythromycin (5 μg/ml) to quantify acquisition
of the marked prophage. The ɸNM1-ErmR2 phage used for infections is a derivative of
ɸNM1-ErmR (ref. (Goldberg et al., 2014)) with a modified ermC 5’ UTR that includes the
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SNP found in the tyc-1 allele previously reported (Gryczan et al., 1980) to improve
constitutive expression of the cassette’s gene product in B. subtilis. To estimate the
concentration of total recipients harboring CRISPR-Cas systems, serial dilutions of the
untreated overnight cultures were plated in the presence of chloramphenicol alone.

Mitomycin C survival assays.
Overnight cultures were grown for 14 hours and then subcultured for 1 hour 15
minutes (~0.3-0.6 attenuance, D600 nm). Subcultures were split into an untreated or treated
tube where MMC was added to a final concentration of 0.5 μg/ml. After an additional
45 minutes of growth, treated and untreated cultures were vortexed, diluted, and plated
to quantify CFUs.
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CHAPTER 4: PERSPECTIVES ON TOLERANCE TO FOREIGN ELEMENTS
THROUGH THE LENS OF PROKARYOTIC IMMUNE SYSTEMS

Although an organism may be defined by its genomic content in a strict genetic sense,
the classical evolutionary definition is concerned most with its phenotype (Doolittle and
Sapienza, 1980). The descriptive power of a genome sequence is therefore limited, in
part, to the extent that phenotypes can vary independently of a particular genotype.
Presumably, phenotypic variability can more predictably be accounted for, given a
better understanding of how multicellular organisms are shaped by environmental
factors, including the microbiota that colonizes them (Amaral et al., 2008; Backhed et al.,
2004; Li et al., 2008; Rakoff-Nahoum et al., 2004; Stappenbeck et al., 2002). Collectively,
the genetic repertoire of a multicellular organism, along with the microbiomes of its
resident microbiota, can be conceptualized as a metagenome. Hence, there is increasing
effort to define metagenomic information, such as microbiomes, that could be correlated
with organismal phenotypes (Bruls and Weissenbach, 2011).
Similar in a sense to how microbiome analyses have uncovered substantial
metagenomic variation among multicellular organisms within a species, comparative
genome analyses of prokaryotes have revealed a surprising degree of genomic
variability among related strains that were traditionally classified as members of the
same species (Murray et al., 2001; Tettelin et al., 2005). Accordingly, a modern view of
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prokaryotic genomes has emerged that distinguishes ‘core’ genome sequences, which
are common to most or all strains of a particular group, from the ‘accessory’ genome
sequences, which are not universally sampled (Lan and Reeves, 2000; Mira et al., 2010).
Accessory sequences typically comprise no more than 10–20% of a given genome
(Makarova et al., 2014), but their gene diversity across strains can be substantially
greater than that observed for core sequences (Koonin and Wolf, 2008). Furthermore, it
has been found that prophages, plasmids and various predicted MGEs are usually
associated with accessory rather than core sequences of the genome (Cortez et al., 2009;
den Bakker et al., 2013; Di Nocera et al., 2011; Lindsay and Holden, 2006; Ozer et al.,
2014). Thus, by analogy to mammal-associated microbiomes, the accessory genomes of
prokaryotes may represent a transient repository for horizontally derived foreign
genetic information that can contribute to adaptability. However, as both microbiomes
and prokaryotic accessory genomes are also liable to harbor parasitic elements, the host
organism may employ its selective defenses to keep these elements in check while
participating in symbiotic interactions or HGT. In turn, the flux of genetic information
in prokaryotic genomes can be selectively moderated by both CRISPR–Cas and R–M
systems through their influence on MGEs and accessory genomic content encountered
via HGT. Although the selectivity of these systems is tied to their resistance
mechanisms, it can be reinforced by tolerance in certain contexts, as I explain below.
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4.1

CRISPR-Cas

As outlined in Chapter 1, a CRISPR–Cas system resists diverse MGEs according to its
spacer content, and this can have evolutionary consequences for lineages that acquire
different spacers. For example, cells that acquire immunity to parasitic elements can
gain a selective advantage (Barrangou et al., 2007), whereas those that target favorable
or ‘self’ elements can be put at a disadvantage and potentially be lost from the
population (Bikard et al., 2014; Bikard et al., 2012; Jiang et al., 2013b; Marraffini and
Sontheimer, 2008). However, just as the risk imposed by particular microorganisms can
be niche- or context-dependent within a mammalian host (Hube, 2004; Stecher et al.,
2007; von Eiff et al., 2001), the fitness contributions associated with a particular MGE are
not always clear-cut in the prokaryotic domain. Temperate phages are a prime example
(Figure 1-5). Although toxic during lytic infections, they can be maintained as
prophages in an alternative, lysogenic state that does not necessarily reduce their host’s
fitness and can even be advantageous (Brüssow et al., 2004; Dykhuizen et al., 1978;
Edlin et al., 1977). Notwithstanding, indiscriminate CRISPR–Cas targeting of temperate
phage DNA compromises the stability of the lysogenic state in addition to preventing
lytic infection (Edgar and Qimron, 2010; Goldberg et al., 2014). This is because the
transition between the two states does not involve genetic alteration of the phage DNA
sequence (Lwoff, 1953) but instead results from changes in its transcriptional activity
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within the host; in fact, most of a lambdoid prophage’s genes are typically repressed
during lysogeny (Ptashne, 2011).
These properties of lambdoid temperate phages, it would appear, allow a
staphylococcal type III CRISPR–Cas system to distinguish between each of their
infection states (that is, lytic versus lysogenic) via transcription-dependent targeting
(Goldberg et al., 2014). Type III CRISPR–Cas systems only initiate an immune response

Figure 4-1. Schematic diagram summarizing selectivity associated with conditional
tolerance by type III CRISPR-Cas systems.
(A) Transcription-dependent targeting by type III CRISPR-Cas systems is only directed
at DNA elements with actively transcribed target sequences. In this example, type III
targeting licenses conditional tolerance of a lambdoid temperate phage. During the
phage’s lytic cycle, when most of its genome is transcribed, type III targeting occurs
readily. During its lysogenic cycle, most prophage sequences are repressed in the host
chromosome, and the prophage DNA may be spared from type III targeting.
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when their target sequences are transcribed (Figure 4-1). As such, they can tolerate nontranscribed prophage targets during lysogeny without withdrawing resistance to lytic
infection by the same phage. Tolerance, at least for temperate phages, may thus be
achieved in a context-dependent, conditional manner, as it is for microbiota in the gut of
a healthy mammal (Belkaid and Hand, 2014). This prokaryotic phenomenon could be
further viewed as a ‘disease tolerance’ paradigm (Gozzelino et al., 2012; Medzhitov et
al., 2012; Soares et al., 2014), insofar as it averts the ‘immunopathology’ associated with
targeting of prophages in the host chromosome without elimination of the target
element. Alternative strategies for disease tolerance, aimed at neutralizing parasitederived toxins (Playfair et al., 1990; Schofield et al., 2002) rather than the parasites
themselves, might also exist in the prokaryotic domain. Past and recent work have
demonstrated that type III CRISPR–Cas systems can cleave RNA targets both in vitro
(Hale et al., 2009; Jiang et al., 2016; Samai et al., 2015; Staals et al., 2014; Tamulaitis et al.,
2014; Zhang et al., 2012) and in vivo (Hale et al., 2012; Jiang et al., 2016; Samai et al., 2015;
Tamulaitis et al., 2014; Zebec et al., 2014) and thus offer the potential to reduce the
toxicity associated with certain viral transcripts. It is currently unclear whether DNA
degradation can be uncoupled from RNA cleavage during canonical type III targeting
circumstances. If this were found to occur, however, cleavage of RNA in the absence of
DNA degradation could potentially represent another avenue for tolerating certain
types of MGEs. To this end, the potential of the recently discovered type VI systems
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might also be explored, since they do not possess any known DNase activities
(Shmakov et al., 2017).

4.2

Restriction-Modification

In certain contexts, R–M systems can also tolerate the insertion of foreign DNA into the
chromosome. Owing to their intracellular, double-strand cleavage mechanism, REases
do not eliminate the DNA of unmodified target elements per se. In fact, it has been
shown that fragments of restriction-sensitive DNA encountered through transduction
or conjugation can be rescued by recombination with the chromosome (McKane and
Milkman, 1995; Milkman et al., 1999; Wood, 1966). This was proposed to contribute to
the genomic mosaicism observed among natural isolates of Escherichia coli (Milkman
and Bridges, 1993). Furthermore, evidence indicates that R–M systems are ineffective at
blocking natural transformation with otherwise restriction-sensitive DNA, at least when
homologous sequences are introduced (Bron et al., 1980; Cohan et al., 1991; HarrisWarrick and Lederberg, 1978; Lacks and Springhorn, 1984; Trautner et al., 1974). These
results have been explained in light of the findings that DNA enters the cell through a
single-stranded intermediate during natural transformation (Lacks, 1962; Piechowska
and Fox, 1971), which remains stable (Eisenstadt et al., 1975; Morrison and Mannarelli,
1979; Mortier-Barriere et al., 2007) before recombination with a methylated
complementary strand (Figure 4-2). Interestingly, an R–M system in Streptococcus
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pneumoniae was found to encode an auxiliary MTase that is upregulated during
competence and allows even non-homologous sequences to be protected from
restriction during natural transformation (Cerritelli et al., 1989; Johnston et al., 2013a).
Known as modification methylase DpnIIB (encoded by dpnA), this MTase

Figure 4-2. Schematic diagram summarizing the selective resistance and tolerance
activities associated with Restriction-Modification.
(A) Intracellular restriction endonuclease enzymes (REases) can recognize and
inactivate double-stranded DNA (dsDNA) of unmodified phages and other mobile
genetic elements but do not recognize single-stranded DNA (ssDNA) intermediates of
natural transformation. Successful homologous recombination may result from pairing
of unmethylated (red) ssDNA with a methylated (red & blue) homologous sequence in
the host chromosome, which promotes rapid modification and tolerance of the newly
incorporated strand. The red ‘x’ represents arbitrary degradation of a donor DNA
strand upon uptake of dsDNA during natural transformation.
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preferentially methylates single-stranded DNA and may thus promote natural
transformation without compromising the ability of the system to resist phages that
enter double stranded. In its absence, replication of non-homologous, unmethylated
single-stranded DNA that has integrated into the chromosome can give rise to
unmethylated double-stranded DNA that is susceptible to the REase (Johnston et al.,
2013b). Hence, I’m suggesting that the specialized action of DpnIIB exemplifies another
disease tolerance strategy in that it is only required to protect the chromosome from
immunopathological damage when foreign, non-homologous sequences are
introduced. Non-homologous fragments of DNA that are introduced through phage
transduction might also be processed to single strands before recombination. The effect
of DpnIIB on transduction efficiency from an unmodified donor should therefore be
examined in future work. Finally, it should be emphasized that the tolerance scenario
observed with DpnIIB closely mirrors that observed with the type III CRISPR–Cas
system, in which a substantial stretch of non-homologous DNA—the prophage—is
allowed to integrate into the chromosome.

4.3

General implications and concluding remarks

Surveillance by both R–M and CRISPR–Cas systems can be optimized for selective
incorporation of foreign genetic information in a manner that reduces the risks of
parasitism and immunopathology. This is similar to the pattern observed for
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multicellular organisms, in which an optimal balance of resistance and tolerance must
be struck to accommodate commensal microbiota without succumbing to infection or
compromising health (Ayres and Schneider, 2012). Mammalian strategies for pathogen
resistance have been studied extensively in the field of immunology. Meanwhile, host
strategies for tolerance of non-self elements, especially as an alternative or, at least,
auxiliary immune function with respect to resistance, have been far less explored in
animal models (Ayres and Schneider, 2012; Howick and Lazzaro, 2014; Raberg et al.,
2009). Efforts to understand tolerance mechanisms hold the promise of revitalizing our
grasp on clinical problems, in which vaccination, antibiotics and other therapeutic
interventions aimed at bolstering resistance have fallen short. Alternative therapeutic
approaches could be aimed at exploiting or reinforcing tolerance (Soares et al., 2014). Of
particular relevance to this discussion, it has been postulated that tolerance strategies
can lead to more stable (or at least more homogeneous) evolutionary outcomes(Miller et
al., 2006; Roy and Kirchner, 2000; Schafer, 1971) that are distinct from the arms race
dynamics that typically result from resistance to pathogens (for further discussion of the
latter, see (Brockhurst and Koskella, 2013)). The outcomes observed for CRISPR–Cas
targeting of temperate phages in prokaryotes are ostensibly consistent with this notion,
as tolerance during lysogeny does not lead to genetic alteration of either the host or its
target prophage. In the absence of tolerance, lysogenization was less frequent and only
occurred in genetic mutants that had either lost their prophage target sequence or
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dismantled their CRISPR–Cas immunity (Goldberg et al., 2014). This latter propensity to
abandon CRISPR–Cas immunity (Bikard et al., 2012; Jiang et al., 2013b; Vercoe et al.,
2013; Yosef et al., 2011) might in part explain the absence of these systems in about half
of sequenced bacteria, especially considering that mechanisms for non-self tolerance
have yet to be identified for most of the CRISPR–Cas types. In these cases, other
mechanisms that allow for phage defense and resistance to MGEs could be helping
these bacteria to survive without CRISPR-Cas systems (Labrie et al., 2010; Ram et al.,
2014). Another point to consider is that the abundance of CRISPR-Cas systems within a
population could also be diminished by fitness costs associated with CRISPR-Cas
immunopathology, even if the systems are intrinsically capable of tolerance. This point
was expressly demonstrated in Chapter 3 for type III-A CRISPR-Cas systems in
lysogenic populations of S. aureus. Chapter 3 also established that type III-A systems
which provide broad-spectrum immunity to diverse temperate phages can put their
host at a greater risk of immunopathology in the event of (poly)lysogenization. At least
in part, however, this increased risk was found to be alleviated by the presence of
spacer-target mismatches that are expected to occur in natural populations. Analogous
immunopathological complications faced by mammalian lineages are dealt with
through well-conserved central and peripheral tolerance mechanisms. The latter
tolerance mechanisms appear to be particularly crucial during encounters with
innocuous non-self elements, including food-derived products and commensal
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microorganisms that are highly abundant in the gut (Pabst and Mowat, 2012). Insofar as
tolerance strategies can work to curb — or even replace — resistance strategies that
would otherwise reduce a particular microbial burden, tolerance may, in turn, influence
microbiome compositions and stability. Therefore, in addition to leading us towards
novel therapeutics for dealing with the complications of infection and
immunopathology (Soares et al., 2014), knowledge of tolerance mechanisms that fulfil
these criteria could prove insightful when attempting to develop clinical interventions
aimed at manipulating specific members of the commensal microbiota.
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